data_1ark_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ark _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' HG21 ' A' ' 5' ' ' ILE . 5.7 mtmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.022 0.439 . . . . 1.0 110.054 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 54.91 169.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.61 . . . . 1.0 110.268 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 7.2 m-85 -142.28 -166.01 2.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 1.0 110.036 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -169.1 142.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.467 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . . . -91.69 163.15 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 1.0 110.038 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 37.1 mtm -136.72 7.08 2.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 1.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' MET . 45.0 m-85 -144.95 167.06 23.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.993 -1.067 . . . . 1.0 110.345 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 29.3 t0 -95.54 73.89 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 1.0 109.633 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -61.85 148.04 44.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 1.0 110.797 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 ttp -115.79 107.2 14.75 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.446 -0.784 . . . . 1.0 109.029 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.66 130.72 17.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 110.652 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.97 -32.3 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 1.0 109.754 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.69 -155.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 1.0 109.721 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.41 18.84 5.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.971 . . . . 1.0 110.202 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -105.9 -22.44 12.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 1.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE2' ' CZ3' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -103.35 -168.62 1.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.039 -1.038 . . . . 1.0 109.867 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.454 ' CG2' ' HG ' ' A' ' 52' ' ' LEU . 27.8 m -131.36 169.36 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.684 . . . . 1.0 109.727 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -121.48 75.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 1.0 110.644 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 9.2 p90 -93.68 148.94 21.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 1.0 109.783 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -111.24 169.66 8.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.069 -1.019 . . . . 1.0 110.721 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -65.25 122.89 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 1.0 110.13 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.7 -24.35 13.49 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.61 154.75 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -1.11 . . . . 1.0 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.96 160.49 16.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 1.0 110.328 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 29' ' ' ILE . 41.4 mt -147.7 170.18 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.825 . . . . 1.0 109.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -106.62 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.159 -0.963 . . . . 1.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.442 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 11.8 t-20 -169.03 79.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.401 -1.437 . . . . 1.0 110.529 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.7 -25.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.184 -0.948 . . . . 1.0 110.067 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.55 179.22 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 1.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.22 103.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 1.0 110.37 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -80.42 -19.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 1.0 110.225 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER 59.99 155.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 1.0 110.538 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' ASP . 19.5 pt-20 38.28 38.85 0.24 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.225 0.536 . . . . 1.0 111.581 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' C ' ' CD1' ' A' ' 38' ' ' TRP . . . -174.37 -82.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.883 -1.287 . . . . 1.0 109.883 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.504 ' CZ3' ' OE2' ' A' ' 19' ' ' GLU . 26.2 m95 -141.63 177.39 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.293 . . . . 1.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mmt -130.9 -166.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 1.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.82 125.64 2.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 1.0 110.098 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.3 37.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.4 m -101.81 117.09 34.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 1.0 110.155 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.84 107.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 1.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -14.76 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.0 110.474 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -73.59 -24.7 60.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.079 -1.013 . . . . 1.0 110.373 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -140.05 -47.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 1.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.74 7.45 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.73 141.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.317 . . . . 1.0 110.221 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -109.87 129.27 55.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 1.0 110.078 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.401 ' CA ' HG12 ' A' ' 20' ' ' VAL . . . -159.41 -164.85 15.31 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.892 -1.283 . . . . 1.0 109.892 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.447 ' CG ' ' HB3' ' A' ' 38' ' ' TRP . 7.2 tpp -95.07 157.74 15.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -1.005 . . . . 1.0 110.847 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 4.0 mp -137.46 141.87 35.2 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.485 -0.759 . . . . 1.0 109.965 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 44.2 Cg_endo -73.63 120.74 6.61 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.552 1.29 . . . . 1.0 110.327 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.14 -19.78 55.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.241 -0.912 . . . . 1.0 110.848 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.71 4.4 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 1.0 110.73 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 11.6 m-85 -117.56 -62.01 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.05 -1.031 . . . . 1.0 110.07 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -78.96 160.73 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' OE2' ' CE ' ' A' ' 9' ' ' MET . 16.5 mt-10 -149.36 179.53 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 1.0 109.983 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.69 171.88 8.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.932 . . . . 1.0 110.325 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.123 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mttt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.238 0.542 . . . . 1.0 110.062 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 mt -107.84 131.87 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 1.0 109.637 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.34 -178.74 3.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 1.0 110.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.59 144.76 19.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 1.0 110.309 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.76 163.72 22.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.318 -0.864 . . . . 1.0 110.114 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.427 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 16.4 mtp -134.55 9.12 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 1.0 110.774 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 9' ' ' MET . 70.5 m-85 -148.31 140.64 24.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.015 -1.053 . . . . 1.0 110.305 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 101.79 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 1.0 109.841 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -104.71 133.2 49.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 1.0 110.849 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 112.6 25.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 1.0 109.429 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 20' ' ' VAL . . . -48.23 117.69 2.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.21 -0.932 . . . . 1.0 110.762 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.92 67.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 1.0 110.046 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 178.77 6.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 1.0 110.147 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 1.0 110.567 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.83 -29.59 44.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 1.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -82.09 173.88 11.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.184 -0.948 . . . . 1.0 110.346 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 23.8 m -109.62 -173.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 1.0 109.976 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.31 89.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.974 . . . . 1.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 10.1 p90 -113.23 149.29 33.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 1.0 110.013 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 164.32 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 1.0 110.514 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.77 115.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 1.0 110.197 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.0 -22.78 8.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.16 160.2 21.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -1.177 . . . . 1.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.14 133.18 51.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 1.0 110.202 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -118.67 156.27 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 1.0 109.789 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -126.98 -143.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.0 109.569 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.445 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 42.0 p-10 -157.15 76.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.795 -1.191 . . . . 1.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.0 -34.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 1.0 110.357 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.45 -72.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.174 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.86 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.853 . . . . 1.0 110.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.54 -49.87 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 1.0 110.076 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 1.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.75 124.17 14.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.0 110.053 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . 121.38 80.22 0.56 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.298 -1.521 . . . . 1.0 109.298 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 40.0 m95 59.67 140.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.864 -0.786 . . . . 1.0 110.59 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ptp -149.6 -176.57 5.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.848 -1.158 . . . . 1.0 110.806 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.402 ' CZ ' ' HE1' ' A' ' 51' ' ' MET . 2.1 m-85 -105.8 141.56 37.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 1.0 109.823 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 52' ' ' LEU . . . -159.79 158.4 29.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.782 -1.327 . . . . 1.0 109.782 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.6 m -114.7 126.95 55.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 1.0 109.952 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.97 108.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 1.0 109.944 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -55.89 -24.23 35.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 1.0 110.502 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -65.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 1.0 110.279 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.5 p -86.33 -65.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 1.0 110.231 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.69 -11.67 3.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -60.91 158.48 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.305 . . . . 1.0 110.158 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.4 m -133.11 123.57 25.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 1.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.02 -159.18 8.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.402 ' HE1' ' CZ ' ' A' ' 40' ' ' TYR . 3.1 mtm -95.19 149.53 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 1.0 110.223 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -136.35 146.15 54.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 1.0 110.052 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.0 Cg_endo -72.58 110.85 3.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.736 1.387 . . . . 1.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.49 68.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -66.66 -17.3 64.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 1.0 110.561 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m-30 -95.27 -62.6 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 1.0 110.227 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.46 156.33 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.0 110.409 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.06 178.89 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 1.0 110.046 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.87 163.91 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 1.0 110.235 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.183 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.37 0.605 . . . . 1.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 5' ' ' ILE . 19.0 mm -138.59 142.5 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.217 -0.927 . . . . 1.0 109.823 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.1 -178.51 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 1.0 109.847 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -154.7 152.79 30.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.0 110.632 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.94 123.76 49.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.838 . . . . 1.0 109.949 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.46 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -100.98 8.96 42.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 1.0 110.926 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 9' ' ' MET . 53.9 m-85 -143.52 161.23 39.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.113 . . . . 1.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.09 96.31 6.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 1.0 109.789 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.69 152.15 20.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 1.0 110.893 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 ttp -118.34 103.72 10.07 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.33 -0.856 . . . . 1.0 109.382 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 20' ' ' VAL . . . -48.35 130.14 16.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.198 -0.939 . . . . 1.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.02 -28.27 18.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 1.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -141.26 170.88 14.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 1.0 110.018 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.12 44.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 1.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -51.52 -40.26 59.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.038 . . . . 1.0 110.429 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' ' N ' ' A' ' 51' ' ' MET . 4.7 pm0 -124.33 -173.2 2.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 1.0 110.657 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.437 HG23 ' CD2' ' A' ' 52' ' ' LEU . 21.4 m -120.11 -151.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.477 -0.764 . . . . 1.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.79 150.99 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.952 -1.093 . . . . 1.0 110.757 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 8.2 p90 -161.62 149.4 14.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 1.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -97.95 179.48 4.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.171 -0.956 . . . . 1.0 110.547 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.97 107.22 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 1.0 110.21 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.65 -19.98 4.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.951 -1.259 . . . . 1.0 109.951 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.09 163.45 27.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 1.0 110.5 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.9 149.06 52.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.345 -0.847 . . . . 1.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mt -143.7 133.77 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 1.0 110.454 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 1.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -151.9 105.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 1.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 32' ' ' GLN . 7.3 p -102.28 -23.21 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 1.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.414 ' N ' HG11 ' A' ' 31' ' ' VAL . 4.6 tm0? -159.03 145.11 16.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 1.0 110.138 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -164.56 120.94 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 1.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.8 -72.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 1.0 110.236 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -176.37 -63.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 1.0 109.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -134.74 23.76 3.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 1.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . -126.05 71.78 0.46 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.35 -1.5 . . . . 1.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.441 ' CE2' ' HA ' ' A' ' 53' ' ' PRO . 12.1 m95 55.25 170.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -1.026 . . . . 1.0 110.435 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 ptp -148.89 165.69 30.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 1.0 110.26 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.431 ' CE1' ' HA2' ' A' ' 50' ' ' GLY . 9.6 t80 -105.75 123.84 48.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -177.31 21.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.9 m -121.2 125.96 48.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.113 . . . . 1.0 110.225 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.71 107.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 1.0 110.125 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.18 -35.63 49.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 1.0 110.457 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -59.78 -62.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 1.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -92.11 -68.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.57 -12.69 3.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -52.34 147.71 7.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.292 . . . . 1.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -116.66 119.35 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 1.0 109.963 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -159.77 170.08 35.89 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.414 ' N ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -66.74 155.7 37.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -1.099 . . . . 1.0 110.217 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.437 ' CD2' HG23 ' A' ' 20' ' ' VAL . 8.4 mt -132.76 155.64 80.96 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.363 -0.836 . . . . 1.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HA ' ' CE2' ' A' ' 38' ' ' TRP . 47.9 Cg_endo -75.31 118.62 5.25 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.587 1.309 . . . . 1.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.83 58.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 1.0 110.348 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -78.39 -2.58 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.923 . . . . 1.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.36 -50.25 3.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.907 -1.12 . . . . 1.0 110.335 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 -176.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 1.0 110.636 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.1 146.52 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 1.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.78 164.79 25.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 1.0 110.321 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.219 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.382 0.611 . . . . 1.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 tt -129.39 167.38 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 1.0 109.906 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -134.44 -177.03 4.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.12 -0.987 . . . . 1.0 110.483 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.35 153.83 16.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 1.0 110.306 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.38 135.99 38.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 1.0 109.893 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.42 -22.36 13.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 1.0 110.617 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -121.43 178.69 4.7 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.057 -1.027 . . . . 1.0 110.102 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 41.8 p-10 -110.2 96.79 6.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 1.0 109.759 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -81.55 146.2 30.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mtm -114.42 94.9 5.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.56 -0.712 . . . . 1.0 109.222 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.82 138.04 6.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.815 . . . . 1.0 111.049 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.43 -22.16 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 1.0 109.911 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -142.97 169.98 16.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 1.0 110.168 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.12 -12.72 53.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 1.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.09 -41.81 60.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.001 -1.062 . . . . 1.0 110.538 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HA ' ' N ' ' A' ' 51' ' ' MET . 2.0 pm0 -124.89 -173.98 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.99 . . . . 1.0 110.624 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.34 -174.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 1.0 110.419 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -129.18 115.59 17.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 1.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 p90 -125.88 160.5 29.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 1.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -108.77 179.52 4.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 1.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -73.79 111.99 9.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 1.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.49 -29.66 3.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.34 151.31 41.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -1.201 . . . . 1.0 110.347 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 156.67 20.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 110.449 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mt -149.1 129.48 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 1.0 110.103 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.401 ' CG2' ' NE2' ' A' ' 44' ' ' GLN . 1.0 OUTLIER -73.71 -159.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.906 . . . . 1.0 110.655 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -114.6 87.19 2.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -0.755 . . . . 1.0 109.624 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.43 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 1.0 110.847 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -166.97 156.76 11.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.968 -1.082 . . . . 1.0 110.595 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.09 146.1 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.16 -80.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 1.0 110.284 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -169.53 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.119 -0.988 . . . . 1.0 111.8 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.31 -170.75 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.788 -1.195 . . . . 1.0 110.475 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.36 -69.52 1.12 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -53.16 135.39 37.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 1.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -133.74 -163.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 1.0 110.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 137.2 52.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 1.0 110.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.05 141.94 10.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.4 m -103.06 104.68 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -1.194 . . . . 1.0 110.415 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -48.33 128.92 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.373 -0.83 . . . . 1.0 110.473 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.401 ' NE2' ' CG2' ' A' ' 29' ' ' ILE . 3.4 mm100 -85.66 9.96 14.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 1.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -58.2 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 1.0 109.876 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -100.7 -26.03 13.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.82 25.48 10.6 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -93.79 149.86 20.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -1.128 . . . . 1.0 110.334 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -121.03 146.69 46.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 110.421 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.68 172.58 44.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.444 ' N ' ' HA ' ' A' ' 19' ' ' GLU . 3.1 ttm -60.7 156.46 16.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -1.191 . . . . 1.0 110.197 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.63 139.17 33.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 1.0 110.659 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 43.8 Cg_endo -70.93 121.04 7.51 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.654 1.344 . . . . 1.0 110.644 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.84 60.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 1.0 110.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.49 24.54 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 1.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 4.9 m-85 -131.78 -40.15 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 1.0 109.996 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.07 173.51 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 1.0 110.123 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.89 . . . . 1.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.58 170.65 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 1.0 110.238 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.232 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.7 mtmm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.221 0.534 . . . . 1.0 110.61 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt 61.25 141.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.512 -0.742 . . . . 1.0 109.97 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 10.4 m-85 -118.69 175.02 5.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.018 -1.051 . . . . 1.0 109.579 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.39 139.48 35.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 1.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' ASP . . . -86.47 124.66 33.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.185 -0.947 . . . . 1.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.0 mtt -92.6 -17.44 24.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 1.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.36 155.86 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 1.0 109.891 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.47 126.32 46.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 1.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -118.71 152.64 35.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.068 -1.02 . . . . 1.0 110.531 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 ttm -116.4 98.57 6.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.405 -0.809 . . . . 1.0 109.429 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.86 124.62 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.475 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.35 -26.46 35.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 1.0 110.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -176.59 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 1.0 110.243 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.95 -12.96 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 1.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.09 -47.16 53.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.045 . . . . 1.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 -165.46 1.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 1.0 110.171 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' A' ' 52' ' ' LEU . 21.9 m -121.07 -172.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 1.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 t -133.26 117.28 17.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -137.54 166.8 23.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 1.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -120.96 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 1.0 110.52 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 12.4 t70 -69.12 130.36 42.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 1.0 110.365 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.76 -11.44 49.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -68.52 155.79 39.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.938 -1.33 . . . . 1.0 110.341 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.65 129.25 56.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 1.0 110.288 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 28' ' ' ILE . 42.3 mt -147.48 171.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 1.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.14 -177.89 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.095 . . . . 1.0 110.252 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -122.42 88.93 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.484 -0.76 . . . . 1.0 110.264 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.54 -65.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.241 -0.912 . . . . 1.0 109.781 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -101.43 -48.25 4.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 1.0 109.828 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 53.31 80.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 1.0 110.68 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.11 -5.17 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 1.0 110.568 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 65.42 -69.92 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.213 -0.93 . . . . 1.0 110.676 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.85 124.43 27.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 1.0 110.396 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.99 61.46 1.93 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.674 -1.37 . . . . 1.0 109.674 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m95 52.56 179.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -1.151 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.88 -174.42 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 1.0 109.879 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -129.28 139.73 51.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -0.969 . . . . 1.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.58 152.83 22.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.3 m -98.95 128.95 45.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -1.183 . . . . 1.0 110.241 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -61.98 97.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 1.0 110.061 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -19.5 25.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 1.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -53.12 16.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 1.0 110.294 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.3 p -97.48 -49.66 4.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 1.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.43 -14.36 5.86 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -168.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.947 -1.325 . . . . 1.0 110.176 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -172.16 151.66 2.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 1.0 110.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.8 -158.74 20.25 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.89 137.41 38.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 1.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.432 ' CD1' HG23 ' A' ' 20' ' ' VAL . 10.7 mp -124.46 151.42 66.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 1.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 46.6 Cg_endo -72.76 108.8 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.721 1.379 . . . . 1.0 110.122 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.13 65.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.7 6.48 34.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.026 . . . . 1.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 1.9 m-85 -114.27 -64.37 1.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.044 -1.035 . . . . 1.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.66 157.17 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 1.0 110.258 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.51 -177.99 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.878 . . . . 1.0 110.294 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.56 148.92 24.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 1.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 pt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.139 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.366 0.603 . . . . 1.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 13.3 tt -127.61 170.51 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 1.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 39.1 m-85 -148.27 177.13 9.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 1.0 110.476 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -140.5 133.07 28.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 1.0 110.063 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.37 136.21 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.967 . . . . 1.0 110.44 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.47 ' HG3' ' CE1' ' A' ' 10' ' ' TYR . 9.2 tpp -128.01 1.2 5.92 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.306 -0.871 . . . . 1.0 109.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 9' ' ' MET . 33.5 m-85 -124.36 -7.68 7.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.905 -1.122 . . . . 1.0 111.316 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t0 60.36 71.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.003 -1.06 . . . . 1.0 108.774 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -77.65 148.68 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 1.0 111.296 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttp -121.59 99.64 6.58 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.9 1.28 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 1.0 110.893 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.48 -33.72 17.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 1.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 -151.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.47 -25.11 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 1.0 110.214 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' CA ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -79.56 -23.44 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.378 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 3.1 mp0 -80.05 172.05 14.28 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 1.0 110.53 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.05 169.0 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.441 -0.787 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -128.89 101.29 6.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.987 -1.071 . . . . 1.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 7.9 p90 -123.32 148.64 45.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 1.0 109.862 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.56 -174.15 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 1.0 110.574 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.49 111.73 12.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 1.0 110.251 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.62 -18.32 7.21 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.28 165.92 5.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.248 . . . . 1.0 110.378 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.89 145.31 51.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 1.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.6 mm -111.27 147.26 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.914 . . . . 1.0 110.033 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 pt -58.88 -169.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 1.0 110.26 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 19.5 p-10 -83.32 55.07 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 40' ' ' TYR . 1.8 p -80.84 -158.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.858 . . . . 1.0 109.997 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.414 ' N ' HG12 ' A' ' 31' ' ' VAL . 19.5 pt20 -160.49 -156.89 0.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.914 -1.116 . . . . 1.0 110.054 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.43 ' CB ' ' CB ' ' A' ' 39' ' ' MET . . . -137.23 -152.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 1.0 109.976 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.437 ' CG1' ' N ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -128.45 -85.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 1.0 109.773 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.437 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 26.2 t0 -108.81 -64.2 1.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.114 . . . . 1.0 110.264 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -177.72 156.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 1.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.57 -55.92 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.674 -1.371 . . . . 1.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -143.55 163.05 34.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -1.223 . . . . 1.0 110.642 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.43 ' CB ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.3 -152.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.716 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.444 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -144.09 166.77 24.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 1.0 109.973 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' HG13 ' A' ' 31' ' ' VAL . . . 175.54 167.14 34.17 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.825 -1.31 . . . . 1.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -118.69 128.43 54.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.341 -1.093 . . . . 1.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.31 117.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 1.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.75 -23.06 50.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 1.0 110.473 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -71.56 0.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 1.0 110.304 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.9 p -72.69 -51.93 17.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 1.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.59 -15.14 27.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.72 166.3 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -1.23 . . . . 1.0 110.248 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -131.57 134.9 46.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 1.0 110.458 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 18' ' ' ASP . . . -160.09 -164.63 15.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.701 -1.36 . . . . 1.0 109.701 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.45 142.55 34.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -1.13 . . . . 1.0 110.183 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.51 142.33 40.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 1.0 110.539 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.72 114.84 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.587 1.309 . . . . 1.0 109.99 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.03 67.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.136 -0.977 . . . . 1.0 110.849 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -71.97 -21.45 61.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.076 -1.015 . . . . 1.0 110.64 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 3.5 m-30 -81.89 -65.54 1.0 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 1.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -52.38 151.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 1.0 110.089 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.4 162.13 25.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.0 110.377 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 145.32 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 1.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.161 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.276 0.56 . . . . 1.0 110.094 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.424 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 11.0 tt -154.7 169.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 1.0 110.123 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 55.9 m-85 -137.25 176.6 8.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.296 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -159.94 145.14 15.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 1.0 109.891 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . . . -87.75 120.6 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 1.0 110.406 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -101.79 12.23 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 1.0 110.561 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.0 m-85 -141.77 140.71 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.0 110.375 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -80.62 115.62 20.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 1.0 109.297 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -121.3 163.1 19.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.911 -1.118 . . . . 1.0 111.129 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.85 115.84 13.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.61 -0.681 . . . . 1.0 109.3 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.31 133.69 15.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.162 -0.961 . . . . 1.0 110.761 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.07 -34.69 60.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.64 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 1.0 110.631 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.64 -32.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.094 -1.004 . . . . 1.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.24 -26.33 0.77 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 1.0 111.027 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -136.23 -168.91 2.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 1.0 110.4 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' CD1' ' A' ' 52' ' ' LEU . 16.7 m -113.39 -174.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 1.0 110.241 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -136.03 115.14 12.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0 110.687 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 8' ' ' ALA . 11.6 p90 -126.46 153.53 44.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 1.0 109.865 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -92.39 173.32 7.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 1.0 110.652 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -70.0 83.51 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.815 . . . . 1.0 109.977 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 156.45 -23.67 0.51 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.58 -1.408 . . . . 1.0 109.58 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.81 158.66 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -1.203 . . . . 1.0 110.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.86 145.81 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.356 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 28' ' ' ILE . 40.5 mm -122.58 170.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 1.0 109.747 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -131.01 -145.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 1.0 110.01 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.471 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 5.1 t-20 -126.84 87.14 2.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 1.0 110.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.11 -59.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 1.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -172.4 178.26 2.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 1.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.2 123.44 5.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 1.0 110.079 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -85.11 -43.92 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 1.0 110.304 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.99 -169.53 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 1.0 110.18 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -25.82 30.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 1.0 109.942 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.4 -75.55 0.29 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -121.83 158.18 29.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -1.159 . . . . 1.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 -163.12 1.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 1.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -139.34 130.48 26.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 1.0 110.277 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.49 -171.18 33.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.407 ' O ' ' NE2' ' A' ' 44' ' ' GLN . 52.9 m -125.2 142.76 51.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 1.0 110.257 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.0 110.81 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.213 -0.93 . . . . 1.0 109.804 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 42' ' ' THR . 2.4 mp0 -60.13 -17.54 41.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 1.0 110.894 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -69.09 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.003 -1.06 . . . . 1.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.2 p -80.03 -41.01 26.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.942 . . . . 1.0 110.296 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 14.66 25.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -70.91 152.22 43.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.278 . . . . 1.0 110.05 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 p -128.34 129.82 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 1.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.83 40.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.6 ttm -71.05 148.87 47.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 1.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.433 ' CD1' HG23 ' A' ' 20' ' ' VAL . 9.8 mp -126.53 140.4 37.26 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 1.0 110.302 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.89 95.84 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.586 1.308 . . . . 1.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.67 -24.06 60.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 1.0 110.456 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -76.79 -10.26 59.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 1.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.71 -45.25 6.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.029 . . . . 1.0 110.103 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.36 163.76 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 1.0 110.029 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.97 178.3 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 1.0 110.332 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 60' ' ' ILE . . . -90.15 14.92 11.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 1.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 37.8 pt . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 117.988 -1.006 . . . . 1.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.486 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 mtpt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.796 0.331 . . . . 1.0 110.217 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.486 ' CG2' ' O ' ' A' ' 4' ' ' LYS . 11.9 tt 47.75 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.571 0.7 . . . . 1.0 111.351 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 5' ' ' ILE . 14.4 m-85 -155.35 -175.18 5.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.0 110.4 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -162.9 132.86 4.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.0 110.05 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.64 147.82 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 1.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 mtp -120.43 -14.98 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 1.0 110.656 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -124.03 125.33 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 1.0 110.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.13 92.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 1.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -82.02 167.37 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 1.0 110.775 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.82 117.2 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.767 . . . . 1.0 109.635 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.73 125.99 11.1 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 1.0 110.774 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.96 -34.52 15.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 1.0 110.291 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.21 -82.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 1.0 110.234 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.36 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.129 -0.982 . . . . 1.0 110.398 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.07 -24.34 6.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 1.0 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.07 171.03 7.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.46 ' CG1' ' CA ' ' A' ' 50' ' ' GLY . 25.7 m -113.46 -156.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 1.0 109.975 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.96 128.12 7.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 1.0 110.579 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.368 -0.832 . . . . 1.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -96.71 -165.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 1.0 110.503 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.83 114.55 18.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.283 -0.886 . . . . 1.0 110.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.38 -2.39 50.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.83 157.15 7.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.912 -1.346 . . . . 1.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.0 130.35 50.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 1.0 110.279 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 29' ' ' ILE . 34.3 mt -145.29 153.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 1.0 109.853 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.441 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.93 -142.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 1.0 110.182 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -153.68 105.28 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 1.0 110.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 32' ' ' GLN . 7.2 p -83.34 -23.04 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 1.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.433 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -172.95 177.72 2.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 1.0 110.171 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.76 136.17 37.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 1.0 110.341 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 34' ' ' ILE . 58.1 mt -77.85 -13.63 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 1.0 110.569 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 63.88 10.97 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.139 -0.976 . . . . 1.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -113.22 -65.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.977 -1.077 . . . . 1.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.37 -52.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.417 ' CE3' ' HB3' ' A' ' 51' ' ' MET . 7.9 m95 -84.2 178.19 7.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 1.0 110.105 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.07 174.37 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0 110.3 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.1 136.37 53.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 1.0 110.51 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 168.19 34.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -116.45 122.9 46.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.86 126.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 1.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -73.23 -30.39 63.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 1.0 110.597 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -24.04 66.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 1.0 110.318 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -131.77 -59.57 0.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.0 110.176 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.92 28.14 1.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -99.97 135.97 40.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 1.0 109.89 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 m -101.3 123.88 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 1.0 110.512 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' CA ' ' CG1' ' A' ' 20' ' ' VAL . . . -153.82 -167.0 15.41 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.417 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 8.0 mtp -78.99 143.68 35.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -1.159 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.42 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.4 mp -126.44 138.03 31.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 1.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.05 113.5 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.529 1.279 . . . . 1.0 110.589 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.31 81.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.035 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -60.75 -17.59 49.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 1.0 110.186 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.44 -59.64 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 1.0 110.011 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.66 170.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 1.0 110.129 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.22 158.51 24.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 1.0 110.312 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 159.66 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 1.0 110.278 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.229 0.537 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 5' ' ' ILE . 23.0 mt 57.59 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.0 110.612 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.9 -178.36 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 1.0 110.031 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -170.03 138.12 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 1.0 110.411 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.13 33.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 1.0 109.879 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.2 mmm -95.77 -14.37 23.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 1.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.448 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 35.2 m-85 -137.75 151.41 48.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.03 -1.044 . . . . 1.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -81.63 84.38 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 1.0 109.28 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -70.1 166.4 19.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 1.0 110.996 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.34 114.3 8.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.632 -0.668 . . . . 1.0 109.344 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.02 121.53 4.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.204 -0.935 . . . . 1.0 110.635 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 1.0 110.548 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.33 -69.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.074 -1.016 . . . . 1.0 110.748 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.63 -34.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.956 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.38 -29.53 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.197 -0.94 . . . . 1.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.07 -177.06 3.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.147 -0.97 . . . . 1.0 109.952 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 52' ' ' LEU . 19.0 m -110.36 -152.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 1.0 110.585 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 t -157.07 141.93 16.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 1.0 110.41 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -150.95 149.69 29.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.353 -0.842 . . . . 1.0 109.78 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -174.87 4.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.516 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.13 114.56 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.98 -21.1 9.02 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.679 -1.369 . . . . 1.0 109.679 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.46 169.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -1.181 . . . . 1.0 110.311 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.3 139.51 51.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.818 . . . . 1.0 110.13 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 28' ' ' ILE . 40.1 mm -123.08 173.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.0 109.992 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -117.96 -140.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 1.0 109.278 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.446 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 12.3 t-20 -172.19 69.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.646 -1.284 . . . . 1.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 ' N ' ' A' ' 32' ' ' GLN . 20.7 m -70.56 -35.74 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.286 -0.884 . . . . 1.0 110.454 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.431 ' N ' HG21 ' A' ' 31' ' ' VAL . 51.8 tt0 -144.53 -65.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 1.0 110.322 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.58 133.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.835 . . . . 1.0 110.577 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 34' ' ' ILE . 50.1 mm -119.8 -7.33 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.061 -1.024 . . . . 1.0 110.663 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 18.5 t0 66.71 -66.54 0.18 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.174 -0.954 . . . . 1.0 110.55 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -94.05 91.21 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.99 . . . . 1.0 110.587 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.85 64.82 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.5 m95 52.9 176.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.356 -1.084 . . . . 1.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 ptp -150.1 178.49 8.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 1.0 109.864 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.11 122.2 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 110.311 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.75 176.68 24.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -126.14 141.54 51.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -1.085 . . . . 1.0 110.096 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.82 110.34 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 1.0 110.297 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -55.68 -28.99 58.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.401 -0.812 . . . . 1.0 110.36 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -66.91 -70.31 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 1.0 110.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -81.93 -55.83 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 1.0 110.312 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.66 30.36 2.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -97.02 128.81 44.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 1.0 110.358 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.0 m -112.99 121.6 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 1.0 110.211 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.85 -147.92 5.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mmt -84.2 138.72 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 1.0 110.198 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 20' ' ' VAL . 7.3 mp -123.25 148.55 55.26 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.19 110.3 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.684 1.36 . . . . 1.0 110.134 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.95 -23.09 65.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.567 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.01 7.95 25.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.9 m-85 -117.13 -58.67 2.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 1.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.12 161.6 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 1.0 110.177 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -169.19 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 1.0 109.964 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 147.11 27.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 1.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 pt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.207 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.334 0.588 . . . . 1.0 110.371 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.85 137.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 1.0 109.744 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -119.37 -176.47 3.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 1.0 109.894 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.68 136.56 5.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 1.0 110.543 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.52 140.73 58.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 1.0 110.155 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.2 mtp -129.0 12.8 6.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 51.2 m-85 -131.76 -7.15 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.063 -1.023 . . . . 1.0 111.463 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.68 90.59 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.963 -1.086 . . . . 1.0 109.697 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 21.7 t80 -111.66 132.34 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 1.0 110.53 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' MET . . . . . 0.433 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 5.2 ptt? -110.81 22.87 14.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.0 110.019 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . . . 57.23 158.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.538 0.685 . . . . 1.0 110.721 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.78 -22.83 11.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 1.0 110.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.02 -155.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.98 20.1 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 1.0 110.205 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -87.55 -36.3 17.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.0 110.606 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -119.76 -173.81 2.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 1.0 110.51 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 52' ' ' LEU . 24.4 m -108.52 -178.01 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 1.0 109.92 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 13' ' ' MET . 2.2 p -131.02 133.44 45.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 1.0 110.648 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.416 ' HB2' ' CB ' ' A' ' 26' ' ' ASP . 6.4 p90 -137.72 168.84 18.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 1.0 109.845 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -94.34 -174.75 3.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.0 110.376 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -77.42 1.09 20.13 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.268 -0.895 . . . . 1.0 110.921 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.89 20.23 5.73 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.801 -1.32 . . . . 1.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 22' ' ' PHE . 37.6 t0 -78.17 155.26 30.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 1.0 110.081 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.68 128.91 55.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 1.0 110.537 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 28' ' ' ILE . 27.7 mt -147.34 171.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -0.81 . . . . 1.0 109.474 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 pt -142.27 -178.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.099 -1.0 . . . . 1.0 110.778 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -88.04 70.2 9.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 1.0 110.365 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.7 t -54.23 -62.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.83 151.68 47.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 109.909 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.24 132.21 27.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 1.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -95.55 -56.52 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 1.0 109.914 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.73 -161.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 134.54 52.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.126 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.21 85.24 1.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.461 -1.456 . . . . 1.0 109.461 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 38' ' ' TRP . 26.6 m95 55.07 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.51 -0.994 . . . . 1.0 110.552 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.0 ptt? -149.61 -147.96 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.15 -0.969 . . . . 1.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.21 128.52 30.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.79 170.39 28.49 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.1 m -123.76 104.17 8.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 1.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -53.07 131.18 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 1.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -85.62 -16.3 39.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 1.0 110.554 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -68.12 -35.71 78.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.0 110.448 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.8 p -124.25 -42.84 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 1.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.88 34.95 2.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -106.2 111.4 24.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -1.151 . . . . 1.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.0 m -92.82 124.93 37.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 1.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 -153.68 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.1 mtt -78.39 143.44 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -1.151 . . . . 1.0 110.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.443 ' CD1' HG23 ' A' ' 20' ' ' VAL . 3.1 mp -132.53 141.65 41.98 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 1.0 110.209 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.08 93.75 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.599 1.315 . . . . 1.0 110.374 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.99 -27.88 61.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 1.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -76.73 -2.39 32.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 1.0 110.917 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.7 m-85 -105.3 -51.61 2.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 1.0 110.237 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.54 152.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 110.168 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.31 173.33 12.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.9 . . . . 1.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.56 139.36 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 1.0 110.163 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.159 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.223 0.535 . . . . 1.0 110.491 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 21.3 mm 54.94 171.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 1.0 110.275 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 38.8 m-85 -145.24 178.25 8.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.953 . . . . 1.0 110.148 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -153.87 117.05 4.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 1.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.27 132.39 52.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 1.0 110.175 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 mtp -114.0 9.76 17.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 1.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 9' ' ' MET . 48.6 m-85 -142.86 152.16 41.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.999 -1.063 . . . . 1.0 110.366 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -85.9 86.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 1.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 25.5 t80 -94.02 131.67 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 1.0 110.484 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.43 22.09 15.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 1.0 110.098 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . . . 55.15 166.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.633 0.73 . . . . 1.0 110.986 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 -19.79 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 1.0 109.908 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.86 -157.86 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 1.0 109.971 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.35 19.29 9.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.196 -0.94 . . . . 1.0 110.401 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.0 -34.92 22.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 1.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -176.97 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.94 . . . . 1.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.44 ' CG2' HD13 ' A' ' 52' ' ' LEU . 12.0 m -105.24 -162.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0 110.179 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -139.55 105.93 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 1.0 110.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -118.77 154.47 32.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 1.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -97.68 178.27 5.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 1.0 110.378 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -69.83 81.73 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.0 110.054 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 163.43 -28.19 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 4.5 m-20 -53.39 151.53 5.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -1.114 . . . . 1.0 110.162 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.47 143.47 50.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 1.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 28' ' ' ILE . 56.8 mt -138.98 146.75 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 1.0 109.926 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.432 HG13 ' CG2' ' A' ' 31' ' ' VAL . 2.9 pt -81.69 -161.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 1.0 110.771 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 32' ' ' GLN . 35.6 m-20 -72.29 -47.42 50.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.369 -0.832 . . . . 1.0 110.937 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.445 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 72.8 t 56.28 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 1.0 110.461 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -171.09 139.93 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 110.522 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.52 145.72 37.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 1.0 110.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -126.86 -33.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 1.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.13 170.09 16.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 1.0 110.408 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.3 -22.8 44.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 1.0 110.306 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.6 -75.73 0.29 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.74 152.88 38.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -1.184 . . . . 1.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.06 -160.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 1.0 110.446 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.474 ' CE1' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -137.15 135.29 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.813 . . . . 1.0 109.807 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA2' ' CG2' ' A' ' 31' ' ' VAL . . . -164.74 159.02 31.98 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.599 -1.286 . . . . 1.0 109.906 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -108.98 121.68 45.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -1.088 . . . . 1.0 109.96 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 t -63.92 122.81 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 1.0 110.319 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -76.03 -10.39 59.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 1.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -68.0 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 110.33 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.72 -40.13 8.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 1.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.44 24.73 3.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -84.48 126.47 33.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -1.164 . . . . 1.0 110.012 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -97.75 133.47 42.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 110.327 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.86 -174.34 46.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.474 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 29.6 mtp -87.6 153.68 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -1.181 . . . . 1.0 110.589 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -126.02 145.02 50.66 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 1.0 109.65 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.11 112.57 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.66 1.347 . . . . 1.0 110.09 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.77 94.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.99 . . . . 1.0 110.206 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -23.15 14.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.171 -0.956 . . . . 1.0 109.956 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.29 -73.66 0.48 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.0 110.126 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -52.9 151.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 1.0 110.075 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -124.24 159.39 30.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 1.0 110.234 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 149.93 29.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 1.0 110.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.278 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.295 0.569 . . . . 1.0 110.411 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mt -122.05 151.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.323 -0.861 . . . . 1.0 109.731 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -119.95 179.23 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -161.88 144.55 11.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 1.0 110.21 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.27 124.71 41.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 1.0 110.099 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.0 mmm -95.5 -3.0 47.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 1.0 110.871 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -127.87 177.43 6.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.931 -1.105 . . . . 1.0 110.336 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.67 83.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.716 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.61 140.94 41.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 1.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.9 mtt -112.16 108.33 17.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.468 -0.77 . . . . 1.0 109.507 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.1 120.92 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.881 . . . . 1.0 110.803 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.18 64.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 1.0 109.847 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.57 -175.25 2.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 1.0 109.939 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -17.36 56.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 1.0 110.313 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.09 -31.65 62.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 1.0 110.298 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 1.9 mp0 -84.92 171.92 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 1.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.418 HG12 ' CA ' ' A' ' 50' ' ' GLY . 35.7 m -116.67 167.62 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 1.0 109.877 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 t -129.56 108.57 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 1.0 110.554 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 1.0 110.098 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.04 178.62 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 1.0 110.601 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -75.03 99.63 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 1.0 110.111 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.08 -28.23 2.38 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.083 -1.607 . . . . 1.0 109.083 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.408 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 9.7 t70 -63.1 165.92 6.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.063 . . . . 1.0 109.994 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.57 169.19 15.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 1.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.441 HG21 ' CG1' ' A' ' 31' ' ' VAL . 27.0 mm -130.78 163.55 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.681 -0.637 . . . . 1.0 109.439 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 28' ' ' ILE . 7.6 pt -151.86 161.25 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.079 . . . . 1.0 110.956 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 51.53 54.2 11.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 1.0 110.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.441 ' CG1' HG21 ' A' ' 28' ' ' ILE . 27.3 m -104.3 170.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.185 -0.947 . . . . 1.0 110.377 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -158.67 -161.86 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0 109.928 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.66 20.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 1.0 110.264 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.81 -70.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.353 -0.842 . . . . 1.0 110.081 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.85 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 1.0 110.032 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 1.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.05 -55.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -54.4 155.89 3.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -1.114 . . . . 1.0 109.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -131.94 -164.1 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 1.0 110.483 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -124.86 158.76 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 1.0 109.872 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.06 159.9 28.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.6 m -126.86 117.23 22.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 1.0 109.866 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.408 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 22.0 t -57.14 109.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 1.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -23.68 63.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.866 . . . . 1.0 110.701 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -75.83 -74.07 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 1.0 110.649 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 p -68.66 -56.79 7.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 1.0 110.312 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.15 32.23 1.72 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -97.48 148.56 23.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 1.0 110.13 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 p -125.21 135.83 52.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 1.0 110.06 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.418 ' CA ' HG12 ' A' ' 20' ' ' VAL . . . -178.56 -163.59 30.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.87 141.86 34.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 1.0 110.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.9 mp -123.1 125.8 26.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.549 -0.719 . . . . 1.0 109.99 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 107.47 2.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.408 1.215 . . . . 1.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.59 55.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 1.0 110.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -62.19 -17.34 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 1.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -98.52 -60.95 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 1.0 109.794 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.51 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 1.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.83 -174.74 2.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.915 . . . . 1.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 60' ' ' ILE . . . -105.23 167.18 9.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 1.0 110.525 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.177 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.3 mttt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.173 0.511 . . . . 1.0 110.15 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm 58.1 159.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.39 -0.819 . . . . 1.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.32 -174.71 3.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 1.0 110.23 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -153.12 164.17 38.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 1.0 110.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.72 133.22 53.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 1.0 110.141 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 8.9 mtp -111.35 -6.3 14.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 1.0 110.743 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -131.79 167.12 20.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 1.0 110.148 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -98.69 105.45 17.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.289 -0.882 . . . . 1.0 109.86 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -109.62 160.94 15.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 1.0 110.908 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 114.45 9.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -0.76 . . . . 1.0 109.759 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.15 117.47 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.642 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.36 49.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 1.0 110.014 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.72 -154.85 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 1.0 109.973 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.46 15.55 27.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 1.0 110.518 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.38 -35.22 21.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.031 -1.043 . . . . 1.0 110.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -124.71 -175.87 3.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 1.0 110.49 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 52' ' ' LEU . 31.6 m -113.7 -165.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 1.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.54 123.78 24.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 1.0 110.331 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.3 153.74 51.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 1.0 110.115 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -97.85 178.58 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 1.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.45 119.36 17.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 1.0 110.191 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.23 -35.36 3.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.38 160.3 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.145 . . . . 1.0 110.347 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 141.22 52.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.211 -0.931 . . . . 1.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.1 mt -143.75 127.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.94 . . . . 1.0 110.199 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.7 -160.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 1.0 110.455 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -160.79 79.1 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.838 . . . . 1.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -52.83 -62.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 1.0 110.13 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -119.6 147.13 44.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.868 . . . . 1.0 109.904 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.64 115.06 9.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 1.0 110.34 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 39.7 mm -93.45 -5.67 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 1.0 110.504 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.41 -72.19 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -0.977 . . . . 1.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.11 47.05 1.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 1.0 110.371 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.74 49.55 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.2 m95 52.99 178.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -1.177 . . . . 1.0 110.123 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.3 ptm -138.66 173.05 11.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 1.0 110.324 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -120.68 158.77 26.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.02 -175.31 47.36 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' THR . . . . . 0.413 ' OG1' ' CG2' ' A' ' 49' ' ' THR . 52.3 m -125.64 122.55 36.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -1.109 . . . . 1.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.67 118.52 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 1.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -21.21 64.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.92 . . . . 1.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -69.56 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 1.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -86.94 -28.34 22.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 1.0 110.354 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.89 8.55 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -106.34 142.9 35.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -1.091 . . . . 1.0 110.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' THR . . . . . 0.413 ' CG2' ' OG1' ' A' ' 42' ' ' THR . 37.2 p -104.95 143.24 33.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.1 178.09 48.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.9 mmm -79.48 153.53 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 1.0 110.216 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 20' ' ' VAL . 12.3 mt -129.64 162.92 50.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 1.0 109.931 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.88 114.99 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 1.0 110.378 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.84 -18.34 62.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 1.0 110.459 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.21 -1.04 57.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.972 . . . . 1.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -110.91 -65.41 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.96 -1.088 . . . . 1.0 110.396 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -56.3 170.33 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 1.0 110.34 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.54 157.87 37.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 1.0 110.298 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.51 140.53 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.208 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.439 0.637 . . . . 1.0 110.407 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mt -106.07 148.83 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 1.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -119.57 179.78 4.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 1.0 110.141 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.37 142.53 12.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.1 155.49 20.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 1.0 110.122 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 mtp -134.19 4.93 3.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 1.0 110.921 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -134.32 129.21 35.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.988 -1.07 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.3 103.47 2.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 1.0 109.825 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -104.22 147.64 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.983 . . . . 1.0 110.722 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.16 105.41 11.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 1.0 109.79 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 120.42 3.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.244 -0.91 . . . . 1.0 110.661 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.46 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 1.0 110.114 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -171.22 2.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 1.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 11.36 15.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 1.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -26.35 43.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 1.0 110.054 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -131.85 -176.97 4.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.308 -0.87 . . . . 1.0 110.243 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 52' ' ' LEU . 29.9 m -115.79 -169.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 1.0 109.964 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.6 p -133.21 123.97 26.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 1.0 110.725 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.04 159.57 37.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 1.0 109.891 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -105.4 176.95 4.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 1.0 110.393 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.96 93.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.221 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.33 -24.45 0.59 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 3.8 t0 -65.01 177.09 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -1.137 . . . . 1.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.99 164.38 33.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 1.0 110.259 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 29' ' ' ILE . 20.8 mm -118.51 172.02 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.334 -0.854 . . . . 1.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -171.61 -35.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.044 -1.035 . . . . 1.0 110.477 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.66 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.209 -0.932 . . . . 1.0 111.117 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.13 -109.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.085 -1.01 . . . . 1.0 110.192 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -176.26 -152.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.469 -1.394 . . . . 1.0 110.125 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.6 129.07 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 1.0 110.455 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.99 -8.4 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.75 146.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.11 -0.994 . . . . 1.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.49 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 1.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.61 27.48 5.47 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.1 m95 54.8 171.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.46 -1.024 . . . . 1.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.425 ' CG ' ' HB2' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -122.56 -167.84 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 1.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -147.61 144.64 28.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.166 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.28 178.39 44.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -106.88 132.53 52.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -1.067 . . . . 1.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 49.3 t -69.75 129.11 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 1.0 109.801 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -70.75 -35.18 72.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 1.0 110.652 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -57.85 8.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 1.0 110.572 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 p -91.93 -52.28 4.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 1.0 110.613 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.96 25.38 6.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.353 -1.499 . . . . 1.0 109.353 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -95.45 138.58 32.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 1.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.34 135.93 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 1.0 110.171 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.78 177.27 47.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.1 mmt -82.6 151.9 26.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -1.148 . . . . 1.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.441 ' CD2' HG23 ' A' ' 20' ' ' VAL . 9.7 mt -128.27 161.92 53.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 1.0 109.917 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.55 115.08 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.677 1.357 . . . . 1.0 110.267 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.37 -17.19 60.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 1.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.2 -8.29 51.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 1.0 110.85 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.94 -60.69 1.48 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.008 -1.058 . . . . 1.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.48 163.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 1.0 109.863 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 -177.46 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.031 -1.043 . . . . 1.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 169.23 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 1.0 110.245 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.216 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mttm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.342 0.592 . . . . 1.0 110.347 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.98 152.88 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 1.0 109.558 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.4 179.84 4.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 1.0 110.409 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 -160.46 155.4 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 1.0 110.377 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.88 149.3 27.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 1.0 110.029 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.473 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 22.7 mtm -139.81 28.75 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 1.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.4 m-85 -150.22 109.86 4.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 110.609 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.21 133.88 49.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.0 109.45 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TYR . . . . . 0.411 ' N ' ' HB2' ' A' ' 22' ' ' PHE . 19.3 t80 -147.24 137.39 23.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.946 -1.096 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.2 ttp -102.74 103.9 14.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.59 115.39 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.473 -0.767 . . . . 1.0 111.356 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.77 -48.6 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 1.0 109.586 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.48 150.1 28.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 1.0 109.664 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.16 -28.37 10.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.0 110.509 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.3 -35.6 79.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 110.366 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 4.7 mp0 -84.75 172.14 11.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.261 -0.899 . . . . 1.0 110.724 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 50' ' ' GLY . 13.5 m -120.94 169.12 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 1.0 110.032 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -103.49 126.02 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.948 . . . . 1.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CZ ' ' HD2' ' A' ' 53' ' ' PRO . 5.4 m-85 -84.36 167.1 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 1.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 24' ' ' ASP . 1.8 tptt -152.93 122.09 6.62 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASP . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 20.4 t0 -46.73 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 1.0 111.035 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 120.65 31.08 1.28 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -105.75 172.82 6.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -1.211 . . . . 1.0 110.065 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.85 41.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 1.0 110.194 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 28' ' ' ILE . 31.6 mm -120.12 135.86 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 1.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' HG21 ' A' ' 31' ' ' VAL . 2.0 pt -69.07 -152.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 1.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -105.0 82.14 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 1.0 110.469 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 29' ' ' ILE . 75.3 t -100.98 -83.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 1.0 110.39 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -167.32 149.31 5.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 1.0 109.945 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . 0.437 ' CB ' ' HG3' ' A' ' 39' ' ' MET . . . -165.92 -166.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 1.0 110.388 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 33' ' ' ALA . 26.5 mt 65.96 -60.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.856 -0.528 . . . . 1.0 110.658 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.09 171.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 1.0 109.975 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.25 -168.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.196 -0.94 . . . . 1.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.46 -25.81 11.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -117.38 162.98 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -1.158 . . . . 1.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' MET . . . . . 0.437 ' HG3' ' CB ' ' A' ' 33' ' ' ALA . 22.7 ttt -90.53 169.65 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 1.0 109.648 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -145.91 136.17 23.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 1.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.423 ' HA2' ' CG1' ' A' ' 31' ' ' VAL . . . -177.23 -177.04 45.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -113.8 137.18 52.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.29 129.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 1.0 109.511 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -14.21 58.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 1.0 110.986 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -86.92 -38.49 16.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.068 . . . . 1.0 110.567 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 p -110.71 -43.79 3.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 1.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.81 -16.97 23.13 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -59.66 139.88 56.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.265 . . . . 1.0 110.348 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -117.39 129.87 56.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.0 110.031 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -159.7 -158.72 9.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.974 -1.251 . . . . 1.0 109.974 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' ASP . 5.0 mmt -87.2 147.32 25.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -1.057 . . . . 1.0 110.415 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.434 ' CD1' HG23 ' A' ' 20' ' ' VAL . 8.3 mp -126.9 132.42 24.31 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.0 109.98 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HD2' ' CZ ' ' A' ' 22' ' ' PHE . 43.4 Cg_endo -71.85 116.52 4.73 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.383 1.202 . . . . 1.0 110.265 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.74 -26.75 62.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.413 -0.804 . . . . 1.0 111.065 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.06 -5.42 31.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.099 -1.001 . . . . 1.0 110.854 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.437 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.3 m-30 -106.2 -66.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.007 -1.058 . . . . 1.0 110.23 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.52 168.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 1.0 110.68 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -170.3 161.26 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 1.0 109.956 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.73 148.09 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 1.0 110.349 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.103 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.246 0.546 . . . . 1.0 109.892 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.82 68.29 0.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 1.0 110.081 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.64 24.62 3.86 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.433 ' O ' HG21 ' A' ' 5' ' ' ILE . 5.7 mtmt -60.5 -53.4 57.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -1.135 . . . . 1.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.433 HG21 ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 54.91 169.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.61 . . . . 1.0 110.268 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 7.2 m-85 -142.28 -166.01 2.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 1.0 110.036 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -169.1 142.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.467 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.403 ' HB3' ' CD1' ' A' ' 22' ' ' PHE . . . -91.69 163.15 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 1.0 110.038 179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 37.1 mtm -136.72 7.08 2.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 1.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' MET . 45.0 m-85 -144.95 167.06 23.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.993 -1.067 . . . . 1.0 110.345 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' LYS . 29.3 t0 -95.54 73.89 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 1.0 109.633 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -61.85 148.04 44.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 1.0 110.797 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 ttp -115.79 107.2 14.75 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.446 -0.784 . . . . 1.0 109.029 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.66 130.72 17.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 110.652 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.97 -32.3 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 1.0 109.754 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.69 -155.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 1.0 109.721 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.41 18.84 5.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.971 . . . . 1.0 110.202 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -105.9 -22.44 12.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 1.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE2' ' CZ3' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -103.35 -168.62 1.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.039 -1.038 . . . . 1.0 109.867 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.454 ' CG2' ' HG ' ' A' ' 52' ' ' LEU . 27.8 m -131.36 169.36 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.684 . . . . 1.0 109.727 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -121.48 75.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 1.0 110.644 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 9.2 p90 -93.68 148.94 21.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 1.0 109.783 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' HA ' ' HA ' ' A' ' 11' ' ' ASP . 0.0 OUTLIER -111.24 169.66 8.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.069 -1.019 . . . . 1.0 110.721 -179.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -65.25 122.89 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 1.0 110.13 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.7 -24.35 13.49 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.61 154.75 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -1.11 . . . . 1.0 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -109.96 160.49 16.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 1.0 110.328 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HG23 ' N ' ' A' ' 29' ' ' ILE . 41.4 mt -147.7 170.18 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.825 . . . . 1.0 109.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.442 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -106.62 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.159 -0.963 . . . . 1.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.442 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 11.8 t-20 -169.03 79.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.401 -1.437 . . . . 1.0 110.529 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.7 -25.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.184 -0.948 . . . . 1.0 110.067 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.55 179.22 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 1.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.22 103.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 1.0 110.37 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -80.42 -19.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 1.0 110.225 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER 59.99 155.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 1.0 110.538 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' ASP . 19.5 pt-20 38.28 38.85 0.24 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.225 0.536 . . . . 1.0 111.581 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' C ' ' CD1' ' A' ' 38' ' ' TRP . . . -174.37 -82.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.883 -1.287 . . . . 1.0 109.883 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.504 ' CZ3' ' OE2' ' A' ' 19' ' ' GLU . 26.2 m95 -141.63 177.39 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.293 . . . . 1.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 3.2 mmt -130.9 -166.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 1.0 110.2 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.82 125.64 2.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 1.0 110.098 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.3 37.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.4 m -101.81 117.09 34.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 1.0 110.155 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.84 107.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 1.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.65 -14.76 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.0 110.474 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -73.59 -24.7 60.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.079 -1.013 . . . . 1.0 110.373 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -140.05 -47.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 1.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.74 7.45 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.73 141.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.317 . . . . 1.0 110.221 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 12.7 p -109.87 129.27 55.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 1.0 110.078 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.401 ' CA ' HG12 ' A' ' 20' ' ' VAL . . . -159.41 -164.85 15.31 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.892 -1.283 . . . . 1.0 109.892 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.447 ' CG ' ' HB3' ' A' ' 38' ' ' TRP . 7.2 tpp -95.07 157.74 15.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -1.005 . . . . 1.0 110.847 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.495 ' N ' ' CD1' ' A' ' 52' ' ' LEU . 4.0 mp -137.46 141.87 35.2 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.485 -0.759 . . . . 1.0 109.965 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.42 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 44.2 Cg_endo -73.63 120.74 6.61 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.552 1.29 . . . . 1.0 110.327 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.14 -19.78 55.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.241 -0.912 . . . . 1.0 110.848 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.71 4.4 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 1.0 110.73 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.42 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 11.6 m-85 -117.56 -62.01 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.05 -1.031 . . . . 1.0 110.07 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.8 m -78.96 160.73 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 110.405 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' OE2' ' CE ' ' A' ' 9' ' ' MET . 16.5 mt-10 -149.36 179.53 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 1.0 109.983 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -93.69 171.88 8.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.932 . . . . 1.0 110.325 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 pt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.123 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.162 0.506 . . . . 1.0 110.242 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.27 -150.2 0.37 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 1.0 110.151 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.87 68.93 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.198 . . . . 1.0 110.104 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -72.73 177.54 4.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.93 -1.335 . . . . 1.0 110.062 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 mt -107.84 131.87 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 1.0 109.637 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.34 -178.74 3.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 1.0 110.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -156.59 144.76 19.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 1.0 110.309 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.76 163.72 22.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.318 -0.864 . . . . 1.0 110.114 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.427 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 16.4 mtp -134.55 9.12 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 1.0 110.774 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 9' ' ' MET . 70.5 m-85 -148.31 140.64 24.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.015 -1.053 . . . . 1.0 110.305 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 101.79 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 1.0 109.841 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -104.71 133.2 49.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 1.0 110.849 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 112.6 25.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 1.0 109.429 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.424 ' CB ' ' O ' ' A' ' 20' ' ' VAL . . . -48.23 117.69 2.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.21 -0.932 . . . . 1.0 110.762 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.92 67.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 1.0 110.046 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 178.77 6.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 1.0 110.147 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 1.0 110.567 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.83 -29.59 44.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 1.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -82.09 173.88 11.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.184 -0.948 . . . . 1.0 110.346 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.424 ' O ' ' CB ' ' A' ' 14' ' ' ALA . 23.8 m -109.62 -173.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 1.0 109.976 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.31 89.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.974 . . . . 1.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 10.1 p90 -113.23 149.29 33.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 1.0 110.013 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 164.32 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 1.0 110.514 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -52.77 115.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 1.0 110.197 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.0 -22.78 8.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.16 160.2 21.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -1.177 . . . . 1.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.14 133.18 51.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 1.0 110.202 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 25.3 mm -118.67 156.27 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 1.0 109.789 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -126.98 -143.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.0 109.569 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.445 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 42.0 p-10 -157.15 76.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.795 -1.191 . . . . 1.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.1 p -60.0 -34.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 1.0 110.357 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -133.45 -72.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.174 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 59.86 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.853 . . . . 1.0 110.534 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.54 -49.87 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 1.0 110.076 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 1.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.75 124.17 14.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.0 110.053 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.421 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . 121.38 80.22 0.56 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.298 -1.521 . . . . 1.0 109.298 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.421 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 40.0 m95 59.67 140.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.864 -0.786 . . . . 1.0 110.59 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ptp -149.6 -176.57 5.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.848 -1.158 . . . . 1.0 110.806 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.402 ' CZ ' ' HE1' ' A' ' 51' ' ' MET . 2.1 m-85 -105.8 141.56 37.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 1.0 109.823 179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.422 ' N ' HD23 ' A' ' 52' ' ' LEU . . . -159.79 158.4 29.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.782 -1.327 . . . . 1.0 109.782 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.6 m -114.7 126.95 55.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 1.0 109.952 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -64.97 108.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 1.0 109.944 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -55.89 -24.23 35.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 1.0 110.502 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -67.23 -65.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 1.0 110.279 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.5 p -86.33 -65.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 1.0 110.231 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.69 -11.67 3.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -60.91 158.48 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.305 . . . . 1.0 110.158 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.4 m -133.11 123.57 25.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 1.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -148.02 -159.18 8.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.402 ' HE1' ' CZ ' ' A' ' 40' ' ' TYR . 3.1 mtm -95.19 149.53 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 1.0 110.223 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.422 HD23 ' N ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -136.35 146.15 54.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 1.0 110.052 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.4 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.0 Cg_endo -72.58 110.85 3.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.736 1.387 . . . . 1.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.49 68.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -66.66 -17.3 64.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 1.0 110.561 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m-30 -95.27 -62.6 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 1.0 110.227 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.46 156.33 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.0 110.409 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.06 178.89 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 1.0 110.046 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.87 163.91 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 1.0 110.235 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 pt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.183 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.207 0.527 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.55 -82.42 0.53 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 1.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.67 -56.32 4.91 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt 45.14 -170.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.489 -1.007 . . . . 1.0 111.165 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.409 HD11 HG22 ' A' ' 5' ' ' ILE . 19.0 mm -138.59 142.5 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.217 -0.927 . . . . 1.0 109.823 -179.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.1 -178.51 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 1.0 109.847 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -154.7 152.79 30.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.0 110.632 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.94 123.76 49.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.838 . . . . 1.0 109.949 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.46 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -100.98 8.96 42.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 1.0 110.926 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 9' ' ' MET . 53.9 m-85 -143.52 161.23 39.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.113 . . . . 1.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.09 96.31 6.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 1.0 109.789 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.69 152.15 20.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 1.0 110.893 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 ttp -118.34 103.72 10.07 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.33 -0.856 . . . . 1.0 109.382 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.418 ' CB ' ' O ' ' A' ' 20' ' ' VAL . . . -48.35 130.14 16.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.198 -0.939 . . . . 1.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.02 -28.27 18.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 1.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -141.26 170.88 14.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 1.0 110.018 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.12 44.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 1.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -51.52 -40.26 59.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.038 . . . . 1.0 110.429 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' ' N ' ' A' ' 51' ' ' MET . 4.7 pm0 -124.33 -173.2 2.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 1.0 110.657 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.437 HG23 ' CD2' ' A' ' 52' ' ' LEU . 21.4 m -120.11 -151.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.477 -0.764 . . . . 1.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.79 150.99 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.952 -1.093 . . . . 1.0 110.757 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 8.2 p90 -161.62 149.4 14.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 1.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -97.95 179.48 4.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.171 -0.956 . . . . 1.0 110.547 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -70.97 107.22 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 1.0 110.21 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.65 -19.98 4.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.951 -1.259 . . . . 1.0 109.951 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.09 163.45 27.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 1.0 110.5 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.9 149.06 52.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.345 -0.847 . . . . 1.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 32.3 mt -143.7 133.77 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 1.0 110.454 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 1.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -151.9 105.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 1.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.414 HG11 ' N ' ' A' ' 32' ' ' GLN . 7.3 p -102.28 -23.21 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 1.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.414 ' N ' HG11 ' A' ' 31' ' ' VAL . 4.6 tm0? -159.03 145.11 16.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 1.0 110.138 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -164.56 120.94 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 1.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.8 -72.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 1.0 110.236 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -176.37 -63.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 1.0 109.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -134.74 23.76 3.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 1.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . -126.05 71.78 0.46 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.35 -1.5 . . . . 1.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.441 ' CE2' ' HA ' ' A' ' 53' ' ' PRO . 12.1 m95 55.25 170.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -1.026 . . . . 1.0 110.435 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.408 ' O ' ' N ' ' A' ' 52' ' ' LEU . 4.6 ptp -148.89 165.69 30.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 1.0 110.26 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.431 ' CE1' ' HA2' ' A' ' 50' ' ' GLY . 9.6 t80 -105.75 123.84 48.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -177.31 21.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 84.9 m -121.2 125.96 48.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.113 . . . . 1.0 110.225 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.71 107.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 1.0 110.125 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.18 -35.63 49.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 1.0 110.457 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -59.78 -62.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 1.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -92.11 -68.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.57 -12.69 3.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -52.34 147.71 7.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.292 . . . . 1.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 2.2 p -116.66 119.35 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 1.0 109.963 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' HA2' ' CE1' ' A' ' 40' ' ' TYR . . . -159.77 170.08 35.89 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.414 ' N ' ' HA ' ' A' ' 19' ' ' GLU . 0.0 OUTLIER -66.74 155.7 37.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -1.099 . . . . 1.0 110.217 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.437 ' CD2' HG23 ' A' ' 20' ' ' VAL . 8.4 mt -132.76 155.64 80.96 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.363 -0.836 . . . . 1.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.441 ' HA ' ' CE2' ' A' ' 38' ' ' TRP . 47.9 Cg_endo -75.31 118.62 5.25 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.587 1.309 . . . . 1.0 110.263 179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.83 58.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 1.0 110.348 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -78.39 -2.58 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.923 . . . . 1.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.36 -50.25 3.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.907 -1.12 . . . . 1.0 110.335 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.1 m -81.13 -176.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 1.0 110.636 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.1 146.52 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 1.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -71.78 164.79 25.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 1.0 110.321 -179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 7.1 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.219 -179.936 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.214 0.531 . . . . 1.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.76 46.76 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 1.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.16 54.01 0.79 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -77.83 -169.43 1.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -1.142 . . . . 1.0 110.241 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 tt -129.39 167.38 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 1.0 109.906 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -134.44 -177.03 4.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.12 -0.987 . . . . 1.0 110.483 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.35 153.83 16.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 1.0 110.306 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.38 135.99 38.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 1.0 109.893 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.42 -22.36 13.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 1.0 110.617 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -121.43 178.69 4.7 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.057 -1.027 . . . . 1.0 110.102 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 41.8 p-10 -110.2 96.79 6.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 1.0 109.759 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -81.55 146.2 30.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mtm -114.42 94.9 5.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.56 -0.712 . . . . 1.0 109.222 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -46.82 138.04 6.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.815 . . . . 1.0 111.049 -179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.43 -22.16 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 1.0 109.911 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -142.97 169.98 16.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 1.0 110.168 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.12 -12.72 53.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 1.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -51.09 -41.81 60.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.001 -1.062 . . . . 1.0 110.538 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' HA ' ' N ' ' A' ' 51' ' ' MET . 2.0 pm0 -124.89 -173.98 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.99 . . . . 1.0 110.624 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 26.8 m -113.34 -174.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 1.0 110.419 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -129.18 115.59 17.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 1.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 p90 -125.88 160.5 29.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 1.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -108.77 179.52 4.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 1.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -73.79 111.99 9.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 1.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.49 -29.66 3.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.34 151.31 41.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -1.201 . . . . 1.0 110.347 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 156.67 20.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 110.449 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 28.3 mt -149.1 129.48 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 1.0 110.103 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.401 ' CG2' ' NE2' ' A' ' 44' ' ' GLN . 1.0 OUTLIER -73.71 -159.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.906 . . . . 1.0 110.655 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -114.6 87.19 2.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -0.755 . . . . 1.0 109.624 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.4 t -73.43 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 1.0 110.847 -179.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -166.97 156.76 11.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.968 -1.082 . . . . 1.0 110.595 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.09 146.1 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.16 -80.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 1.0 110.284 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -169.53 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.119 -0.988 . . . . 1.0 111.8 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.31 -170.75 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.788 -1.195 . . . . 1.0 110.475 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.36 -69.52 1.12 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -53.16 135.39 37.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 1.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -133.74 -163.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 1.0 110.141 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 137.2 52.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 1.0 110.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -144.05 141.94 10.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.4 m -103.06 104.68 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -1.194 . . . . 1.0 110.415 -179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.8 m -48.33 128.92 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.373 -0.83 . . . . 1.0 110.473 179.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.401 ' NE2' ' CG2' ' A' ' 29' ' ' ILE . 3.4 mm100 -85.66 9.96 14.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 1.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -58.2 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 1.0 109.876 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -100.7 -26.03 13.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.82 25.48 10.6 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 84.2 mtm180 -93.79 149.86 20.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -1.128 . . . . 1.0 110.334 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 1.5 m -121.03 146.69 46.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 110.421 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.68 172.58 44.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.444 ' N ' ' HA ' ' A' ' 19' ' ' GLU . 3.1 ttm -60.7 156.46 16.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -1.191 . . . . 1.0 110.197 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 1.1 mp -132.63 139.17 33.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 1.0 110.659 -179.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.439 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 43.8 Cg_endo -70.93 121.04 7.51 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.654 1.344 . . . . 1.0 110.644 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.84 60.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 1.0 110.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.49 24.54 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 1.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 4.9 m-85 -131.78 -40.15 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 1.0 109.996 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.07 173.51 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 1.0 110.123 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.89 . . . . 1.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.58 170.65 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 1.0 110.238 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.232 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.212 0.529 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.27 169.74 17.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 1.0 110.146 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.06 -45.82 0.22 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.361 -1.496 . . . . 1.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.7 mtmm -54.6 -68.05 0.22 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -1.13 . . . . 1.0 110.61 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt 61.25 141.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.512 -0.742 . . . . 1.0 109.97 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.407 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 10.4 m-85 -118.69 175.02 5.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.018 -1.051 . . . . 1.0 109.579 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.39 139.48 35.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 1.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.409 ' O ' ' HA ' ' A' ' 24' ' ' ASP . . . -86.47 124.66 33.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.185 -0.947 . . . . 1.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.0 mtt -92.6 -17.44 24.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 1.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.36 155.86 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 1.0 109.891 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.47 126.32 46.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 1.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -118.71 152.64 35.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.068 -1.02 . . . . 1.0 110.531 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 ttm -116.4 98.57 6.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.405 -0.809 . . . . 1.0 109.429 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.86 124.62 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.475 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.35 -26.46 35.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 1.0 110.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -176.59 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 1.0 110.243 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.95 -12.96 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 1.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.09 -47.16 53.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.045 . . . . 1.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 -165.46 1.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 1.0 110.171 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.432 HG23 ' CD1' ' A' ' 52' ' ' LEU . 21.9 m -121.07 -172.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 1.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 t -133.26 117.28 17.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -137.54 166.8 23.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 1.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -120.96 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 1.0 110.52 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.409 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 12.4 t70 -69.12 130.36 42.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 1.0 110.365 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.76 -11.44 49.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -68.52 155.79 39.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.938 -1.33 . . . . 1.0 110.341 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.65 129.25 56.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 1.0 110.288 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.43 HD11 HG22 ' A' ' 28' ' ' ILE . 42.3 mt -147.48 171.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 1.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.514 ' N ' ' CD1' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.14 -177.89 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.095 . . . . 1.0 110.252 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -122.42 88.93 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.484 -0.76 . . . . 1.0 110.264 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.54 -65.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.241 -0.912 . . . . 1.0 109.781 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -101.43 -48.25 4.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 1.0 109.828 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 53.31 80.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 1.0 110.68 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 61.7 mt -84.11 -5.17 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 1.0 110.568 179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 65.42 -69.92 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.213 -0.93 . . . . 1.0 110.676 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -75.85 124.43 27.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 1.0 110.396 -179.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.99 61.46 1.93 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.674 -1.37 . . . . 1.0 109.674 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m95 52.56 179.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -1.151 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 2.5 ptp -136.88 -174.42 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 1.0 109.879 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -129.28 139.73 51.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -0.969 . . . . 1.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.58 152.83 22.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 88.3 m -98.95 128.95 45.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -1.183 . . . . 1.0 110.241 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.2 t -61.98 97.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 1.0 110.061 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -19.5 25.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 1.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -53.12 16.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 1.0 110.294 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 20.3 p -97.48 -49.66 4.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 1.0 110.296 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.43 -14.36 5.86 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.54 -168.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.947 -1.325 . . . . 1.0 110.176 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 4.9 t -172.16 151.66 2.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 1.0 110.37 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.8 -158.74 20.25 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -77.89 137.41 38.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 1.0 110.073 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.432 ' CD1' HG23 ' A' ' 20' ' ' VAL . 10.7 mp -124.46 151.42 66.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 1.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.402 ' HB2' ' HB2' ' A' ' 56' ' ' TYR . 46.6 Cg_endo -72.76 108.8 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.721 1.379 . . . . 1.0 110.122 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.13 65.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.7 6.48 34.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.026 . . . . 1.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' A' ' 53' ' ' PRO . 1.9 m-85 -114.27 -64.37 1.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.044 -1.035 . . . . 1.0 110.156 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.66 157.17 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 1.0 110.258 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.51 -177.99 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.878 . . . . 1.0 110.294 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.56 148.92 24.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 1.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 pt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.139 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.267 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.06 164.83 26.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 1.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.28 43.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 1.0 109.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -69.58 -171.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -1.139 . . . . 1.0 110.259 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 13.3 tt -127.61 170.51 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 1.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 39.1 m-85 -148.27 177.13 9.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 1.0 110.476 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.6 ttp180 -140.5 133.07 28.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 1.0 110.063 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.37 136.21 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.967 . . . . 1.0 110.44 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.47 ' HG3' ' CE1' ' A' ' 10' ' ' TYR . 9.2 tpp -128.01 1.2 5.92 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.306 -0.871 . . . . 1.0 109.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CE1' ' HG3' ' A' ' 9' ' ' MET . 33.5 m-85 -124.36 -7.68 7.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.905 -1.122 . . . . 1.0 111.316 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t0 60.36 71.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.003 -1.06 . . . . 1.0 108.774 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -77.65 148.68 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 1.0 111.296 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttp -121.59 99.64 6.58 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -47.55 115.9 1.28 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 1.0 110.893 -179.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.48 -33.72 17.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 1.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 -151.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.47 -25.11 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 1.0 110.214 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' CA ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -79.56 -23.44 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.378 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.403 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 3.1 mp0 -80.05 172.05 14.28 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 1.0 110.53 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.7 m -117.05 169.0 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.441 -0.787 . . . . 1.0 109.626 179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -128.89 101.29 6.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.987 -1.071 . . . . 1.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 7.9 p90 -123.32 148.64 45.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 1.0 109.862 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.56 -174.15 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 1.0 110.574 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.49 111.73 12.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 1.0 110.251 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.62 -18.32 7.21 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.28 165.92 5.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.248 . . . . 1.0 110.378 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.89 145.31 51.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 1.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.6 mm -111.27 147.26 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.914 . . . . 1.0 110.033 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.2 pt -58.88 -169.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 1.0 110.26 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 19.5 p-10 -83.32 55.07 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.444 ' CG1' ' O ' ' A' ' 40' ' ' TYR . 1.8 p -80.84 -158.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.858 . . . . 1.0 109.997 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.414 ' N ' HG12 ' A' ' 31' ' ' VAL . 19.5 pt20 -160.49 -156.89 0.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.914 -1.116 . . . . 1.0 110.054 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.43 ' CB ' ' CB ' ' A' ' 39' ' ' MET . . . -137.23 -152.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 1.0 109.976 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.437 ' CG1' ' N ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -128.45 -85.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 1.0 109.773 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.437 ' N ' ' CG1' ' A' ' 34' ' ' ILE . 26.2 t0 -108.81 -64.2 1.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.114 . . . . 1.0 110.264 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -177.72 156.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 1.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.57 -55.92 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.674 -1.371 . . . . 1.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -143.55 163.05 34.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -1.223 . . . . 1.0 110.642 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.43 ' CB ' ' CB ' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.3 -152.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.716 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.444 ' O ' ' CG1' ' A' ' 31' ' ' VAL . 0.4 OUTLIER -144.09 166.77 24.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 1.0 109.973 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' CA ' HG13 ' A' ' 31' ' ' VAL . . . 175.54 167.14 34.17 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.825 -1.31 . . . . 1.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.5 m -118.69 128.43 54.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.341 -1.093 . . . . 1.0 110.066 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.31 117.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 1.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -57.75 -23.06 50.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 1.0 110.473 -179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -71.56 0.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 1.0 110.304 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.9 p -72.69 -51.93 17.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 1.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 111.59 -15.14 27.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.72 166.3 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -1.23 . . . . 1.0 110.248 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 41.3 p -131.57 134.9 46.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 1.0 110.458 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.424 ' CA ' ' O ' ' A' ' 18' ' ' ASP . . . -160.09 -164.63 15.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.701 -1.36 . . . . 1.0 109.701 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -80.45 142.55 34.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -1.13 . . . . 1.0 110.183 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 7.0 mp -124.51 142.33 40.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 1.0 110.539 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -76.72 114.84 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.587 1.309 . . . . 1.0 109.99 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.03 67.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.136 -0.977 . . . . 1.0 110.849 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -71.97 -21.45 61.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.076 -1.015 . . . . 1.0 110.64 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.439 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 3.5 m-30 -81.89 -65.54 1.0 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 1.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -52.38 151.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 1.0 110.089 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.4 162.13 25.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.0 110.377 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 145.32 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 1.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 pt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.161 179.887 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.208 0.528 . . . . 1.0 110.173 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.44 33.28 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 1.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.63 20.43 32.0 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -87.23 -174.05 4.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -1.181 . . . . 1.0 110.094 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.424 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 11.0 tt -154.7 169.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 1.0 110.123 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 55.9 m-85 -137.25 176.6 8.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.296 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -159.94 145.14 15.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 1.0 109.891 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HB3' ' CE1' ' A' ' 22' ' ' PHE . . . -87.75 120.6 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 1.0 110.406 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -101.79 12.23 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 1.0 110.561 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.0 m-85 -141.77 140.71 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.0 110.375 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -80.62 115.62 20.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 1.0 109.297 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -121.3 163.1 19.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.911 -1.118 . . . . 1.0 111.129 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.85 115.84 13.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.61 -0.681 . . . . 1.0 109.3 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.31 133.69 15.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.162 -0.961 . . . . 1.0 110.761 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.07 -34.69 60.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -175.64 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 1.0 110.631 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -176.64 -32.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.094 -1.004 . . . . 1.0 110.876 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.24 -26.33 0.77 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 1.0 111.027 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -136.23 -168.91 2.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 1.0 110.4 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.433 HG23 ' CD1' ' A' ' 52' ' ' LEU . 16.7 m -113.39 -174.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 1.0 110.241 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -136.03 115.14 12.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0 110.687 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 8' ' ' ALA . 11.6 p90 -126.46 153.53 44.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 1.0 109.865 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -92.39 173.32 7.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 1.0 110.652 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -70.0 83.51 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.815 . . . . 1.0 109.977 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 156.45 -23.67 0.51 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.58 -1.408 . . . . 1.0 109.58 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.81 158.66 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -1.203 . . . . 1.0 110.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.86 145.81 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.356 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.408 HG21 HD11 ' A' ' 28' ' ' ILE . 40.5 mm -122.58 170.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 1.0 109.747 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.471 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -131.01 -145.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 1.0 110.01 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.471 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 5.1 t-20 -126.84 87.14 2.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 1.0 110.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 60.5 t -91.11 -59.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 1.0 110.323 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -172.4 178.26 2.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 1.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.2 123.44 5.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 1.0 110.079 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 72.5 mt -85.11 -43.92 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 1.0 110.304 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -148.99 -169.53 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 1.0 110.18 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -25.82 30.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 1.0 109.942 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.4 -75.55 0.29 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -121.83 158.18 29.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -1.159 . . . . 1.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -123.44 -163.12 1.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 1.0 110.038 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -139.34 130.48 26.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 1.0 110.277 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -167.49 -171.18 33.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.407 ' O ' ' NE2' ' A' ' 44' ' ' GLN . 52.9 m -125.2 142.76 51.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 1.0 110.257 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.0 110.81 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.213 -0.93 . . . . 1.0 109.804 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 42' ' ' THR . 2.4 mp0 -60.13 -17.54 41.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 1.0 110.894 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -69.09 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.003 -1.06 . . . . 1.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.2 p -80.03 -41.01 26.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.942 . . . . 1.0 110.296 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 14.66 25.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -70.91 152.22 43.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.278 . . . . 1.0 110.05 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 p -128.34 129.82 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 1.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.83 40.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 12.6 ttm -71.05 148.87 47.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 1.0 110.291 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.433 ' CD1' HG23 ' A' ' 20' ' ' VAL . 9.8 mp -126.53 140.4 37.26 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 1.0 110.302 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.89 95.84 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.586 1.308 . . . . 1.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.67 -24.06 60.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 1.0 110.456 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -76.79 -10.26 59.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 1.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.71 -45.25 6.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.029 . . . . 1.0 110.103 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.36 163.76 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 1.0 110.029 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.97 178.3 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 1.0 110.332 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 60' ' ' ILE . . . -90.15 14.92 11.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 1.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.431 ' CG1' ' O ' ' A' ' 59' ' ' ALA . 37.8 pt . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 117.988 -1.006 . . . . 1.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.26 0.553 . . . . 1.0 110.212 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.47 163.46 6.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 1.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.68 -37.0 0.09 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.486 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.7 mtpt -54.96 -43.24 73.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -1.17 . . . . 1.0 110.217 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 ' CG2' ' O ' ' A' ' 4' ' ' LYS . 11.9 tt 47.75 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.571 0.7 . . . . 1.0 111.351 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 5' ' ' ILE . 14.4 m-85 -155.35 -175.18 5.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.0 110.4 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 18.2 tpp180 -162.9 132.86 4.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.0 110.05 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -83.64 147.82 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 1.0 110.303 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 mtp -120.43 -14.98 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 1.0 110.656 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -124.03 125.33 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 1.0 110.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.13 92.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 1.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -82.02 167.37 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 1.0 110.775 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.82 117.2 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.767 . . . . 1.0 109.635 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.73 125.99 11.1 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 1.0 110.774 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.96 -34.52 15.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 1.0 110.291 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.21 -82.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 1.0 110.234 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.36 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.129 -0.982 . . . . 1.0 110.398 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.07 -24.34 6.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 1.0 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.07 171.03 7.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.46 ' CG1' ' CA ' ' A' ' 50' ' ' GLY . 25.7 m -113.46 -156.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 1.0 109.975 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.96 128.12 7.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 1.0 110.579 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.1 p90 -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.368 -0.832 . . . . 1.0 109.878 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 4.4 pttt -96.71 -165.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 1.0 110.503 -179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.83 114.55 18.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.283 -0.886 . . . . 1.0 110.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.38 -2.39 50.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.83 157.15 7.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.912 -1.346 . . . . 1.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.0 130.35 50.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 1.0 110.279 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.441 HG21 ' N ' ' A' ' 29' ' ' ILE . 34.3 mt -145.29 153.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 1.0 109.853 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.441 ' N ' HG21 ' A' ' 28' ' ' ILE . 0.2 OUTLIER -112.93 -142.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 1.0 110.182 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -153.68 105.28 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 1.0 110.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG11 ' N ' ' A' ' 32' ' ' GLN . 7.2 p -83.34 -23.04 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 1.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.433 ' N ' HG11 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -172.95 177.72 2.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 1.0 110.171 -179.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.76 136.17 37.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 1.0 110.341 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.425 HD12 HG22 ' A' ' 34' ' ' ILE . 58.1 mt -77.85 -13.63 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 1.0 110.569 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 63.88 10.97 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.139 -0.976 . . . . 1.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -113.22 -65.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.977 -1.077 . . . . 1.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.37 -52.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.417 ' CE3' ' HB3' ' A' ' 51' ' ' MET . 7.9 m95 -84.2 178.19 7.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 1.0 110.105 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.07 174.37 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0 110.3 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -116.1 136.37 53.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 1.0 110.51 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 168.19 34.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -116.45 122.9 46.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.86 126.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 1.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -73.23 -30.39 63.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 1.0 110.597 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -24.04 66.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 1.0 110.318 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -131.77 -59.57 0.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.0 110.176 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.92 28.14 1.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -99.97 135.97 40.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 1.0 109.89 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 25.5 m -101.3 123.88 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 1.0 110.512 -179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' CA ' ' CG1' ' A' ' 20' ' ' VAL . . . -153.82 -167.0 15.41 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.417 ' HB3' ' CE3' ' A' ' 38' ' ' TRP . 8.0 mtp -78.99 143.68 35.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -1.159 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.42 HD13 ' CG2' ' A' ' 20' ' ' VAL . 9.4 mp -126.44 138.03 31.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 1.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -74.05 113.5 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.529 1.279 . . . . 1.0 110.589 -179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.31 81.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.035 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -60.75 -17.59 49.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 1.0 110.186 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -95.44 -59.64 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 1.0 110.011 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.0 m -71.66 170.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 1.0 110.129 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.22 158.51 24.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 1.0 110.312 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 159.66 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 1.0 110.278 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 33.7 pt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.209 179.961 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.311 0.577 . . . . 1.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.02 72.22 6.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 1.0 110.294 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.69 -50.13 4.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 1.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -74.13 -43.74 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -1.114 . . . . 1.0 110.221 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.449 HD12 HG22 ' A' ' 5' ' ' ILE . 23.0 mt 57.59 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.0 110.612 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.9 -178.36 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 1.0 110.031 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 15.0 ttt85 -170.03 138.12 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 1.0 110.411 -179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.13 33.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 1.0 109.879 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.2 mmm -95.77 -14.37 23.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 1.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 35.2 m-85 -137.75 151.41 48.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.03 -1.044 . . . . 1.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -81.63 84.38 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 1.0 109.28 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -70.1 166.4 19.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 1.0 110.996 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.34 114.3 8.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.632 -0.668 . . . . 1.0 109.344 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.02 121.53 4.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.204 -0.935 . . . . 1.0 110.635 -179.471 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 1.0 110.548 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.33 -69.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.074 -1.016 . . . . 1.0 110.748 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.63 -34.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.956 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.38 -29.53 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.197 -0.94 . . . . 1.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.07 -177.06 3.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.147 -0.97 . . . . 1.0 109.952 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.431 HG23 ' CD1' ' A' ' 52' ' ' LEU . 19.0 m -110.36 -152.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 1.0 110.585 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 t -157.07 141.93 16.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 1.0 110.41 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -150.95 149.69 29.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.353 -0.842 . . . . 1.0 109.78 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -174.87 4.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.516 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.13 114.56 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.98 -21.1 9.02 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.679 -1.369 . . . . 1.0 109.679 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.46 169.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -1.181 . . . . 1.0 110.311 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -118.3 139.51 51.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.818 . . . . 1.0 110.13 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.404 HG21 HD11 ' A' ' 28' ' ' ILE . 40.1 mm -123.08 173.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.0 109.992 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.446 ' CG2' ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -117.96 -140.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 1.0 109.278 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.446 ' N ' ' CG2' ' A' ' 29' ' ' ILE . 12.3 t-20 -172.19 69.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.646 -1.284 . . . . 1.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.431 HG21 ' N ' ' A' ' 32' ' ' GLN . 20.7 m -70.56 -35.74 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.286 -0.884 . . . . 1.0 110.454 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.431 ' N ' HG21 ' A' ' 31' ' ' VAL . 51.8 tt0 -144.53 -65.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 1.0 110.322 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 61.58 133.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.835 . . . . 1.0 110.577 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.445 HG22 HD11 ' A' ' 34' ' ' ILE . 50.1 mm -119.8 -7.33 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.061 -1.024 . . . . 1.0 110.663 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 18.5 t0 66.71 -66.54 0.18 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.174 -0.954 . . . . 1.0 110.55 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -94.05 91.21 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.99 . . . . 1.0 110.587 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.85 64.82 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.5 m95 52.9 176.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.356 -1.084 . . . . 1.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 ptp -150.1 178.49 8.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 1.0 109.864 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -124.11 122.2 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 110.311 -179.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.75 176.68 24.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 85.3 m -126.14 141.54 51.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -1.085 . . . . 1.0 110.096 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.82 110.34 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 1.0 110.297 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -55.68 -28.99 58.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.401 -0.812 . . . . 1.0 110.36 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -66.91 -70.31 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 1.0 110.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -81.93 -55.83 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 1.0 110.312 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.66 30.36 2.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -97.02 128.81 44.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 1.0 110.358 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 98.0 m -112.99 121.6 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 1.0 110.211 179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.85 -147.92 5.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.3 mmt -84.2 138.72 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 1.0 110.198 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.431 ' CD1' HG23 ' A' ' 20' ' ' VAL . 7.3 mp -123.25 148.55 55.26 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.19 110.3 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.684 1.36 . . . . 1.0 110.134 179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.95 -23.09 65.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.567 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.01 7.95 25.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.9 m-85 -117.13 -58.67 2.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 1.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.12 161.6 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 1.0 110.177 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -169.19 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 1.0 109.964 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 147.11 27.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 1.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 pt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.207 179.838 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.228 0.537 . . . . 1.0 110.305 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.49 -172.91 4.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 1.0 110.438 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.55 22.01 32.74 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -78.17 -168.99 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 1.0 110.371 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.85 137.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 1.0 109.744 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -119.37 -176.47 3.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 1.0 109.894 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.68 136.56 5.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 1.0 110.543 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.52 140.73 58.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 1.0 110.155 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.2 mtp -129.0 12.8 6.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.487 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 51.2 m-85 -131.76 -7.15 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.063 -1.023 . . . . 1.0 111.463 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.68 90.59 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.963 -1.086 . . . . 1.0 109.697 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.483 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 21.7 t80 -111.66 132.34 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 1.0 110.53 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' MET . . . . . 0.433 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 5.2 ptt? -110.81 22.87 14.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.0 110.019 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.483 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . . . 57.23 158.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.538 0.685 . . . . 1.0 110.721 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.78 -22.83 11.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 1.0 110.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.02 -155.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.98 20.1 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 1.0 110.205 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -87.55 -36.3 17.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.0 110.606 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -119.76 -173.81 2.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 1.0 110.51 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.443 HG23 ' CD1' ' A' ' 52' ' ' LEU . 24.4 m -108.52 -178.01 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 1.0 109.92 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.433 ' CB ' ' HA ' ' A' ' 13' ' ' MET . 2.2 p -131.02 133.44 45.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 1.0 110.648 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.416 ' HB2' ' CB ' ' A' ' 26' ' ' ASP . 6.4 p90 -137.72 168.84 18.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 1.0 109.845 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -94.34 -174.75 3.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.0 110.376 -179.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -77.42 1.09 20.13 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.268 -0.895 . . . . 1.0 110.921 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.89 20.23 5.73 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.801 -1.32 . . . . 1.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 22' ' ' PHE . 37.6 t0 -78.17 155.26 30.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 1.0 110.081 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.68 128.91 55.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 1.0 110.537 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.416 HD11 HG22 ' A' ' 28' ' ' ILE . 27.7 mt -147.34 171.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -0.81 . . . . 1.0 109.474 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 7.0 pt -142.27 -178.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.099 -1.0 . . . . 1.0 110.778 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -88.04 70.2 9.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 1.0 110.365 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.7 t -54.23 -62.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.83 151.68 47.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 109.909 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.24 132.21 27.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 1.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -95.55 -56.52 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 1.0 109.914 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.73 -161.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 134.54 52.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.126 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.21 85.24 1.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.461 -1.456 . . . . 1.0 109.461 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 38' ' ' TRP . 26.6 m95 55.07 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.51 -0.994 . . . . 1.0 110.552 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.0 ptt? -149.61 -147.96 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.15 -0.969 . . . . 1.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.21 128.52 30.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.79 170.39 28.49 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.1 m -123.76 104.17 8.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 1.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 61.0 t -53.07 131.18 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 1.0 110.093 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -85.62 -16.3 39.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 1.0 110.554 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -68.12 -35.71 78.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.0 110.448 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.8 p -124.25 -42.84 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 1.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.88 34.95 2.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -106.2 111.4 24.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -1.151 . . . . 1.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.0 m -92.82 124.93 37.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 1.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 -153.68 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 7.1 mtt -78.39 143.44 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -1.151 . . . . 1.0 110.283 -179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.443 ' CD1' HG23 ' A' ' 20' ' ' VAL . 3.1 mp -132.53 141.65 41.98 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 1.0 110.209 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.08 93.75 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.599 1.315 . . . . 1.0 110.374 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.99 -27.88 61.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 1.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -76.73 -2.39 32.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 1.0 110.917 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.487 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.7 m-85 -105.3 -51.61 2.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 1.0 110.237 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.9 m -76.54 152.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 110.168 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.31 173.33 12.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.9 . . . . 1.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.56 139.36 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 1.0 110.163 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.159 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 1.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.61 -178.21 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 1.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.15 -39.06 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -56.51 -63.21 1.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 1.0 110.491 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' C ' ' CD1' ' A' ' 6' ' ' PHE . 21.3 mm 54.94 171.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 1.0 110.275 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.426 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 38.8 m-85 -145.24 178.25 8.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.953 . . . . 1.0 110.148 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -153.87 117.05 4.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 1.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.27 132.39 52.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 1.0 110.175 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 mtp -114.0 9.76 17.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 1.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 9' ' ' MET . 48.6 m-85 -142.86 152.16 41.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.999 -1.063 . . . . 1.0 110.366 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -85.9 86.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 1.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.478 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 25.5 t80 -94.02 131.67 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 1.0 110.484 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.43 22.09 15.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 1.0 110.098 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.478 ' HA ' ' CE2' ' A' ' 12' ' ' TYR . . . 55.15 166.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.633 0.73 . . . . 1.0 110.986 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 -19.79 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 1.0 109.908 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.86 -157.86 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 1.0 109.971 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.35 19.29 9.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.196 -0.94 . . . . 1.0 110.401 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.0 -34.92 22.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 1.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.4 -176.97 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.94 . . . . 1.0 110.303 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.44 ' CG2' HD13 ' A' ' 52' ' ' LEU . 12.0 m -105.24 -162.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0 110.179 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -139.55 105.93 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 1.0 110.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -118.77 154.47 32.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 1.0 109.897 179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -97.68 178.27 5.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 1.0 110.378 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -69.83 81.73 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.0 110.054 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 163.43 -28.19 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 4.5 m-20 -53.39 151.53 5.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -1.114 . . . . 1.0 110.162 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.47 143.47 50.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 1.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.429 HD11 HG22 ' A' ' 28' ' ' ILE . 56.8 mt -138.98 146.75 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 1.0 109.926 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.432 HG13 ' CG2' ' A' ' 31' ' ' VAL . 2.9 pt -81.69 -161.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 1.0 110.771 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 32' ' ' GLN . 35.6 m-20 -72.29 -47.42 50.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.369 -0.832 . . . . 1.0 110.937 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.445 ' CG2' ' HA2' ' A' ' 41' ' ' GLY . 72.8 t 56.28 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 1.0 110.461 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -171.09 139.93 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 110.522 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.52 145.72 37.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 1.0 110.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -126.86 -33.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 1.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.13 170.09 16.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 1.0 110.408 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -79.3 -22.8 44.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 1.0 110.306 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.6 -75.73 0.29 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.74 152.88 38.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -1.184 . . . . 1.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.06 -160.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 1.0 110.446 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.474 ' CE1' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -137.15 135.29 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.813 . . . . 1.0 109.807 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.445 ' HA2' ' CG2' ' A' ' 31' ' ' VAL . . . -164.74 159.02 31.98 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.599 -1.286 . . . . 1.0 109.906 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 55.5 m -108.98 121.68 45.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -1.088 . . . . 1.0 109.96 179.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 34.1 t -63.92 122.81 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 1.0 110.319 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -76.03 -10.39 59.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 1.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.44 -68.0 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 110.33 -179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.72 -40.13 8.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 1.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.44 24.73 3.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -84.48 126.47 33.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -1.164 . . . . 1.0 110.012 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 15.6 p -97.75 133.47 42.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 110.327 -179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 178.86 -174.34 46.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.474 ' HG3' ' CE1' ' A' ' 40' ' ' TYR . 29.6 mtp -87.6 153.68 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -1.181 . . . . 1.0 110.589 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -126.02 145.02 50.66 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 1.0 109.65 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -72.11 112.57 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.66 1.347 . . . . 1.0 110.09 179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.03 -39.77 94.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.99 . . . . 1.0 110.206 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -23.15 14.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.171 -0.956 . . . . 1.0 109.956 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.29 -73.66 0.48 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.0 110.126 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 33.2 m -52.9 151.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 1.0 110.075 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -124.24 159.39 30.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 1.0 110.234 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 149.93 29.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 1.0 110.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.278 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.255 0.55 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.37 178.46 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 1.0 110.199 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.99 25.93 8.72 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -100.24 -174.35 2.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -1.121 . . . . 1.0 110.411 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mt -122.05 151.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.323 -0.861 . . . . 1.0 109.731 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -119.95 179.23 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -161.88 144.55 11.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 1.0 110.21 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.27 124.71 41.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 1.0 110.099 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 3.0 mmm -95.5 -3.0 47.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 1.0 110.871 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -127.87 177.43 6.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.931 -1.105 . . . . 1.0 110.336 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.67 83.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.716 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.61 140.94 41.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 1.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.9 mtt -112.16 108.33 17.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.468 -0.77 . . . . 1.0 109.507 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.1 120.92 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.881 . . . . 1.0 110.803 -179.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.18 64.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 1.0 109.847 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.57 -175.25 2.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 1.0 109.939 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -17.36 56.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 1.0 110.313 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.09 -31.65 62.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 1.0 110.298 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 1.9 mp0 -84.92 171.92 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 1.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.418 HG12 ' CA ' ' A' ' 50' ' ' GLY . 35.7 m -116.67 167.62 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 1.0 109.877 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 t -129.56 108.57 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 1.0 110.554 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 1.0 110.098 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.04 178.62 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 1.0 110.601 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -75.03 99.63 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 1.0 110.111 179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.08 -28.23 2.38 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.083 -1.607 . . . . 1.0 109.083 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.408 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 9.7 t70 -63.1 165.92 6.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.063 . . . . 1.0 109.994 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.57 169.19 15.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 1.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.441 HG21 ' CG1' ' A' ' 31' ' ' VAL . 27.0 mm -130.78 163.55 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.681 -0.637 . . . . 1.0 109.439 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.415 ' CG2' ' O ' ' A' ' 28' ' ' ILE . 7.6 pt -151.86 161.25 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.079 . . . . 1.0 110.956 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 51.53 54.2 11.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 1.0 110.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.441 ' CG1' HG21 ' A' ' 28' ' ' ILE . 27.3 m -104.3 170.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.185 -0.947 . . . . 1.0 110.377 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -158.67 -161.86 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0 109.928 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.66 20.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 1.0 110.264 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.0 mp -78.81 -70.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.353 -0.842 . . . . 1.0 110.081 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.85 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 1.0 110.032 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 1.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.05 -55.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -54.4 155.89 3.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -1.114 . . . . 1.0 109.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.9 ptt? -131.94 -164.1 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 1.0 110.483 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -124.86 158.76 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 1.0 109.872 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -175.06 159.9 28.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 54.6 m -126.86 117.23 22.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 1.0 109.866 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.408 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 22.0 t -57.14 109.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 1.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -23.68 63.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.866 . . . . 1.0 110.701 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -75.83 -74.07 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 1.0 110.649 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 p -68.66 -56.79 7.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 1.0 110.312 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.15 32.23 1.72 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -97.48 148.56 23.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 1.0 110.13 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 29.7 p -125.21 135.83 52.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 1.0 110.06 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.418 ' CA ' HG12 ' A' ' 20' ' ' VAL . . . -178.56 -163.59 30.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -80.87 141.86 34.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 1.0 110.129 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 8.9 mp -123.1 125.8 26.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.549 -0.719 . . . . 1.0 109.99 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 107.47 2.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.408 1.215 . . . . 1.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.59 55.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 1.0 110.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -62.19 -17.34 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 1.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -98.52 -60.95 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 1.0 109.794 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 28.7 m -78.51 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 1.0 110.078 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.83 -174.74 2.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.915 . . . . 1.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.427 ' O ' ' CG2' ' A' ' 60' ' ' ILE . . . -105.23 167.18 9.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 1.0 110.525 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.427 ' CG2' ' O ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.177 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.289 0.566 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 72.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 1.0 110.135 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.94 62.86 0.55 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.479 -1.449 . . . . 1.0 109.479 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -74.26 -34.01 63.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -1.105 . . . . 1.0 110.15 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm 58.1 159.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.39 -0.819 . . . . 1.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.32 -174.71 3.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 1.0 110.23 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -153.12 164.17 38.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 1.0 110.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.72 133.22 53.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 1.0 110.141 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 8.9 mtp -111.35 -6.3 14.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 1.0 110.743 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -131.79 167.12 20.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 1.0 110.148 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -98.69 105.45 17.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.289 -0.882 . . . . 1.0 109.86 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -109.62 160.94 15.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 1.0 110.908 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 114.45 9.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -0.76 . . . . 1.0 109.759 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -50.15 117.47 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.642 -179.657 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.36 49.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 1.0 110.014 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.72 -154.85 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 1.0 109.973 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.46 15.55 27.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 1.0 110.518 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -85.38 -35.22 21.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.031 -1.043 . . . . 1.0 110.255 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.5 pm0 -124.71 -175.87 3.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 1.0 110.49 179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.426 HG23 ' CD2' ' A' ' 52' ' ' LEU . 31.6 m -113.7 -165.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 1.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.54 123.78 24.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 1.0 110.331 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.3 153.74 51.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 1.0 110.115 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -97.85 178.58 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 1.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.45 119.36 17.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 1.0 110.191 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.23 -35.36 3.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.38 160.3 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.145 . . . . 1.0 110.347 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 141.22 52.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.211 -0.931 . . . . 1.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 39.1 mt -143.75 127.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.94 . . . . 1.0 110.199 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.7 -160.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 1.0 110.455 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -160.79 79.1 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.838 . . . . 1.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 40.4 t -52.83 -62.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 1.0 110.13 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -119.6 147.13 44.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.868 . . . . 1.0 109.904 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.64 115.06 9.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 1.0 110.34 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 39.7 mm -93.45 -5.67 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 1.0 110.504 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.41 -72.19 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -0.977 . . . . 1.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.11 47.05 1.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 1.0 110.371 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.74 49.55 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.2 m95 52.99 178.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -1.177 . . . . 1.0 110.123 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 5.3 ptm -138.66 173.05 11.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 1.0 110.324 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -120.68 158.77 26.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.02 -175.31 47.36 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' THR . . . . . 0.413 ' OG1' ' CG2' ' A' ' 49' ' ' THR . 52.3 m -125.64 122.55 36.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -1.109 . . . . 1.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.67 118.52 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 1.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -21.21 64.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.92 . . . . 1.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -69.56 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 1.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -86.94 -28.34 22.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 1.0 110.354 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.89 8.55 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -106.34 142.9 35.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -1.091 . . . . 1.0 110.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' THR . . . . . 0.413 ' CG2' ' OG1' ' A' ' 42' ' ' THR . 37.2 p -104.95 143.24 33.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -179.1 178.09 48.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 4.9 mmm -79.48 153.53 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 1.0 110.216 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.426 ' CD2' HG23 ' A' ' 20' ' ' VAL . 12.3 mt -129.64 162.92 50.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 1.0 109.931 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -74.88 114.99 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 1.0 110.378 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.84 -18.34 62.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 1.0 110.459 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.21 -1.04 57.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.972 . . . . 1.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -110.91 -65.41 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.96 -1.088 . . . . 1.0 110.396 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -56.3 170.33 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 1.0 110.34 -179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.54 157.87 37.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 1.0 110.298 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.51 140.53 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.208 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.279 0.562 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.57 162.05 39.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 1.0 110.325 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.19 31.23 3.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.433 -1.467 . . . . 1.0 109.433 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -56.05 -168.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -1.074 . . . . 1.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mt -106.07 148.83 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 1.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -119.57 179.78 4.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 1.0 110.141 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.37 142.53 12.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.1 155.49 20.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 1.0 110.122 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 mtp -134.19 4.93 3.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 1.0 110.921 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -134.32 129.21 35.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.988 -1.07 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.3 103.47 2.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 1.0 109.825 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -104.22 147.64 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.983 . . . . 1.0 110.722 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.16 105.41 11.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 1.0 109.79 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.84 120.42 3.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.244 -0.91 . . . . 1.0 110.661 -179.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.46 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 1.0 110.114 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -171.22 2.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 1.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 11.36 15.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 1.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -26.35 43.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 1.0 110.054 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -131.85 -176.97 4.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.308 -0.87 . . . . 1.0 110.243 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.441 HG23 ' CD2' ' A' ' 52' ' ' LEU . 29.9 m -115.79 -169.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 1.0 109.964 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.6 p -133.21 123.97 26.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 1.0 110.725 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.04 159.57 37.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 1.0 109.891 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -105.4 176.95 4.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 1.0 110.393 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.96 93.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.221 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.33 -24.45 0.59 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 3.8 t0 -65.01 177.09 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -1.137 . . . . 1.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.99 164.38 33.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 1.0 110.259 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.4 ' O ' HG12 ' A' ' 29' ' ' ILE . 20.8 mm -118.51 172.02 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.334 -0.854 . . . . 1.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.4 HG12 ' O ' ' A' ' 28' ' ' ILE . 0.3 OUTLIER -171.61 -35.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.044 -1.035 . . . . 1.0 110.477 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.66 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.209 -0.932 . . . . 1.0 111.117 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 42.5 t -95.13 -109.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.085 -1.01 . . . . 1.0 110.192 -179.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -176.26 -152.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.469 -1.394 . . . . 1.0 110.125 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.6 129.07 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 1.0 110.455 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.99 -8.4 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.75 146.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.11 -0.994 . . . . 1.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.49 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 1.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.61 27.48 5.47 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.1 m95 54.8 171.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.46 -1.024 . . . . 1.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.425 ' CG ' ' HB2' ' A' ' 52' ' ' LEU . 0.6 OUTLIER -122.56 -167.84 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 1.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -147.61 144.64 28.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.166 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.28 178.39 44.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -106.88 132.53 52.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -1.067 . . . . 1.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 49.3 t -69.75 129.11 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 1.0 109.801 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -70.75 -35.18 72.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 1.0 110.652 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -57.85 8.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 1.0 110.572 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 p -91.93 -52.28 4.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 1.0 110.613 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.96 25.38 6.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.353 -1.499 . . . . 1.0 109.353 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -95.45 138.58 32.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 1.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.34 135.93 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 1.0 110.171 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.78 177.27 47.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 11.1 mmt -82.6 151.9 26.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -1.148 . . . . 1.0 109.99 179.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.441 ' CD2' HG23 ' A' ' 20' ' ' VAL . 9.7 mt -128.27 161.92 53.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 1.0 109.917 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -74.55 115.08 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.677 1.357 . . . . 1.0 110.267 179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.37 -17.19 60.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 1.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.2 -8.29 51.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 1.0 110.85 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.94 -60.69 1.48 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.008 -1.058 . . . . 1.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -70.48 163.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 1.0 109.863 179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 -177.46 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.031 -1.043 . . . . 1.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 169.23 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 1.0 110.245 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.216 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 2' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.875 0.369 . . . . 1.0 110.938 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.425 ' N ' HG22 ' A' ' 1' ' ' THR . . . -152.88 30.38 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.141 . . . . 1.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.06 -18.93 5.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.927 -1.269 . . . . 1.0 109.927 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -73.18 -172.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -1.205 . . . . 1.0 110.347 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.98 152.88 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 1.0 109.558 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.4 179.84 4.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 1.0 110.409 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.4 ttp85 -160.46 155.4 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 1.0 110.377 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.88 149.3 27.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 1.0 110.029 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.473 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 22.7 mtm -139.81 28.75 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 1.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.4 m-85 -150.22 109.86 4.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 110.609 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.21 133.88 49.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.0 109.45 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TYR . . . . . 0.411 ' N ' ' HB2' ' A' ' 22' ' ' PHE . 19.3 t80 -147.24 137.39 23.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.946 -1.096 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.2 ttp -102.74 103.9 14.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -45.59 115.39 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.473 -0.767 . . . . 1.0 111.356 -179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.77 -48.6 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 1.0 109.586 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.48 150.1 28.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 1.0 109.664 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.16 -28.37 10.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.0 110.509 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.3 -35.6 79.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 110.366 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 4.7 mp0 -84.75 172.14 11.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.261 -0.899 . . . . 1.0 110.724 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.445 ' CG1' ' N ' ' A' ' 50' ' ' GLY . 13.5 m -120.94 169.12 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 1.0 110.032 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -103.49 126.02 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.948 . . . . 1.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.461 ' CZ ' ' HD2' ' A' ' 53' ' ' PRO . 5.4 m-85 -84.36 167.1 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 1.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.426 ' HD2' ' N ' ' A' ' 24' ' ' ASP . 1.8 tptt -152.93 122.09 6.62 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASP . . . . . 0.426 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 20.4 t0 -46.73 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 1.0 111.035 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 120.65 31.08 1.28 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -105.75 172.82 6.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -1.211 . . . . 1.0 110.065 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -148.1 155.85 41.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 1.0 110.194 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ILE . . . . . 0.465 HD11 HG22 ' A' ' 28' ' ' ILE . 31.6 mm -120.12 135.86 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 1.0 110.031 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.443 ' CD1' HG21 ' A' ' 31' ' ' VAL . 2.0 pt -69.07 -152.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 1.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -105.0 82.14 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 1.0 110.469 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.443 HG21 ' CD1' ' A' ' 29' ' ' ILE . 75.3 t -100.98 -83.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 1.0 110.39 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -167.32 149.31 5.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 1.0 109.945 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . 0.437 ' CB ' ' HG3' ' A' ' 39' ' ' MET . . . -165.92 -166.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 1.0 110.388 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 33' ' ' ALA . 26.5 mt 65.96 -60.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.856 -0.528 . . . . 1.0 110.658 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -56.09 171.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 1.0 109.975 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.25 -168.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.196 -0.94 . . . . 1.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.46 -25.81 11.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -117.38 162.98 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -1.158 . . . . 1.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' MET . . . . . 0.437 ' HG3' ' CB ' ' A' ' 33' ' ' ALA . 22.7 ttt -90.53 169.65 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 1.0 109.648 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -145.91 136.17 23.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 1.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.423 ' HA2' ' CG1' ' A' ' 31' ' ' VAL . . . -177.23 -177.04 45.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 94.8 m -113.8 137.18 52.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 1.0 110.346 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 18.8 t -70.29 129.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 1.0 109.511 179.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -14.21 58.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 1.0 110.986 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 3.5 ttt85 -86.92 -38.49 16.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.068 . . . . 1.0 110.567 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 p -110.71 -43.79 3.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 1.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 112.81 -16.97 23.13 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -59.66 139.88 56.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.265 . . . . 1.0 110.348 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -117.39 129.87 56.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.0 110.031 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -159.7 -158.72 9.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.974 -1.251 . . . . 1.0 109.974 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.413 ' N ' ' O ' ' A' ' 18' ' ' ASP . 5.0 mmt -87.2 147.32 25.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -1.057 . . . . 1.0 110.415 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.434 ' CD1' HG23 ' A' ' 20' ' ' VAL . 8.3 mp -126.9 132.42 24.31 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.0 109.98 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.461 ' HD2' ' CZ ' ' A' ' 22' ' ' PHE . 43.4 Cg_endo -71.85 116.52 4.73 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.383 1.202 . . . . 1.0 110.265 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.74 -26.75 62.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.413 -0.804 . . . . 1.0 111.065 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.06 -5.42 31.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.099 -1.001 . . . . 1.0 110.854 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.437 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.3 m-30 -106.2 -66.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.007 -1.058 . . . . 1.0 110.23 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.52 168.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 1.0 110.68 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -170.3 161.26 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 1.0 109.956 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.73 148.09 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 1.0 110.349 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.103 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' HG22 ' A' ' 5' ' ' ILE . 5.7 mtmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.022 0.439 . . . . 1.0 110.054 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 54.91 169.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.61 . . . . 1.0 110.268 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 7.2 m-85 -142.28 -166.01 2.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 1.0 110.036 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -169.1 142.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.467 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.69 163.15 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 1.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 37.1 mtm -136.72 7.08 2.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 1.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' MET . 45.0 m-85 -144.95 167.06 23.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.993 -1.067 . . . . 1.0 110.345 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -95.54 73.89 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 1.0 109.633 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -61.85 148.04 44.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 1.0 110.797 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 ttp -115.79 107.2 14.75 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.446 -0.784 . . . . 1.0 109.029 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.66 130.72 17.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 110.652 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.97 -32.3 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 1.0 109.754 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.69 -155.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 1.0 109.721 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.41 18.84 5.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.971 . . . . 1.0 110.202 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -105.9 -22.44 12.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 1.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE2' ' CZ3' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -103.35 -168.62 1.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.039 -1.038 . . . . 1.0 109.867 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.561 HG13 ' HA3' ' A' ' 50' ' ' GLY . 27.8 m -131.36 169.36 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.684 . . . . 1.0 109.727 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -121.48 75.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 1.0 110.644 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE2' HD23 ' A' ' 52' ' ' LEU . 9.2 p90 -93.68 148.94 21.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 1.0 109.783 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 169.66 8.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.069 -1.019 . . . . 1.0 110.721 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -65.25 122.89 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 1.0 110.13 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.7 -24.35 13.49 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.61 154.75 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -1.11 . . . . 1.0 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' GLN . . . -109.96 160.49 16.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 1.0 110.328 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 29' ' ' ILE . 41.4 mt -147.7 170.18 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.825 . . . . 1.0 109.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.677 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -106.62 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.159 -0.963 . . . . 1.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.677 ' N ' HG23 ' A' ' 29' ' ' ILE . 11.8 t-20 -169.03 79.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.401 -1.437 . . . . 1.0 110.529 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.7 -25.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.184 -0.948 . . . . 1.0 110.067 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.55 179.22 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 1.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.22 103.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 1.0 110.37 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -80.42 -19.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 1.0 110.225 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER 59.99 155.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 1.0 110.538 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' ASP . 19.5 pt-20 38.28 38.85 0.24 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.225 0.536 . . . . 1.0 111.581 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' C ' ' CD1' ' A' ' 38' ' ' TRP . . . -174.37 -82.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.883 -1.287 . . . . 1.0 109.883 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.504 ' CZ3' ' OE2' ' A' ' 19' ' ' GLU . 26.2 m95 -141.63 177.39 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.293 . . . . 1.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 3.2 mmt -130.9 -166.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 1.0 110.2 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.82 125.64 2.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 1.0 110.098 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.3 37.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.4 m -101.81 117.09 34.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 1.0 110.155 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.84 107.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 1.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -63.65 -14.76 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.0 110.474 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -73.59 -24.7 60.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.079 -1.013 . . . . 1.0 110.373 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -140.05 -47.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 1.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.74 7.45 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.73 141.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.317 . . . . 1.0 110.221 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.548 HG22 ' OG1' ' A' ' 42' ' ' THR . 12.7 p -109.87 129.27 55.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 1.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.41 -164.85 15.31 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.892 -1.283 . . . . 1.0 109.892 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.61 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.2 tpp -95.07 157.74 15.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -1.005 . . . . 1.0 110.847 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 52' ' ' LEU . 4.0 mp -137.46 141.87 35.2 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.485 -0.759 . . . . 1.0 109.965 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 44.2 Cg_endo -73.63 120.74 6.61 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.552 1.29 . . . . 1.0 110.327 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.14 -19.78 55.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.241 -0.912 . . . . 1.0 110.848 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.71 4.4 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 1.0 110.73 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 11.6 m-85 -117.56 -62.01 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.05 -1.031 . . . . 1.0 110.07 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 57' ' ' VAL . 34.8 m -78.96 160.73 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 110.405 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' OE2' ' CE ' ' A' ' 9' ' ' MET . 16.5 mt-10 -149.36 179.53 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 1.0 109.983 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -93.69 171.88 8.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.932 . . . . 1.0 110.325 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 59' ' ' ALA . 4.5 pt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mttt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.238 0.542 . . . . 1.0 110.062 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 mt -107.84 131.87 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 1.0 109.637 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.34 -178.74 3.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 1.0 110.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HB3' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.59 144.76 19.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 1.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.76 163.72 22.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.318 -0.864 . . . . 1.0 110.114 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.442 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 16.4 mtp -134.55 9.12 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 1.0 110.774 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 9' ' ' MET . 70.5 m-85 -148.31 140.64 24.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.015 -1.053 . . . . 1.0 110.305 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 101.79 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 1.0 109.841 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -104.71 133.2 49.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 1.0 110.849 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 112.6 25.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 1.0 109.429 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.23 117.69 2.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.21 -0.932 . . . . 1.0 110.762 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.92 67.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 1.0 110.046 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 178.77 6.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 1.0 110.147 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 1.0 110.567 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.83 -29.59 44.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 1.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -82.09 173.88 11.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.184 -0.948 . . . . 1.0 110.346 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.899 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 23.8 m -109.62 -173.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 1.0 109.976 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.31 89.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.974 . . . . 1.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 10.1 p90 -113.23 149.29 33.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 1.0 110.013 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 164.32 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 1.0 110.514 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 17.9 t70 -52.77 115.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 1.0 110.197 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.0 -22.78 8.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.16 160.2 21.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -1.177 . . . . 1.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.14 133.18 51.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 1.0 110.202 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 52' ' ' LEU . 25.3 mm -118.67 156.27 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 1.0 109.789 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.724 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -126.98 -143.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.0 109.569 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.724 ' N ' HG23 ' A' ' 29' ' ' ILE . 42.0 p-10 -157.15 76.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.795 -1.191 . . . . 1.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 32' ' ' GLN . 14.1 p -60.0 -34.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 1.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.45 -72.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 59.86 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.853 . . . . 1.0 110.534 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.54 -49.87 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 1.0 110.076 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 1.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.75 124.17 14.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.0 110.053 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . 121.38 80.22 0.56 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.298 -1.521 . . . . 1.0 109.298 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 40.0 m95 59.67 140.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.864 -0.786 . . . . 1.0 110.59 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ptp -149.6 -176.57 5.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.848 -1.158 . . . . 1.0 110.806 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -105.8 141.56 37.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 1.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.663 ' N ' HD21 ' A' ' 52' ' ' LEU . . . -159.79 158.4 29.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.782 -1.327 . . . . 1.0 109.782 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.6 m -114.7 126.95 55.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 1.0 109.952 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 45' ' ' ARG . 21.8 t -64.97 108.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 1.0 109.944 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -55.89 -24.23 35.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 1.0 110.502 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -67.23 -65.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 1.0 110.279 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.5 p -86.33 -65.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 1.0 110.231 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.69 -11.67 3.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -60.91 158.48 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.305 . . . . 1.0 110.158 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.4 m -133.11 123.57 25.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 1.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -148.02 -159.18 8.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.652 ' C ' HD23 ' A' ' 52' ' ' LEU . 3.1 mtm -95.19 149.53 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 1.0 110.223 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.663 HD21 ' N ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -136.35 146.15 54.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 1.0 110.052 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.0 Cg_endo -72.58 110.85 3.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.736 1.387 . . . . 1.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.49 68.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -66.66 -17.3 64.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 1.0 110.561 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m-30 -95.27 -62.6 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 1.0 110.227 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.46 156.33 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.0 110.409 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.06 178.89 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 1.0 110.046 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.87 163.91 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 1.0 110.235 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 7' ' ' ARG . 1.1 pt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.37 0.605 . . . . 1.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -138.59 142.5 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.217 -0.927 . . . . 1.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.1 -178.51 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 1.0 109.847 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -154.7 152.79 30.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.0 110.632 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -108.94 123.76 49.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.838 . . . . 1.0 109.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.46 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -100.98 8.96 42.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 1.0 110.926 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 9' ' ' MET . 53.9 m-85 -143.52 161.23 39.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.113 . . . . 1.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.09 96.31 6.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 1.0 109.789 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.69 152.15 20.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 1.0 110.893 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 ttp -118.34 103.72 10.07 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.33 -0.856 . . . . 1.0 109.382 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.35 130.14 16.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.198 -0.939 . . . . 1.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.02 -28.27 18.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 1.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -141.26 170.88 14.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 1.0 110.018 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.12 44.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 1.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -51.52 -40.26 59.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.038 . . . . 1.0 110.429 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' ' N ' ' A' ' 51' ' ' MET . 4.7 pm0 -124.33 -173.2 2.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 1.0 110.657 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.953 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.4 m -120.11 -151.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.477 -0.764 . . . . 1.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.79 150.99 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.952 -1.093 . . . . 1.0 110.757 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 8.2 p90 -161.62 149.4 14.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 1.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -97.95 179.48 4.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.171 -0.956 . . . . 1.0 110.547 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 36.6 t70 -70.97 107.22 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 1.0 110.21 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.65 -19.98 4.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.951 -1.259 . . . . 1.0 109.951 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.09 163.45 27.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 1.0 110.5 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.9 149.06 52.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.345 -0.847 . . . . 1.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 42' ' ' THR . 32.3 mt -143.7 133.77 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 1.0 110.454 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 1.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -151.9 105.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 1.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.3 p -102.28 -23.21 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 1.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -159.03 145.11 16.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 1.0 110.138 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -164.56 120.94 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 1.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.8 -72.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 1.0 110.236 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -176.37 -63.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 1.0 109.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -134.74 23.76 3.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 1.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . -126.05 71.78 0.46 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.35 -1.5 . . . . 1.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 12.1 m95 55.25 170.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -1.026 . . . . 1.0 110.435 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 51' ' ' MET . 4.6 ptp -148.89 165.69 30.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 1.0 110.26 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' CE1' ' HA2' ' A' ' 50' ' ' GLY . 9.6 t80 -105.75 123.84 48.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -177.31 21.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 28' ' ' ILE . 84.9 m -121.2 125.96 48.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.113 . . . . 1.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.71 107.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 1.0 110.125 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.18 -35.63 49.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 1.0 110.457 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -59.78 -62.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 1.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -92.11 -68.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 42' ' ' THR . . . 137.57 -12.69 3.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -52.34 147.71 7.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.292 . . . . 1.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 2.2 p -116.66 119.35 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 1.0 109.963 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.77 170.08 35.89 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.74 155.7 37.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -1.099 . . . . 1.0 110.217 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 51' ' ' MET . 8.4 mt -132.76 155.64 80.96 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.363 -0.836 . . . . 1.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.31 118.62 5.25 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.587 1.309 . . . . 1.0 110.263 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.83 58.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 1.0 110.348 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -78.39 -2.58 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.923 . . . . 1.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.36 -50.25 3.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.907 -1.12 . . . . 1.0 110.335 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 8' ' ' ALA . 34.1 m -81.13 -176.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 1.0 110.636 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.1 146.52 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 1.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -71.78 164.79 25.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 1.0 110.321 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.424 HG23 ' C ' ' A' ' 59' ' ' ALA . 7.1 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.382 0.611 . . . . 1.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 tt -129.39 167.38 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 1.0 109.906 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -134.44 -177.03 4.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.12 -0.987 . . . . 1.0 110.483 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.35 153.83 16.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 1.0 110.306 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.38 135.99 38.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 1.0 109.893 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.42 -22.36 13.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 1.0 110.617 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -121.43 178.69 4.7 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.057 -1.027 . . . . 1.0 110.102 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 41.8 p-10 -110.2 96.79 6.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 1.0 109.759 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -81.55 146.2 30.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mtm -114.42 94.9 5.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.56 -0.712 . . . . 1.0 109.222 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -46.82 138.04 6.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.815 . . . . 1.0 111.049 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.43 -22.16 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 1.0 109.911 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -142.97 169.98 16.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 1.0 110.168 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.12 -12.72 53.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 1.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -51.09 -41.81 60.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.001 -1.062 . . . . 1.0 110.538 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' N ' ' A' ' 51' ' ' MET . 2.0 pm0 -124.89 -173.98 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.99 . . . . 1.0 110.624 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 26.8 m -113.34 -174.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 1.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -129.18 115.59 17.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 1.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 p90 -125.88 160.5 29.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 1.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -108.77 179.52 4.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 1.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -73.79 111.99 9.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 1.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.49 -29.66 3.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.34 151.31 41.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -1.201 . . . . 1.0 110.347 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 156.67 20.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 110.449 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 52' ' ' LEU . 28.3 mt -149.1 129.48 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 1.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -73.71 -159.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.906 . . . . 1.0 110.655 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -114.6 87.19 2.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -0.755 . . . . 1.0 109.624 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 29' ' ' ILE . 84.4 t -73.43 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 1.0 110.847 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -166.97 156.76 11.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.968 -1.082 . . . . 1.0 110.595 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.09 146.1 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.16 -80.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 1.0 110.284 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -169.53 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.119 -0.988 . . . . 1.0 111.8 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.31 -170.75 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.788 -1.195 . . . . 1.0 110.475 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.36 -69.52 1.12 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -53.16 135.39 37.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 1.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -133.74 -163.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 1.0 110.141 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 137.2 52.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 1.0 110.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.679 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -144.05 141.94 10.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.61 ' OG1' HG23 ' A' ' 49' ' ' THR . 55.4 m -103.06 104.68 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -1.194 . . . . 1.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 48' ' ' ARG . 2.8 m -48.33 128.92 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.373 -0.83 . . . . 1.0 110.473 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.66 9.96 14.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 1.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -58.2 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 1.0 109.876 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -100.7 -26.03 13.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.82 25.48 10.6 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 43' ' ' VAL . 84.2 mtm180 -93.79 149.86 20.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -1.128 . . . . 1.0 110.334 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.61 HG23 ' OG1' ' A' ' 42' ' ' THR . 1.5 m -121.03 146.69 46.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 110.421 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.68 172.58 44.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.544 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.1 ttm -60.7 156.46 16.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -1.191 . . . . 1.0 110.197 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.679 HD22 ' HA3' ' A' ' 41' ' ' GLY . 1.1 mp -132.63 139.17 33.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 1.0 110.659 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 43.8 Cg_endo -70.93 121.04 7.51 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.654 1.344 . . . . 1.0 110.644 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.84 60.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 1.0 110.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.49 24.54 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 1.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 4.9 m-85 -131.78 -40.15 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 1.0 109.996 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.07 173.51 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 1.0 110.123 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.89 . . . . 1.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.58 170.65 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 1.0 110.238 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.232 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.7 mtmm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.221 0.534 . . . . 1.0 110.61 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt 61.25 141.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.512 -0.742 . . . . 1.0 109.97 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 10.4 m-85 -118.69 175.02 5.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.018 -1.051 . . . . 1.0 109.579 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.39 139.48 35.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 1.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' ASP . . . -86.47 124.66 33.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.185 -0.947 . . . . 1.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.0 mtt -92.6 -17.44 24.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 1.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.36 155.86 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 1.0 109.891 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.47 126.32 46.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 1.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -118.71 152.64 35.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.068 -1.02 . . . . 1.0 110.531 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 ttm -116.4 98.57 6.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.405 -0.809 . . . . 1.0 109.429 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.895 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.86 124.62 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.475 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.35 -26.46 35.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 1.0 110.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -176.59 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 1.0 110.243 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.95 -12.96 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 1.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.09 -47.16 53.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.045 . . . . 1.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 -165.46 1.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 1.0 110.171 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.895 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.9 m -121.07 -172.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 1.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 t -133.26 117.28 17.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -137.54 166.8 23.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 1.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -120.96 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 1.0 110.52 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 12.4 t70 -69.12 130.36 42.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 1.0 110.365 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.76 -11.44 49.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -68.52 155.79 39.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.938 -1.33 . . . . 1.0 110.341 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.65 129.25 56.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 1.0 110.288 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 29' ' ' ILE . 42.3 mt -147.48 171.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 1.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.14 -177.89 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.095 . . . . 1.0 110.252 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -122.42 88.93 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.484 -0.76 . . . . 1.0 110.264 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.54 -65.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.241 -0.912 . . . . 1.0 109.781 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -101.43 -48.25 4.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 1.0 109.828 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 53.31 80.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 1.0 110.68 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 36' ' ' GLU . 61.7 mt -84.11 -5.17 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 1.0 110.568 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 65.42 -69.92 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.213 -0.93 . . . . 1.0 110.676 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' ILE . 4.5 mt-10 -75.85 124.43 27.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 1.0 110.396 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.99 61.46 1.93 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.674 -1.37 . . . . 1.0 109.674 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m95 52.56 179.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -1.151 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG3' ' HB2' ' A' ' 52' ' ' LEU . 2.5 ptp -136.88 -174.42 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 1.0 109.879 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -129.28 139.73 51.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -0.969 . . . . 1.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.58 152.83 22.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ARG . 88.3 m -98.95 128.95 45.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -1.183 . . . . 1.0 110.241 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 46' ' ' THR . 45.2 t -61.98 97.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 1.0 110.061 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -19.5 25.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 1.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -53.12 16.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 1.0 110.294 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.423 ' H ' HG12 ' A' ' 43' ' ' VAL . 20.3 p -97.48 -49.66 4.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 1.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.43 -14.36 5.86 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -70.54 -168.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.947 -1.325 . . . . 1.0 110.176 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 42' ' ' THR . 4.9 t -172.16 151.66 2.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 1.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.8 -158.74 20.25 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.814 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.89 137.41 38.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 1.0 110.073 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 51' ' ' MET . 10.7 mp -124.46 151.42 66.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 1.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.76 108.8 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.721 1.379 . . . . 1.0 110.122 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.13 65.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.7 6.48 34.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.026 . . . . 1.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -114.27 -64.37 1.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.044 -1.035 . . . . 1.0 110.156 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.66 157.17 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 1.0 110.258 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.51 -177.99 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.878 . . . . 1.0 110.294 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.56 148.92 24.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 1.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 pt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.139 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.366 0.603 . . . . 1.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 13.3 tt -127.61 170.51 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 1.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 39.1 m-85 -148.27 177.13 9.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 1.0 110.476 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.571 ' HB2' HG21 ' A' ' 60' ' ' ILE . 11.6 ttp180 -140.5 133.07 28.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 1.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.37 136.21 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.967 . . . . 1.0 110.44 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.49 ' HG3' ' CE1' ' A' ' 10' ' ' TYR . 9.2 tpp -128.01 1.2 5.92 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.306 -0.871 . . . . 1.0 109.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 9' ' ' MET . 33.5 m-85 -124.36 -7.68 7.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.905 -1.122 . . . . 1.0 111.316 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t0 60.36 71.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.003 -1.06 . . . . 1.0 108.774 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -77.65 148.68 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 1.0 111.296 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttp -121.59 99.64 6.58 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -47.55 115.9 1.28 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 1.0 110.893 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.48 -33.72 17.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 1.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 -151.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.47 -25.11 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 1.0 110.214 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' CA ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -79.56 -23.44 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.378 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 3.1 mp0 -80.05 172.05 14.28 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 1.0 110.53 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.761 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.7 m -117.05 169.0 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.441 -0.787 . . . . 1.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -128.89 101.29 6.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.987 -1.071 . . . . 1.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 7.9 p90 -123.32 148.64 45.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 1.0 109.862 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.56 -174.15 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 1.0 110.574 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.49 111.73 12.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 1.0 110.251 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.62 -18.32 7.21 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.28 165.92 5.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.248 . . . . 1.0 110.378 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.89 145.31 51.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 1.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.6 mm -111.27 147.26 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.914 . . . . 1.0 110.033 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 HE21 ' A' ' 44' ' ' GLN . 1.2 pt -58.88 -169.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 1.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 19.5 p-10 -83.32 55.07 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA2' ' A' ' 41' ' ' GLY . 1.8 p -80.84 -158.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.858 . . . . 1.0 109.997 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.624 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.5 pt20 -160.49 -156.89 0.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.914 -1.116 . . . . 1.0 110.054 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 39' ' ' MET . . . -137.23 -152.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 1.0 109.976 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -128.45 -85.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 1.0 109.773 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' H ' HG23 ' A' ' 34' ' ' ILE . 26.2 t0 -108.81 -64.2 1.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.114 . . . . 1.0 110.264 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -177.72 156.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 1.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.57 -55.92 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.674 -1.371 . . . . 1.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -143.55 163.05 34.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -1.223 . . . . 1.0 110.642 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.444 ' CB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.3 -152.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.716 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.539 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -144.09 166.77 24.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 1.0 109.973 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . 175.54 167.14 34.17 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.825 -1.31 . . . . 1.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 49' ' ' THR . 85.5 m -118.69 128.43 54.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.341 -1.093 . . . . 1.0 110.066 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.31 117.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 1.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.485 HE21 HG22 ' A' ' 29' ' ' ILE . 4.2 mm-40 -57.75 -23.06 50.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 1.0 110.473 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -71.56 0.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 1.0 110.304 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.9 p -72.69 -51.93 17.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 1.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 42' ' ' THR . . . 111.59 -15.14 27.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.72 166.3 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -1.23 . . . . 1.0 110.248 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 42' ' ' THR . 41.3 p -131.57 134.9 46.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 1.0 110.458 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -160.09 -164.63 15.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.701 -1.36 . . . . 1.0 109.701 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -80.45 142.55 34.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -1.13 . . . . 1.0 110.183 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 51' ' ' MET . 7.0 mp -124.51 142.33 40.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 1.0 110.539 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 49.1 Cg_endo -76.72 114.84 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.587 1.309 . . . . 1.0 109.99 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.03 67.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.136 -0.977 . . . . 1.0 110.849 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -71.97 -21.45 61.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.076 -1.015 . . . . 1.0 110.64 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.484 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 3.5 m-30 -81.89 -65.54 1.0 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 1.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -52.38 151.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 1.0 110.089 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.4 162.13 25.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.0 110.377 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 145.32 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 1.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 7' ' ' ARG . 4.9 pt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.161 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.276 0.56 . . . . 1.0 110.094 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.801 HG23 HD11 ' A' ' 60' ' ' ILE . 11.0 tt -154.7 169.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 1.0 110.123 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 55.9 m-85 -137.25 176.6 8.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.296 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.656 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -159.94 145.14 15.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 1.0 109.891 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.75 120.6 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 1.0 110.406 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -101.79 12.23 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 1.0 110.561 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.0 m-85 -141.77 140.71 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.0 110.375 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -80.62 115.62 20.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 1.0 109.297 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -121.3 163.1 19.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.911 -1.118 . . . . 1.0 111.129 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.85 115.84 13.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.61 -0.681 . . . . 1.0 109.3 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.31 133.69 15.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.162 -0.961 . . . . 1.0 110.761 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.07 -34.69 60.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -175.64 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 1.0 110.631 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 16' ' ' ASP . . . -176.64 -32.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.094 -1.004 . . . . 1.0 110.876 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.24 -26.33 0.77 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 1.0 111.027 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -136.23 -168.91 2.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 1.0 110.4 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.39 -174.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 1.0 110.241 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -136.03 115.14 12.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0 110.687 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -126.46 153.53 44.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 1.0 109.865 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -92.39 173.32 7.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 1.0 110.652 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -70.0 83.51 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.815 . . . . 1.0 109.977 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 156.45 -23.67 0.51 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.58 -1.408 . . . . 1.0 109.58 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.81 158.66 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -1.203 . . . . 1.0 110.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.86 145.81 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.356 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 29' ' ' ILE . 40.5 mm -122.58 170.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 1.0 109.747 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -131.01 -145.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 1.0 110.01 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.723 ' N ' HG23 ' A' ' 29' ' ' ILE . 5.1 t-20 -126.84 87.14 2.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 1.0 110.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -91.11 -59.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 1.0 110.323 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -172.4 178.26 2.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 1.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.2 123.44 5.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 1.0 110.079 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.489 HG22 ' OD2' ' A' ' 35' ' ' ASP . 72.5 mt -85.11 -43.92 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 1.0 110.304 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' OD2' HG22 ' A' ' 34' ' ' ILE . 3.0 m-20 -148.99 -169.53 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 1.0 110.18 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -25.82 30.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 1.0 109.942 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.4 -75.55 0.29 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -121.83 158.18 29.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -1.159 . . . . 1.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -123.44 -163.12 1.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 1.0 110.038 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -139.34 130.48 26.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 1.0 110.277 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -167.49 -171.18 33.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.407 ' O ' ' NE2' ' A' ' 44' ' ' GLN . 52.9 m -125.2 142.76 51.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 1.0 110.257 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.0 110.81 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.213 -0.93 . . . . 1.0 109.804 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 42' ' ' THR . 2.4 mp0 -60.13 -17.54 41.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 1.0 110.894 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -69.09 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.003 -1.06 . . . . 1.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.2 p -80.03 -41.01 26.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.942 . . . . 1.0 110.296 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 14.66 25.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -70.91 152.22 43.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.278 . . . . 1.0 110.05 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 p -128.34 129.82 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 1.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.83 40.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.768 ' C ' HD12 ' A' ' 52' ' ' LEU . 12.6 ttm -71.05 148.87 47.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 1.0 110.291 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 51' ' ' MET . 9.8 mp -126.53 140.4 37.26 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 1.0 110.302 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.89 95.84 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.586 1.308 . . . . 1.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.67 -24.06 60.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 1.0 110.456 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -76.79 -10.26 59.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 1.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.71 -45.25 6.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.029 . . . . 1.0 110.103 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.36 163.76 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 1.0 110.029 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.97 178.3 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 1.0 110.332 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 60' ' ' ILE . . . -90.15 14.92 11.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 1.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HG23 ' A' ' 5' ' ' ILE . 37.8 pt . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 117.988 -1.006 . . . . 1.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 5' ' ' ILE . 1.7 mtpt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.796 0.331 . . . . 1.0 110.217 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 4' ' ' LYS . 11.9 tt 47.75 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.571 0.7 . . . . 1.0 111.351 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 5' ' ' ILE . 14.4 m-85 -155.35 -175.18 5.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.0 110.4 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.72 ' HB2' HG21 ' A' ' 60' ' ' ILE . 18.2 tpp180 -162.9 132.86 4.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.0 110.05 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 22' ' ' PHE . . . -83.64 147.82 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 1.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 mtp -120.43 -14.98 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 1.0 110.656 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -124.03 125.33 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 1.0 110.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.13 92.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 1.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -82.02 167.37 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 1.0 110.775 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.82 117.2 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.767 . . . . 1.0 109.635 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.73 125.99 11.1 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 1.0 110.774 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.96 -34.52 15.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 1.0 110.291 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.21 -82.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 1.0 110.234 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.36 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.129 -0.982 . . . . 1.0 110.398 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.07 -24.34 6.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 1.0 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.07 171.03 7.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 52' ' ' LEU . 25.7 m -113.46 -156.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 1.0 109.975 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.96 128.12 7.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 1.0 110.579 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' CD1' ' HB1' ' A' ' 8' ' ' ALA . 17.1 p90 -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.368 -0.832 . . . . 1.0 109.878 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 4.4 pttt -96.71 -165.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 1.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.83 114.55 18.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.283 -0.886 . . . . 1.0 110.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.38 -2.39 50.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.83 157.15 7.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.912 -1.346 . . . . 1.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.0 130.35 50.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 1.0 110.279 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.4 HG21 ' CD2' ' A' ' 52' ' ' LEU . 34.3 mt -145.29 153.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 1.0 109.853 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -112.93 -142.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 1.0 110.182 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -153.68 105.28 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 1.0 110.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.2 p -83.34 -23.04 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 1.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.95 177.72 2.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 1.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.76 136.17 37.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 1.0 110.341 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.85 -13.63 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 1.0 110.569 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 63.88 10.97 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.139 -0.976 . . . . 1.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -113.22 -65.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.977 -1.077 . . . . 1.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.37 -52.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 51' ' ' MET . 7.9 m95 -84.2 178.19 7.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 1.0 110.105 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -147.07 174.37 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0 110.3 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.424 ' CE1' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -116.1 136.37 53.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 1.0 110.51 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 168.19 34.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -116.45 122.9 46.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.86 126.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 1.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -73.23 -30.39 63.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 1.0 110.597 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -24.04 66.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 1.0 110.318 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -131.77 -59.57 0.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.0 110.176 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.92 28.14 1.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -99.97 135.97 40.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 1.0 109.89 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 40' ' ' TYR . 25.5 m -101.3 123.88 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 1.0 110.512 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' CA ' ' CG1' ' A' ' 20' ' ' VAL . . . -153.82 -167.0 15.41 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.805 ' C ' HD12 ' A' ' 52' ' ' LEU . 8.0 mtp -78.99 143.68 35.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -1.159 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 51' ' ' MET . 9.4 mp -126.44 138.03 31.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 1.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.745 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.1 Cg_endo -74.05 113.5 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.529 1.279 . . . . 1.0 110.589 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.31 81.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.035 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -60.75 -17.59 49.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 1.0 110.186 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.8 m-85 -95.44 -59.64 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 1.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 53' ' ' PRO . 28.0 m -71.66 170.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 1.0 110.129 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.22 158.51 24.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 1.0 110.312 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 159.66 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 1.0 110.278 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.72 HG21 ' HB2' ' A' ' 7' ' ' ARG . 33.7 pt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.209 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.229 0.537 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mt 57.59 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.0 110.612 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.9 -178.36 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 1.0 110.031 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 60' ' ' ILE . 15.0 ttt85 -170.03 138.12 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 1.0 110.411 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.13 33.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 1.0 109.879 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.2 mmm -95.77 -14.37 23.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 1.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 35.2 m-85 -137.75 151.41 48.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.03 -1.044 . . . . 1.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -81.63 84.38 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 1.0 109.28 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -70.1 166.4 19.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 1.0 110.996 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.34 114.3 8.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.632 -0.668 . . . . 1.0 109.344 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.02 121.53 4.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.204 -0.935 . . . . 1.0 110.635 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 1.0 110.548 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.33 -69.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.074 -1.016 . . . . 1.0 110.748 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.63 -34.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.956 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.38 -29.53 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.197 -0.94 . . . . 1.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.07 -177.06 3.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.147 -0.97 . . . . 1.0 109.952 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 19.0 m -110.36 -152.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 1.0 110.585 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 t -157.07 141.93 16.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 1.0 110.41 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -150.95 149.69 29.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.353 -0.842 . . . . 1.0 109.78 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -174.87 4.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.516 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.13 114.56 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.98 -21.1 9.02 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.679 -1.369 . . . . 1.0 109.679 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.46 169.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -1.181 . . . . 1.0 110.311 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' O ' HD13 ' A' ' 28' ' ' ILE . . . -118.3 139.51 51.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.818 . . . . 1.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 27' ' ' ALA . 40.1 mm -123.08 173.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.0 109.992 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.717 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -117.96 -140.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 1.0 109.278 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.717 ' N ' HG23 ' A' ' 29' ' ' ILE . 12.3 t-20 -172.19 69.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.646 -1.284 . . . . 1.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 32' ' ' GLN . 20.7 m -70.56 -35.74 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.286 -0.884 . . . . 1.0 110.454 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.519 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 51.8 tt0 -144.53 -65.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 1.0 110.322 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 61.58 133.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.835 . . . . 1.0 110.577 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' GLU . 50.1 mm -119.8 -7.33 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.061 -1.024 . . . . 1.0 110.663 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 18.5 t0 66.71 -66.54 0.18 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.174 -0.954 . . . . 1.0 110.55 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -94.05 91.21 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.99 . . . . 1.0 110.587 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.85 64.82 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.5 m95 52.9 176.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.356 -1.084 . . . . 1.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 ptp -150.1 178.49 8.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 1.0 109.864 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CE2' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -124.11 122.2 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 110.311 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.75 176.68 24.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.658 ' H ' HG22 ' A' ' 29' ' ' ILE . 85.3 m -126.14 141.54 51.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -1.085 . . . . 1.0 110.096 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.82 110.34 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 1.0 110.297 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -55.68 -28.99 58.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.401 -0.812 . . . . 1.0 110.36 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -66.91 -70.31 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 1.0 110.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -81.93 -55.83 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 1.0 110.312 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.66 30.36 2.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -97.02 128.81 44.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 1.0 110.358 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' CE2' ' A' ' 40' ' ' TYR . 98.0 m -112.99 121.6 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 1.0 110.211 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.85 -147.92 5.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.588 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.3 mmt -84.2 138.72 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 1.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 51' ' ' MET . 7.3 mp -123.25 148.55 55.26 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.8 Cg_endo -72.19 110.3 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.684 1.36 . . . . 1.0 110.134 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.95 -23.09 65.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.567 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.01 7.95 25.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.9 m-85 -117.13 -58.67 2.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 1.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.12 161.6 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 1.0 110.177 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -169.19 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 1.0 109.964 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 147.11 27.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 1.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 7' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.207 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.334 0.588 . . . . 1.0 110.371 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.85 137.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 1.0 109.744 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -119.37 -176.47 3.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 1.0 109.894 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.68 136.56 5.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 1.0 110.543 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 23' ' ' LYS . . . -65.52 140.73 58.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 1.0 110.155 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.2 mtp -129.0 12.8 6.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 51.2 m-85 -131.76 -7.15 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.063 -1.023 . . . . 1.0 111.463 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.68 90.59 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.963 -1.086 . . . . 1.0 109.697 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 21.7 t80 -111.66 132.34 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 1.0 110.53 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' MET . . . . . 0.484 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 5.2 ptt? -110.81 22.87 14.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.0 110.019 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 12' ' ' TYR . . . 57.23 158.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.538 0.685 . . . . 1.0 110.721 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.78 -22.83 11.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 1.0 110.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.02 -155.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.98 20.1 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 1.0 110.205 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -87.55 -36.3 17.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.0 110.606 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -119.76 -173.81 2.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 1.0 110.51 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.625 ' CG2' HD11 ' A' ' 52' ' ' LEU . 24.4 m -108.52 -178.01 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 1.0 109.92 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 13' ' ' MET . 2.2 p -131.02 133.44 45.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 1.0 110.648 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' A' ' 26' ' ' ASP . 6.4 p90 -137.72 168.84 18.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 1.0 109.845 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 13.9 mttp -94.34 -174.75 3.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -77.42 1.09 20.13 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.268 -0.895 . . . . 1.0 110.921 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.89 20.23 5.73 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.801 -1.32 . . . . 1.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' HG13 ' A' ' 43' ' ' VAL . 37.6 t0 -78.17 155.26 30.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 1.0 110.081 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.68 128.91 55.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 1.0 110.537 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 29' ' ' ILE . 27.7 mt -147.34 171.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -0.81 . . . . 1.0 109.474 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.506 ' N ' HG22 ' A' ' 28' ' ' ILE . 7.0 pt -142.27 -178.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.099 -1.0 . . . . 1.0 110.778 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -88.04 70.2 9.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 1.0 110.365 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.7 t -54.23 -62.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.83 151.68 47.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 109.909 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.24 132.21 27.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 1.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -95.55 -56.52 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 1.0 109.914 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.73 -161.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 134.54 52.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.126 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.21 85.24 1.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.461 -1.456 . . . . 1.0 109.461 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 38' ' ' TRP . 26.6 m95 55.07 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.51 -0.994 . . . . 1.0 110.552 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.0 ptt? -149.61 -147.96 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.15 -0.969 . . . . 1.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.21 128.52 30.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.79 170.39 28.49 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.1 m -123.76 104.17 8.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 1.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 26' ' ' ASP . 61.0 t -53.07 131.18 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 1.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -85.62 -16.3 39.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 1.0 110.554 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -68.12 -35.71 78.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.0 110.448 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.8 p -124.25 -42.84 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 1.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.88 34.95 2.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -106.2 111.4 24.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -1.151 . . . . 1.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.0 m -92.82 124.93 37.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 1.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 -153.68 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.818 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.1 mtt -78.39 143.44 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -1.151 . . . . 1.0 110.283 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 51' ' ' MET . 3.1 mp -132.53 141.65 41.98 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 1.0 110.209 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.08 93.75 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.599 1.315 . . . . 1.0 110.374 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.99 -27.88 61.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 1.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -76.73 -2.39 32.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 1.0 110.917 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.7 m-85 -105.3 -51.61 2.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 1.0 110.237 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 57' ' ' VAL . 33.9 m -76.54 152.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 110.168 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.31 173.33 12.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.9 . . . . 1.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.56 139.36 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 1.0 110.163 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.159 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.223 0.535 . . . . 1.0 110.491 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 6' ' ' PHE . 21.3 mm 54.94 171.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 1.0 110.275 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' H ' HG22 ' A' ' 5' ' ' ILE . 38.8 m-85 -145.24 178.25 8.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.953 . . . . 1.0 110.148 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -153.87 117.05 4.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 1.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -62.27 132.39 52.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 1.0 110.175 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 mtp -114.0 9.76 17.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 1.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 9' ' ' MET . 48.6 m-85 -142.86 152.16 41.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.999 -1.063 . . . . 1.0 110.366 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -85.9 86.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 1.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 25.5 t80 -94.02 131.67 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 1.0 110.484 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.43 22.09 15.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 1.0 110.098 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . 55.15 166.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.633 0.73 . . . . 1.0 110.986 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 -19.79 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 1.0 109.908 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.86 -157.86 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 1.0 109.971 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.35 19.29 9.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.196 -0.94 . . . . 1.0 110.401 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.0 -34.92 22.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 1.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -122.4 -176.97 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.94 . . . . 1.0 110.303 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' A' ' 52' ' ' LEU . 12.0 m -105.24 -162.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0 110.179 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -139.55 105.93 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 1.0 110.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' HE2' HD12 ' A' ' 52' ' ' LEU . 4.4 p90 -118.77 154.47 32.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 1.0 109.897 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -97.68 178.27 5.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 1.0 110.378 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -69.83 81.73 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.0 110.054 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 163.43 -28.19 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 4.5 m-20 -53.39 151.53 5.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -1.114 . . . . 1.0 110.162 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.47 143.47 50.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 1.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 41' ' ' GLY . 56.8 mt -138.98 146.75 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 1.0 109.926 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.901 HG13 HG23 ' A' ' 31' ' ' VAL . 2.9 pt -81.69 -161.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 1.0 110.771 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 32' ' ' GLN . 35.6 m-20 -72.29 -47.42 50.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.369 -0.832 . . . . 1.0 110.937 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.901 HG23 HG13 ' A' ' 29' ' ' ILE . 72.8 t 56.28 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 1.0 110.461 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -171.09 139.93 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 110.522 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.52 145.72 37.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 1.0 110.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -126.86 -33.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 1.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.13 170.09 16.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 1.0 110.408 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.6 tm-20 -79.3 -22.8 44.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 1.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.6 -75.73 0.29 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.74 152.88 38.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -1.184 . . . . 1.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.06 -160.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 1.0 110.446 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -137.15 135.29 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.813 . . . . 1.0 109.807 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -164.74 159.02 31.98 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.599 -1.286 . . . . 1.0 109.906 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 49' ' ' THR . 55.5 m -108.98 121.68 45.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -1.088 . . . . 1.0 109.96 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 45' ' ' ARG . 34.1 t -63.92 122.81 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 1.0 110.319 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -76.03 -10.39 59.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 1.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.496 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -70.44 -68.0 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 110.33 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.72 -40.13 8.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 1.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.44 24.73 3.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -84.48 126.47 33.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -1.164 . . . . 1.0 110.012 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 15.6 p -97.75 133.47 42.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 110.327 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . 178.86 -174.34 46.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.845 ' O ' HD13 ' A' ' 52' ' ' LEU . 29.6 mtp -87.6 153.68 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -1.181 . . . . 1.0 110.589 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -126.02 145.02 50.66 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 1.0 109.65 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 47.6 Cg_endo -72.11 112.57 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.66 1.347 . . . . 1.0 110.09 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 36' ' ' GLU . . . -64.03 -39.77 94.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.99 . . . . 1.0 110.206 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -23.15 14.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.171 -0.956 . . . . 1.0 109.956 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 1.7 m-85 -88.29 -73.66 0.48 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.0 110.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 8' ' ' ALA . 33.2 m -52.9 151.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 1.0 110.075 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -124.24 159.39 30.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 1.0 110.234 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 149.93 29.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 1.0 110.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.278 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.295 0.569 . . . . 1.0 110.411 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mt -122.05 151.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.323 -0.861 . . . . 1.0 109.731 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -119.95 179.23 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -161.88 144.55 11.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 1.0 110.21 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.27 124.71 41.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 1.0 110.099 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.411 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 3.0 mmm -95.5 -3.0 47.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 1.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -127.87 177.43 6.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.931 -1.105 . . . . 1.0 110.336 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.67 83.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.716 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.61 140.94 41.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 1.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.9 mtt -112.16 108.33 17.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.468 -0.77 . . . . 1.0 109.507 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -48.1 120.92 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.881 . . . . 1.0 110.803 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.18 64.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 1.0 109.847 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.57 -175.25 2.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 1.0 109.939 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -17.36 56.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 1.0 110.313 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.09 -31.65 62.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 1.0 110.298 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 1.9 mp0 -84.92 171.92 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 1.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG13 ' HA3' ' A' ' 50' ' ' GLY . 35.7 m -116.67 167.62 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 1.0 109.877 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 t -129.56 108.57 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 1.0 110.554 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 1.0 110.098 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.04 178.62 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 1.0 110.601 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 34.3 t0 -75.03 99.63 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 1.0 110.111 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.08 -28.23 2.38 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.083 -1.607 . . . . 1.0 109.083 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.618 ' OD1' HG13 ' A' ' 43' ' ' VAL . 9.7 t70 -63.1 165.92 6.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.063 . . . . 1.0 109.994 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.57 169.19 15.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 1.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.525 ' C ' HG23 ' A' ' 29' ' ' ILE . 27.0 mm -130.78 163.55 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.681 -0.637 . . . . 1.0 109.439 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.525 HG23 ' C ' ' A' ' 28' ' ' ILE . 7.6 pt -151.86 161.25 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.079 . . . . 1.0 110.956 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.9 m120 51.53 54.2 11.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 1.0 110.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 28' ' ' ILE . 27.3 m -104.3 170.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.185 -0.947 . . . . 1.0 110.377 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -158.67 -161.86 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0 109.928 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.66 20.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 1.0 110.264 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 34' ' ' ILE . 3.0 mp -78.81 -70.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.353 -0.842 . . . . 1.0 110.081 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.85 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 1.0 110.032 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 1.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.05 -55.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -54.4 155.89 3.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -1.114 . . . . 1.0 109.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.426 ' CE ' HG21 ' A' ' 57' ' ' VAL . 1.9 ptt? -131.94 -164.1 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 1.0 110.483 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -124.86 158.76 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 1.0 109.872 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -175.06 159.9 28.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.772 ' OG1' HG22 ' A' ' 49' ' ' THR . 54.6 m -126.86 117.23 22.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 1.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' OD1' ' A' ' 26' ' ' ASP . 22.0 t -57.14 109.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 1.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -23.68 63.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.866 . . . . 1.0 110.701 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -75.83 -74.07 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 1.0 110.649 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 p -68.66 -56.79 7.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 1.0 110.312 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.15 32.23 1.72 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -97.48 148.56 23.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 1.0 110.13 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.772 HG22 ' OG1' ' A' ' 42' ' ' THR . 29.7 p -125.21 135.83 52.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 1.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.522 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -178.56 -163.59 30.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.793 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.87 141.86 34.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 1.0 110.129 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 51' ' ' MET . 8.9 mp -123.1 125.8 26.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.549 -0.719 . . . . 1.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 107.47 2.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.408 1.215 . . . . 1.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.59 55.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 1.0 110.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -62.19 -17.34 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 1.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -98.52 -60.95 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 1.0 109.794 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 ' CE ' ' A' ' 39' ' ' MET . 28.7 m -78.51 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 1.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.83 -174.74 2.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.915 . . . . 1.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -105.23 167.18 9.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 1.0 110.525 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.177 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.3 mttt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.173 0.511 . . . . 1.0 110.15 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm 58.1 159.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.39 -0.819 . . . . 1.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.32 -174.71 3.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 1.0 110.23 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -153.12 164.17 38.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 1.0 110.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.72 133.22 53.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 1.0 110.141 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 8.9 mtp -111.35 -6.3 14.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 1.0 110.743 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -131.79 167.12 20.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 1.0 110.148 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -98.69 105.45 17.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.289 -0.882 . . . . 1.0 109.86 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -109.62 160.94 15.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 1.0 110.908 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 114.45 9.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -0.76 . . . . 1.0 109.759 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.15 117.47 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.642 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.36 49.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 1.0 110.014 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.72 -154.85 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 1.0 109.973 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.46 15.55 27.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 1.0 110.518 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 1.1 t70 -85.38 -35.22 21.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.031 -1.043 . . . . 1.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 18' ' ' ASP . 6.5 pm0 -124.71 -175.87 3.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 1.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.6 m -113.7 -165.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 1.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.54 123.78 24.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 1.0 110.331 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.3 153.74 51.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 1.0 110.115 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -97.85 178.58 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 1.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.45 119.36 17.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 1.0 110.191 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.23 -35.36 3.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.38 160.3 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.145 . . . . 1.0 110.347 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 141.22 52.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.211 -0.931 . . . . 1.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 52' ' ' LEU . 39.1 mt -143.75 127.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.94 . . . . 1.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.7 -160.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 1.0 110.455 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -160.79 79.1 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.838 . . . . 1.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 31' ' ' VAL . 40.4 t -52.83 -62.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 1.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -119.6 147.13 44.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.868 . . . . 1.0 109.904 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.64 115.06 9.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 1.0 110.34 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 39.7 mm -93.45 -5.67 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 1.0 110.504 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.41 -72.19 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -0.977 . . . . 1.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.11 47.05 1.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 1.0 110.371 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.74 49.55 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.2 m95 52.99 178.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -1.177 . . . . 1.0 110.123 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.694 ' CE ' HD12 ' A' ' 52' ' ' LEU . 5.3 ptm -138.66 173.05 11.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 1.0 110.324 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -120.68 158.77 26.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.02 -175.31 47.36 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.847 ' OG1' HG22 ' A' ' 49' ' ' THR . 52.3 m -125.64 122.55 36.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -1.109 . . . . 1.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.67 118.52 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 1.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -21.21 64.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.92 . . . . 1.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -69.56 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 1.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -86.94 -28.34 22.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 1.0 110.354 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.89 8.55 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -106.34 142.9 35.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -1.091 . . . . 1.0 110.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' THR . . . . . 0.847 HG22 ' OG1' ' A' ' 42' ' ' THR . 37.2 p -104.95 143.24 33.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.1 178.09 48.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.933 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.9 mmm -79.48 153.53 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 1.0 110.216 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.933 HD23 ' O ' ' A' ' 51' ' ' MET . 12.3 mt -129.64 162.92 50.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 1.0 109.931 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.5 Cg_endo -74.88 114.99 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 1.0 110.378 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.84 -18.34 62.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 1.0 110.459 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.21 -1.04 57.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.972 . . . . 1.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -110.91 -65.41 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.96 -1.088 . . . . 1.0 110.396 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 53' ' ' PRO . 19.8 m -56.3 170.33 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 1.0 110.34 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.54 157.87 37.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 1.0 110.298 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.51 140.53 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.208 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.439 0.637 . . . . 1.0 110.407 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mt -106.07 148.83 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 1.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -119.57 179.78 4.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 1.0 110.141 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.37 142.53 12.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.1 155.49 20.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 1.0 110.122 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 mtp -134.19 4.93 3.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 1.0 110.921 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -134.32 129.21 35.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.988 -1.07 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.3 103.47 2.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 1.0 109.825 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -104.22 147.64 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.983 . . . . 1.0 110.722 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.16 105.41 11.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 1.0 109.79 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.84 120.42 3.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.244 -0.91 . . . . 1.0 110.661 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.46 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 1.0 110.114 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -171.22 2.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 1.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 11.36 15.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 1.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -26.35 43.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 1.0 110.054 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -131.85 -176.97 4.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.308 -0.87 . . . . 1.0 110.243 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 29.9 m -115.79 -169.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 1.0 109.964 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.6 p -133.21 123.97 26.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 1.0 110.725 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.04 159.57 37.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 1.0 109.891 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -105.4 176.95 4.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 1.0 110.393 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.96 93.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.221 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.33 -24.45 0.59 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 3.8 t0 -65.01 177.09 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -1.137 . . . . 1.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.99 164.38 33.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 1.0 110.259 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 29' ' ' ILE . 20.8 mm -118.51 172.02 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.334 -0.854 . . . . 1.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.424 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -171.61 -35.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.044 -1.035 . . . . 1.0 110.477 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.66 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.209 -0.932 . . . . 1.0 111.117 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 32' ' ' GLN . 42.5 t -95.13 -109.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.085 -1.01 . . . . 1.0 110.192 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.9 tt0 -176.26 -152.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.469 -1.394 . . . . 1.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 39' ' ' MET . . . -122.6 129.07 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 1.0 110.455 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.99 -8.4 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.75 146.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.11 -0.994 . . . . 1.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.49 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 1.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.61 27.48 5.47 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.1 m95 54.8 171.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.46 -1.024 . . . . 1.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.538 ' SD ' HD12 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -122.56 -167.84 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 1.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -147.61 144.64 28.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.166 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.28 178.39 44.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -106.88 132.53 52.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -1.067 . . . . 1.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 49.3 t -69.75 129.11 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 1.0 109.801 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -70.75 -35.18 72.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 1.0 110.652 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -57.85 8.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 1.0 110.572 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 p -91.93 -52.28 4.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 1.0 110.613 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.96 25.38 6.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.353 -1.499 . . . . 1.0 109.353 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -95.45 138.58 32.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 1.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.34 135.93 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 1.0 110.171 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.78 177.27 47.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.876 ' O ' HD23 ' A' ' 52' ' ' LEU . 11.1 mmt -82.6 151.9 26.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -1.148 . . . . 1.0 109.99 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.876 HD23 ' O ' ' A' ' 51' ' ' MET . 9.7 mt -128.27 161.92 53.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 1.0 109.917 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.593 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.4 Cg_endo -74.55 115.08 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.677 1.357 . . . . 1.0 110.267 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.37 -17.19 60.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 1.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.2 -8.29 51.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 1.0 110.85 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.94 -60.69 1.48 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.008 -1.058 . . . . 1.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 53' ' ' PRO . 26.9 m -70.48 163.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 1.0 109.863 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 -177.46 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.031 -1.043 . . . . 1.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 169.23 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 1.0 110.245 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.216 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mttm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.342 0.592 . . . . 1.0 110.347 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.98 152.88 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 1.0 109.558 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.4 179.84 4.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 1.0 110.409 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.4 ttp85 -160.46 155.4 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 1.0 110.377 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.88 149.3 27.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 1.0 110.029 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . 0.473 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 22.7 mtm -139.81 28.75 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 1.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.4 m-85 -150.22 109.86 4.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 110.609 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.21 133.88 49.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.0 109.45 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 19.3 t80 -147.24 137.39 23.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.946 -1.096 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.2 ttp -102.74 103.9 14.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -45.59 115.39 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.473 -0.767 . . . . 1.0 111.356 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.77 -48.6 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 1.0 109.586 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.48 150.1 28.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 1.0 109.664 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.16 -28.37 10.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.0 110.509 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.3 -35.6 79.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 110.366 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 4.7 mp0 -84.75 172.14 11.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.261 -0.899 . . . . 1.0 110.724 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 52' ' ' LEU . 13.5 m -120.94 169.12 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 1.0 110.032 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -103.49 126.02 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.948 . . . . 1.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 53' ' ' PRO . 5.4 m-85 -84.36 167.1 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 1.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.8 tptt -152.93 122.09 6.62 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 20.4 t0 -46.73 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 1.0 111.035 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 120.65 31.08 1.28 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -105.75 172.82 6.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -1.211 . . . . 1.0 110.065 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . . . -148.1 155.85 41.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 1.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.12 135.86 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 1.0 110.031 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.619 HG13 HG23 ' A' ' 31' ' ' VAL . 2.0 pt -69.07 -152.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 1.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -105.0 82.14 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 1.0 110.469 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' A' ' 41' ' ' GLY . 75.3 t -100.98 -83.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 1.0 110.39 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -167.32 149.31 5.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 1.0 109.945 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 35' ' ' ASP . . . -165.92 -166.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 1.0 110.388 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' ALA . 26.5 mt 65.96 -60.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.856 -0.528 . . . . 1.0 110.658 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' ALA . 5.8 t70 -56.09 171.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 1.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.25 -168.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.196 -0.94 . . . . 1.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.46 -25.81 11.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -117.38 162.98 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -1.158 . . . . 1.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 22.7 ttt -90.53 169.65 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 1.0 109.648 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -145.91 136.17 23.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 1.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 31' ' ' VAL . . . -177.23 -177.04 45.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 47' ' ' GLY . 94.8 m -113.8 137.18 52.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 1.0 110.346 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 45' ' ' ARG . 18.8 t -70.29 129.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 1.0 109.511 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -14.21 58.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 1.0 110.986 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ARG . . . . . 0.431 ' H ' HG12 ' A' ' 43' ' ' VAL . 3.5 ttt85 -86.92 -38.49 16.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.068 . . . . 1.0 110.567 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 p -110.71 -43.79 3.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 1.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 42' ' ' THR . . . 112.81 -16.97 23.13 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -59.66 139.88 56.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.265 . . . . 1.0 110.348 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -117.39 129.87 56.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.0 110.031 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -159.7 -158.72 9.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.974 -1.251 . . . . 1.0 109.974 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.709 ' C ' HD12 ' A' ' 52' ' ' LEU . 5.0 mmt -87.2 147.32 25.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -1.057 . . . . 1.0 110.415 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 51' ' ' MET . 8.3 mp -126.9 132.42 24.31 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.0 109.98 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' CZ ' ' A' ' 22' ' ' PHE . 43.4 Cg_endo -71.85 116.52 4.73 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.383 1.202 . . . . 1.0 110.265 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.74 -26.75 62.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.413 -0.804 . . . . 1.0 111.065 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.06 -5.42 31.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.099 -1.001 . . . . 1.0 110.854 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.3 m-30 -106.2 -66.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.007 -1.058 . . . . 1.0 110.23 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.52 168.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 1.0 110.68 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -170.3 161.26 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 1.0 109.956 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.73 148.09 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 1.0 110.349 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.103 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.246 0.546 . . . . 1.0 109.892 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.82 68.29 0.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 1.0 110.081 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.64 24.62 3.86 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' HG22 ' A' ' 5' ' ' ILE . 5.7 mtmt -60.5 -53.4 57.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -1.135 . . . . 1.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 54.91 169.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.61 . . . . 1.0 110.268 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 7.2 m-85 -142.28 -166.01 2.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 1.0 110.036 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -169.1 142.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.467 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.69 163.15 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 1.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 37.1 mtm -136.72 7.08 2.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 1.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' MET . 45.0 m-85 -144.95 167.06 23.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.993 -1.067 . . . . 1.0 110.345 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -95.54 73.89 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 1.0 109.633 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -61.85 148.04 44.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 1.0 110.797 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 ttp -115.79 107.2 14.75 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.446 -0.784 . . . . 1.0 109.029 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.66 130.72 17.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 110.652 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.97 -32.3 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 1.0 109.754 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.69 -155.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 1.0 109.721 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.41 18.84 5.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.971 . . . . 1.0 110.202 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -105.9 -22.44 12.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 1.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE2' ' CZ3' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -103.35 -168.62 1.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.039 -1.038 . . . . 1.0 109.867 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.561 HG13 ' HA3' ' A' ' 50' ' ' GLY . 27.8 m -131.36 169.36 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.684 . . . . 1.0 109.727 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -121.48 75.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 1.0 110.644 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE2' HD23 ' A' ' 52' ' ' LEU . 9.2 p90 -93.68 148.94 21.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 1.0 109.783 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 169.66 8.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.069 -1.019 . . . . 1.0 110.721 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -65.25 122.89 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 1.0 110.13 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.7 -24.35 13.49 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.61 154.75 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -1.11 . . . . 1.0 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' GLN . . . -109.96 160.49 16.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 1.0 110.328 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 29' ' ' ILE . 41.4 mt -147.7 170.18 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.825 . . . . 1.0 109.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.677 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -106.62 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.159 -0.963 . . . . 1.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.677 ' N ' HG23 ' A' ' 29' ' ' ILE . 11.8 t-20 -169.03 79.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.401 -1.437 . . . . 1.0 110.529 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.7 -25.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.184 -0.948 . . . . 1.0 110.067 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.55 179.22 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 1.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.22 103.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 1.0 110.37 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -80.42 -19.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 1.0 110.225 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER 59.99 155.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 1.0 110.538 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' ASP . 19.5 pt-20 38.28 38.85 0.24 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.225 0.536 . . . . 1.0 111.581 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' C ' ' CD1' ' A' ' 38' ' ' TRP . . . -174.37 -82.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.883 -1.287 . . . . 1.0 109.883 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.504 ' CZ3' ' OE2' ' A' ' 19' ' ' GLU . 26.2 m95 -141.63 177.39 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.293 . . . . 1.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 3.2 mmt -130.9 -166.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 1.0 110.2 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.82 125.64 2.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 1.0 110.098 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.3 37.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.4 m -101.81 117.09 34.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 1.0 110.155 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.84 107.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 1.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -63.65 -14.76 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.0 110.474 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -73.59 -24.7 60.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.079 -1.013 . . . . 1.0 110.373 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -140.05 -47.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 1.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.74 7.45 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.73 141.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.317 . . . . 1.0 110.221 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.548 HG22 ' OG1' ' A' ' 42' ' ' THR . 12.7 p -109.87 129.27 55.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 1.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.41 -164.85 15.31 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.892 -1.283 . . . . 1.0 109.892 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.61 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.2 tpp -95.07 157.74 15.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -1.005 . . . . 1.0 110.847 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 52' ' ' LEU . 4.0 mp -137.46 141.87 35.2 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.485 -0.759 . . . . 1.0 109.965 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 44.2 Cg_endo -73.63 120.74 6.61 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.552 1.29 . . . . 1.0 110.327 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.14 -19.78 55.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.241 -0.912 . . . . 1.0 110.848 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.71 4.4 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 1.0 110.73 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 11.6 m-85 -117.56 -62.01 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.05 -1.031 . . . . 1.0 110.07 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 57' ' ' VAL . 34.8 m -78.96 160.73 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 110.405 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' OE2' ' CE ' ' A' ' 9' ' ' MET . 16.5 mt-10 -149.36 179.53 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 1.0 109.983 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -93.69 171.88 8.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.932 . . . . 1.0 110.325 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 59' ' ' ALA . 4.5 pt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.162 0.506 . . . . 1.0 110.242 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.27 -150.2 0.37 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 1.0 110.151 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.87 68.93 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.198 . . . . 1.0 110.104 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -72.73 177.54 4.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.93 -1.335 . . . . 1.0 110.062 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 mt -107.84 131.87 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 1.0 109.637 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.34 -178.74 3.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 1.0 110.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HB3' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.59 144.76 19.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 1.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.76 163.72 22.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.318 -0.864 . . . . 1.0 110.114 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.442 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 16.4 mtp -134.55 9.12 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 1.0 110.774 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 9' ' ' MET . 70.5 m-85 -148.31 140.64 24.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.015 -1.053 . . . . 1.0 110.305 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 101.79 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 1.0 109.841 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -104.71 133.2 49.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 1.0 110.849 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 112.6 25.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 1.0 109.429 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.23 117.69 2.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.21 -0.932 . . . . 1.0 110.762 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.92 67.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 1.0 110.046 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 178.77 6.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 1.0 110.147 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 1.0 110.567 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.83 -29.59 44.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 1.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -82.09 173.88 11.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.184 -0.948 . . . . 1.0 110.346 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.899 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 23.8 m -109.62 -173.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 1.0 109.976 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.31 89.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.974 . . . . 1.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 10.1 p90 -113.23 149.29 33.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 1.0 110.013 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 164.32 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 1.0 110.514 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 17.9 t70 -52.77 115.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 1.0 110.197 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.0 -22.78 8.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.16 160.2 21.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -1.177 . . . . 1.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.14 133.18 51.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 1.0 110.202 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 52' ' ' LEU . 25.3 mm -118.67 156.27 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 1.0 109.789 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.724 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -126.98 -143.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.0 109.569 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.724 ' N ' HG23 ' A' ' 29' ' ' ILE . 42.0 p-10 -157.15 76.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.795 -1.191 . . . . 1.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 32' ' ' GLN . 14.1 p -60.0 -34.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 1.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.45 -72.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 59.86 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.853 . . . . 1.0 110.534 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.54 -49.87 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 1.0 110.076 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 1.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.75 124.17 14.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.0 110.053 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . 121.38 80.22 0.56 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.298 -1.521 . . . . 1.0 109.298 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 40.0 m95 59.67 140.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.864 -0.786 . . . . 1.0 110.59 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ptp -149.6 -176.57 5.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.848 -1.158 . . . . 1.0 110.806 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -105.8 141.56 37.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 1.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.663 ' N ' HD21 ' A' ' 52' ' ' LEU . . . -159.79 158.4 29.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.782 -1.327 . . . . 1.0 109.782 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.6 m -114.7 126.95 55.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 1.0 109.952 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 45' ' ' ARG . 21.8 t -64.97 108.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 1.0 109.944 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -55.89 -24.23 35.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 1.0 110.502 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -67.23 -65.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 1.0 110.279 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.5 p -86.33 -65.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 1.0 110.231 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.69 -11.67 3.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -60.91 158.48 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.305 . . . . 1.0 110.158 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.4 m -133.11 123.57 25.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 1.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -148.02 -159.18 8.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.652 ' C ' HD23 ' A' ' 52' ' ' LEU . 3.1 mtm -95.19 149.53 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 1.0 110.223 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.663 HD21 ' N ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -136.35 146.15 54.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 1.0 110.052 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.0 Cg_endo -72.58 110.85 3.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.736 1.387 . . . . 1.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.49 68.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -66.66 -17.3 64.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 1.0 110.561 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m-30 -95.27 -62.6 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 1.0 110.227 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.46 156.33 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.0 110.409 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.06 178.89 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 1.0 110.046 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.87 163.91 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 1.0 110.235 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 7' ' ' ARG . 1.1 pt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.207 0.527 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.55 -82.42 0.53 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 1.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.67 -56.32 4.91 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt 45.14 -170.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.489 -1.007 . . . . 1.0 111.165 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -138.59 142.5 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.217 -0.927 . . . . 1.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.1 -178.51 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 1.0 109.847 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -154.7 152.79 30.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.0 110.632 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -108.94 123.76 49.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.838 . . . . 1.0 109.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.46 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -100.98 8.96 42.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 1.0 110.926 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 9' ' ' MET . 53.9 m-85 -143.52 161.23 39.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.113 . . . . 1.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.09 96.31 6.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 1.0 109.789 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.69 152.15 20.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 1.0 110.893 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 ttp -118.34 103.72 10.07 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.33 -0.856 . . . . 1.0 109.382 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.35 130.14 16.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.198 -0.939 . . . . 1.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.02 -28.27 18.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 1.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -141.26 170.88 14.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 1.0 110.018 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.12 44.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 1.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -51.52 -40.26 59.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.038 . . . . 1.0 110.429 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' ' N ' ' A' ' 51' ' ' MET . 4.7 pm0 -124.33 -173.2 2.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 1.0 110.657 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.953 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.4 m -120.11 -151.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.477 -0.764 . . . . 1.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.79 150.99 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.952 -1.093 . . . . 1.0 110.757 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 8.2 p90 -161.62 149.4 14.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 1.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -97.95 179.48 4.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.171 -0.956 . . . . 1.0 110.547 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 36.6 t70 -70.97 107.22 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 1.0 110.21 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.65 -19.98 4.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.951 -1.259 . . . . 1.0 109.951 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.09 163.45 27.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 1.0 110.5 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.9 149.06 52.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.345 -0.847 . . . . 1.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 42' ' ' THR . 32.3 mt -143.7 133.77 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 1.0 110.454 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 1.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -151.9 105.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 1.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.3 p -102.28 -23.21 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 1.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -159.03 145.11 16.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 1.0 110.138 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -164.56 120.94 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 1.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.8 -72.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 1.0 110.236 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -176.37 -63.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 1.0 109.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -134.74 23.76 3.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 1.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . -126.05 71.78 0.46 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.35 -1.5 . . . . 1.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 12.1 m95 55.25 170.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -1.026 . . . . 1.0 110.435 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 51' ' ' MET . 4.6 ptp -148.89 165.69 30.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 1.0 110.26 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' CE1' ' HA2' ' A' ' 50' ' ' GLY . 9.6 t80 -105.75 123.84 48.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -177.31 21.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 28' ' ' ILE . 84.9 m -121.2 125.96 48.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.113 . . . . 1.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.71 107.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 1.0 110.125 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.18 -35.63 49.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 1.0 110.457 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -59.78 -62.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 1.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -92.11 -68.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 42' ' ' THR . . . 137.57 -12.69 3.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -52.34 147.71 7.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.292 . . . . 1.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 2.2 p -116.66 119.35 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 1.0 109.963 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.77 170.08 35.89 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.74 155.7 37.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -1.099 . . . . 1.0 110.217 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 51' ' ' MET . 8.4 mt -132.76 155.64 80.96 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.363 -0.836 . . . . 1.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.31 118.62 5.25 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.587 1.309 . . . . 1.0 110.263 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.83 58.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 1.0 110.348 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -78.39 -2.58 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.923 . . . . 1.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.36 -50.25 3.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.907 -1.12 . . . . 1.0 110.335 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 8' ' ' ALA . 34.1 m -81.13 -176.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 1.0 110.636 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.1 146.52 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 1.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -71.78 164.79 25.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 1.0 110.321 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.424 HG23 ' C ' ' A' ' 59' ' ' ALA . 7.1 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.214 0.531 . . . . 1.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.76 46.76 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 1.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.16 54.01 0.79 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -77.83 -169.43 1.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -1.142 . . . . 1.0 110.241 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 tt -129.39 167.38 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 1.0 109.906 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -134.44 -177.03 4.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.12 -0.987 . . . . 1.0 110.483 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.35 153.83 16.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 1.0 110.306 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.38 135.99 38.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 1.0 109.893 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.42 -22.36 13.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 1.0 110.617 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -121.43 178.69 4.7 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.057 -1.027 . . . . 1.0 110.102 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 41.8 p-10 -110.2 96.79 6.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 1.0 109.759 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -81.55 146.2 30.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mtm -114.42 94.9 5.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.56 -0.712 . . . . 1.0 109.222 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -46.82 138.04 6.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.815 . . . . 1.0 111.049 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.43 -22.16 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 1.0 109.911 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -142.97 169.98 16.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 1.0 110.168 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.12 -12.72 53.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 1.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -51.09 -41.81 60.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.001 -1.062 . . . . 1.0 110.538 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' N ' ' A' ' 51' ' ' MET . 2.0 pm0 -124.89 -173.98 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.99 . . . . 1.0 110.624 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 26.8 m -113.34 -174.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 1.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -129.18 115.59 17.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 1.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 p90 -125.88 160.5 29.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 1.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -108.77 179.52 4.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 1.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -73.79 111.99 9.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 1.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.49 -29.66 3.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.34 151.31 41.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -1.201 . . . . 1.0 110.347 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 156.67 20.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 110.449 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 52' ' ' LEU . 28.3 mt -149.1 129.48 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 1.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -73.71 -159.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.906 . . . . 1.0 110.655 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -114.6 87.19 2.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -0.755 . . . . 1.0 109.624 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 29' ' ' ILE . 84.4 t -73.43 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 1.0 110.847 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -166.97 156.76 11.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.968 -1.082 . . . . 1.0 110.595 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.09 146.1 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.16 -80.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 1.0 110.284 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -169.53 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.119 -0.988 . . . . 1.0 111.8 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.31 -170.75 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.788 -1.195 . . . . 1.0 110.475 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.36 -69.52 1.12 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -53.16 135.39 37.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 1.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -133.74 -163.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 1.0 110.141 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 137.2 52.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 1.0 110.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.679 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -144.05 141.94 10.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.61 ' OG1' HG23 ' A' ' 49' ' ' THR . 55.4 m -103.06 104.68 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -1.194 . . . . 1.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 48' ' ' ARG . 2.8 m -48.33 128.92 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.373 -0.83 . . . . 1.0 110.473 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -85.66 9.96 14.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 1.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -58.2 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 1.0 109.876 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -100.7 -26.03 13.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.82 25.48 10.6 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 43' ' ' VAL . 84.2 mtm180 -93.79 149.86 20.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -1.128 . . . . 1.0 110.334 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.61 HG23 ' OG1' ' A' ' 42' ' ' THR . 1.5 m -121.03 146.69 46.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 110.421 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.68 172.58 44.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.544 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.1 ttm -60.7 156.46 16.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -1.191 . . . . 1.0 110.197 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.679 HD22 ' HA3' ' A' ' 41' ' ' GLY . 1.1 mp -132.63 139.17 33.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 1.0 110.659 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 43.8 Cg_endo -70.93 121.04 7.51 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.654 1.344 . . . . 1.0 110.644 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.84 60.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 1.0 110.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.49 24.54 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 1.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 4.9 m-85 -131.78 -40.15 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 1.0 109.996 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.07 173.51 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 1.0 110.123 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.89 . . . . 1.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.58 170.65 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 1.0 110.238 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.232 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.212 0.529 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.27 169.74 17.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 1.0 110.146 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.06 -45.82 0.22 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.361 -1.496 . . . . 1.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.7 mtmm -54.6 -68.05 0.22 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -1.13 . . . . 1.0 110.61 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt 61.25 141.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.512 -0.742 . . . . 1.0 109.97 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 10.4 m-85 -118.69 175.02 5.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.018 -1.051 . . . . 1.0 109.579 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.39 139.48 35.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 1.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' ASP . . . -86.47 124.66 33.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.185 -0.947 . . . . 1.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.0 mtt -92.6 -17.44 24.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 1.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.36 155.86 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 1.0 109.891 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.47 126.32 46.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 1.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -118.71 152.64 35.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.068 -1.02 . . . . 1.0 110.531 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 ttm -116.4 98.57 6.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.405 -0.809 . . . . 1.0 109.429 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.895 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.86 124.62 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.475 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.35 -26.46 35.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 1.0 110.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -176.59 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 1.0 110.243 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.95 -12.96 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 1.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.09 -47.16 53.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.045 . . . . 1.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 -165.46 1.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 1.0 110.171 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.895 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.9 m -121.07 -172.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 1.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 t -133.26 117.28 17.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -137.54 166.8 23.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 1.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -120.96 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 1.0 110.52 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 12.4 t70 -69.12 130.36 42.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 1.0 110.365 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.76 -11.44 49.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -68.52 155.79 39.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.938 -1.33 . . . . 1.0 110.341 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.65 129.25 56.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 1.0 110.288 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 29' ' ' ILE . 42.3 mt -147.48 171.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 1.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.14 -177.89 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.095 . . . . 1.0 110.252 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -122.42 88.93 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.484 -0.76 . . . . 1.0 110.264 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.54 -65.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.241 -0.912 . . . . 1.0 109.781 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -101.43 -48.25 4.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 1.0 109.828 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 53.31 80.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 1.0 110.68 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 36' ' ' GLU . 61.7 mt -84.11 -5.17 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 1.0 110.568 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 65.42 -69.92 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.213 -0.93 . . . . 1.0 110.676 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' ILE . 4.5 mt-10 -75.85 124.43 27.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 1.0 110.396 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.99 61.46 1.93 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.674 -1.37 . . . . 1.0 109.674 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m95 52.56 179.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -1.151 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG3' ' HB2' ' A' ' 52' ' ' LEU . 2.5 ptp -136.88 -174.42 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 1.0 109.879 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -129.28 139.73 51.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -0.969 . . . . 1.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.58 152.83 22.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ARG . 88.3 m -98.95 128.95 45.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -1.183 . . . . 1.0 110.241 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 46' ' ' THR . 45.2 t -61.98 97.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 1.0 110.061 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -19.5 25.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 1.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -53.12 16.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 1.0 110.294 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.423 ' H ' HG12 ' A' ' 43' ' ' VAL . 20.3 p -97.48 -49.66 4.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 1.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.43 -14.36 5.86 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -70.54 -168.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.947 -1.325 . . . . 1.0 110.176 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 42' ' ' THR . 4.9 t -172.16 151.66 2.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 1.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.8 -158.74 20.25 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.814 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.89 137.41 38.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 1.0 110.073 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 51' ' ' MET . 10.7 mp -124.46 151.42 66.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 1.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.76 108.8 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.721 1.379 . . . . 1.0 110.122 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.13 65.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.7 6.48 34.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.026 . . . . 1.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -114.27 -64.37 1.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.044 -1.035 . . . . 1.0 110.156 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.66 157.17 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 1.0 110.258 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.51 -177.99 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.878 . . . . 1.0 110.294 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.56 148.92 24.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 1.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 pt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.139 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.267 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.06 164.83 26.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 1.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.28 43.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 1.0 109.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -69.58 -171.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -1.139 . . . . 1.0 110.259 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 13.3 tt -127.61 170.51 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 1.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 39.1 m-85 -148.27 177.13 9.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 1.0 110.476 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.571 ' HB2' HG21 ' A' ' 60' ' ' ILE . 11.6 ttp180 -140.5 133.07 28.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 1.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.37 136.21 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.967 . . . . 1.0 110.44 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.49 ' HG3' ' CE1' ' A' ' 10' ' ' TYR . 9.2 tpp -128.01 1.2 5.92 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.306 -0.871 . . . . 1.0 109.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 9' ' ' MET . 33.5 m-85 -124.36 -7.68 7.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.905 -1.122 . . . . 1.0 111.316 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t0 60.36 71.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.003 -1.06 . . . . 1.0 108.774 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -77.65 148.68 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 1.0 111.296 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttp -121.59 99.64 6.58 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -47.55 115.9 1.28 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 1.0 110.893 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.48 -33.72 17.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 1.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 -151.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.47 -25.11 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 1.0 110.214 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' CA ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -79.56 -23.44 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.378 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 3.1 mp0 -80.05 172.05 14.28 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 1.0 110.53 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.761 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.7 m -117.05 169.0 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.441 -0.787 . . . . 1.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -128.89 101.29 6.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.987 -1.071 . . . . 1.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 7.9 p90 -123.32 148.64 45.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 1.0 109.862 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.56 -174.15 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 1.0 110.574 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.49 111.73 12.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 1.0 110.251 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.62 -18.32 7.21 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.28 165.92 5.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.248 . . . . 1.0 110.378 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.89 145.31 51.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 1.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.6 mm -111.27 147.26 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.914 . . . . 1.0 110.033 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 HE21 ' A' ' 44' ' ' GLN . 1.2 pt -58.88 -169.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 1.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 19.5 p-10 -83.32 55.07 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA2' ' A' ' 41' ' ' GLY . 1.8 p -80.84 -158.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.858 . . . . 1.0 109.997 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.624 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.5 pt20 -160.49 -156.89 0.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.914 -1.116 . . . . 1.0 110.054 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 39' ' ' MET . . . -137.23 -152.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 1.0 109.976 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -128.45 -85.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 1.0 109.773 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' H ' HG23 ' A' ' 34' ' ' ILE . 26.2 t0 -108.81 -64.2 1.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.114 . . . . 1.0 110.264 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -177.72 156.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 1.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.57 -55.92 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.674 -1.371 . . . . 1.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -143.55 163.05 34.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -1.223 . . . . 1.0 110.642 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.444 ' CB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.3 -152.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.716 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.539 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -144.09 166.77 24.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 1.0 109.973 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . 175.54 167.14 34.17 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.825 -1.31 . . . . 1.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 49' ' ' THR . 85.5 m -118.69 128.43 54.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.341 -1.093 . . . . 1.0 110.066 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.31 117.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 1.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.485 HE21 HG22 ' A' ' 29' ' ' ILE . 4.2 mm-40 -57.75 -23.06 50.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 1.0 110.473 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -71.56 0.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 1.0 110.304 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.9 p -72.69 -51.93 17.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 1.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 42' ' ' THR . . . 111.59 -15.14 27.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.72 166.3 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -1.23 . . . . 1.0 110.248 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 42' ' ' THR . 41.3 p -131.57 134.9 46.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 1.0 110.458 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -160.09 -164.63 15.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.701 -1.36 . . . . 1.0 109.701 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -80.45 142.55 34.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -1.13 . . . . 1.0 110.183 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 51' ' ' MET . 7.0 mp -124.51 142.33 40.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 1.0 110.539 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 49.1 Cg_endo -76.72 114.84 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.587 1.309 . . . . 1.0 109.99 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.03 67.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.136 -0.977 . . . . 1.0 110.849 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -71.97 -21.45 61.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.076 -1.015 . . . . 1.0 110.64 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.484 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 3.5 m-30 -81.89 -65.54 1.0 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 1.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -52.38 151.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 1.0 110.089 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.4 162.13 25.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.0 110.377 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 145.32 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 1.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 7' ' ' ARG . 4.9 pt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.161 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.208 0.528 . . . . 1.0 110.173 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.44 33.28 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 1.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.63 20.43 32.0 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -87.23 -174.05 4.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -1.181 . . . . 1.0 110.094 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.801 HG23 HD11 ' A' ' 60' ' ' ILE . 11.0 tt -154.7 169.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 1.0 110.123 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 55.9 m-85 -137.25 176.6 8.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.296 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.656 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -159.94 145.14 15.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 1.0 109.891 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.75 120.6 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 1.0 110.406 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -101.79 12.23 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 1.0 110.561 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.0 m-85 -141.77 140.71 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.0 110.375 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -80.62 115.62 20.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 1.0 109.297 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -121.3 163.1 19.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.911 -1.118 . . . . 1.0 111.129 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.85 115.84 13.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.61 -0.681 . . . . 1.0 109.3 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.31 133.69 15.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.162 -0.961 . . . . 1.0 110.761 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.07 -34.69 60.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -175.64 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 1.0 110.631 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 16' ' ' ASP . . . -176.64 -32.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.094 -1.004 . . . . 1.0 110.876 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.24 -26.33 0.77 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 1.0 111.027 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -136.23 -168.91 2.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 1.0 110.4 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.39 -174.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 1.0 110.241 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -136.03 115.14 12.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0 110.687 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -126.46 153.53 44.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 1.0 109.865 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -92.39 173.32 7.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 1.0 110.652 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -70.0 83.51 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.815 . . . . 1.0 109.977 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 156.45 -23.67 0.51 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.58 -1.408 . . . . 1.0 109.58 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.81 158.66 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -1.203 . . . . 1.0 110.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.86 145.81 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.356 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 29' ' ' ILE . 40.5 mm -122.58 170.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 1.0 109.747 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -131.01 -145.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 1.0 110.01 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.723 ' N ' HG23 ' A' ' 29' ' ' ILE . 5.1 t-20 -126.84 87.14 2.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 1.0 110.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -91.11 -59.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 1.0 110.323 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -172.4 178.26 2.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 1.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.2 123.44 5.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 1.0 110.079 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.489 HG22 ' OD2' ' A' ' 35' ' ' ASP . 72.5 mt -85.11 -43.92 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 1.0 110.304 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' OD2' HG22 ' A' ' 34' ' ' ILE . 3.0 m-20 -148.99 -169.53 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 1.0 110.18 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -25.82 30.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 1.0 109.942 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.4 -75.55 0.29 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -121.83 158.18 29.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -1.159 . . . . 1.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -123.44 -163.12 1.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 1.0 110.038 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -139.34 130.48 26.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 1.0 110.277 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -167.49 -171.18 33.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.407 ' O ' ' NE2' ' A' ' 44' ' ' GLN . 52.9 m -125.2 142.76 51.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 1.0 110.257 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.0 110.81 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.213 -0.93 . . . . 1.0 109.804 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 42' ' ' THR . 2.4 mp0 -60.13 -17.54 41.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 1.0 110.894 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -69.09 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.003 -1.06 . . . . 1.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.2 p -80.03 -41.01 26.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.942 . . . . 1.0 110.296 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 14.66 25.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -70.91 152.22 43.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.278 . . . . 1.0 110.05 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 p -128.34 129.82 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 1.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.83 40.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.768 ' C ' HD12 ' A' ' 52' ' ' LEU . 12.6 ttm -71.05 148.87 47.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 1.0 110.291 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 51' ' ' MET . 9.8 mp -126.53 140.4 37.26 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 1.0 110.302 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.89 95.84 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.586 1.308 . . . . 1.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.67 -24.06 60.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 1.0 110.456 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -76.79 -10.26 59.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 1.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.71 -45.25 6.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.029 . . . . 1.0 110.103 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.36 163.76 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 1.0 110.029 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.97 178.3 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 1.0 110.332 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 60' ' ' ILE . . . -90.15 14.92 11.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 1.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HG23 ' A' ' 5' ' ' ILE . 37.8 pt . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 117.988 -1.006 . . . . 1.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.26 0.553 . . . . 1.0 110.212 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.47 163.46 6.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 1.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.68 -37.0 0.09 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 5' ' ' ILE . 1.7 mtpt -54.96 -43.24 73.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -1.17 . . . . 1.0 110.217 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 4' ' ' LYS . 11.9 tt 47.75 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.571 0.7 . . . . 1.0 111.351 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 5' ' ' ILE . 14.4 m-85 -155.35 -175.18 5.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.0 110.4 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.72 ' HB2' HG21 ' A' ' 60' ' ' ILE . 18.2 tpp180 -162.9 132.86 4.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.0 110.05 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 22' ' ' PHE . . . -83.64 147.82 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 1.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 mtp -120.43 -14.98 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 1.0 110.656 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -124.03 125.33 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 1.0 110.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.13 92.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 1.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -82.02 167.37 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 1.0 110.775 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.82 117.2 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.767 . . . . 1.0 109.635 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.73 125.99 11.1 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 1.0 110.774 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.96 -34.52 15.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 1.0 110.291 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.21 -82.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 1.0 110.234 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.36 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.129 -0.982 . . . . 1.0 110.398 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.07 -24.34 6.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 1.0 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.07 171.03 7.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 52' ' ' LEU . 25.7 m -113.46 -156.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 1.0 109.975 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.96 128.12 7.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 1.0 110.579 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' CD1' ' HB1' ' A' ' 8' ' ' ALA . 17.1 p90 -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.368 -0.832 . . . . 1.0 109.878 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 4.4 pttt -96.71 -165.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 1.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.83 114.55 18.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.283 -0.886 . . . . 1.0 110.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.38 -2.39 50.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.83 157.15 7.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.912 -1.346 . . . . 1.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.0 130.35 50.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 1.0 110.279 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG21 ' CD2' ' A' ' 52' ' ' LEU . 34.3 mt -145.29 153.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 1.0 109.853 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -112.93 -142.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 1.0 110.182 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -153.68 105.28 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 1.0 110.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.2 p -83.34 -23.04 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 1.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.95 177.72 2.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 1.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.76 136.17 37.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 1.0 110.341 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.85 -13.63 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 1.0 110.569 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 63.88 10.97 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.139 -0.976 . . . . 1.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -113.22 -65.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.977 -1.077 . . . . 1.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.37 -52.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 51' ' ' MET . 7.9 m95 -84.2 178.19 7.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 1.0 110.105 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -147.07 174.37 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0 110.3 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.424 ' CE1' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -116.1 136.37 53.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 1.0 110.51 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 168.19 34.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -116.45 122.9 46.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.86 126.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 1.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -73.23 -30.39 63.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 1.0 110.597 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -24.04 66.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 1.0 110.318 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -131.77 -59.57 0.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.0 110.176 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.92 28.14 1.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -99.97 135.97 40.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 1.0 109.89 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 40' ' ' TYR . 25.5 m -101.3 123.88 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 1.0 110.512 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' CA ' ' CG1' ' A' ' 20' ' ' VAL . . . -153.82 -167.0 15.41 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.805 ' C ' HD12 ' A' ' 52' ' ' LEU . 8.0 mtp -78.99 143.68 35.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -1.159 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 51' ' ' MET . 9.4 mp -126.44 138.03 31.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 1.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.745 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.1 Cg_endo -74.05 113.5 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.529 1.279 . . . . 1.0 110.589 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.31 81.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.035 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -60.75 -17.59 49.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 1.0 110.186 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.8 m-85 -95.44 -59.64 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 1.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 53' ' ' PRO . 28.0 m -71.66 170.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 1.0 110.129 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.22 158.51 24.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 1.0 110.312 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 159.66 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 1.0 110.278 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.72 HG21 ' HB2' ' A' ' 7' ' ' ARG . 33.7 pt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.209 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.311 0.577 . . . . 1.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.02 72.22 6.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 1.0 110.294 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.69 -50.13 4.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 1.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -74.13 -43.74 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -1.114 . . . . 1.0 110.221 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mt 57.59 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.0 110.612 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.9 -178.36 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 1.0 110.031 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 60' ' ' ILE . 15.0 ttt85 -170.03 138.12 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 1.0 110.411 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.13 33.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 1.0 109.879 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.2 mmm -95.77 -14.37 23.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 1.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 35.2 m-85 -137.75 151.41 48.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.03 -1.044 . . . . 1.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -81.63 84.38 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 1.0 109.28 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -70.1 166.4 19.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 1.0 110.996 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.34 114.3 8.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.632 -0.668 . . . . 1.0 109.344 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.02 121.53 4.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.204 -0.935 . . . . 1.0 110.635 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 1.0 110.548 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.33 -69.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.074 -1.016 . . . . 1.0 110.748 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.63 -34.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.956 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.38 -29.53 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.197 -0.94 . . . . 1.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.07 -177.06 3.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.147 -0.97 . . . . 1.0 109.952 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 19.0 m -110.36 -152.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 1.0 110.585 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 t -157.07 141.93 16.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 1.0 110.41 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -150.95 149.69 29.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.353 -0.842 . . . . 1.0 109.78 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -174.87 4.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.516 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.13 114.56 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.98 -21.1 9.02 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.679 -1.369 . . . . 1.0 109.679 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.46 169.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -1.181 . . . . 1.0 110.311 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' O ' HD13 ' A' ' 28' ' ' ILE . . . -118.3 139.51 51.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.818 . . . . 1.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 27' ' ' ALA . 40.1 mm -123.08 173.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.0 109.992 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.717 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -117.96 -140.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 1.0 109.278 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.717 ' N ' HG23 ' A' ' 29' ' ' ILE . 12.3 t-20 -172.19 69.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.646 -1.284 . . . . 1.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 32' ' ' GLN . 20.7 m -70.56 -35.74 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.286 -0.884 . . . . 1.0 110.454 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.519 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 51.8 tt0 -144.53 -65.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 1.0 110.322 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 61.58 133.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.835 . . . . 1.0 110.577 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' GLU . 50.1 mm -119.8 -7.33 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.061 -1.024 . . . . 1.0 110.663 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 18.5 t0 66.71 -66.54 0.18 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.174 -0.954 . . . . 1.0 110.55 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -94.05 91.21 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.99 . . . . 1.0 110.587 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.85 64.82 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.5 m95 52.9 176.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.356 -1.084 . . . . 1.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 ptp -150.1 178.49 8.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 1.0 109.864 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CE2' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -124.11 122.2 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 110.311 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.75 176.68 24.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.658 ' H ' HG22 ' A' ' 29' ' ' ILE . 85.3 m -126.14 141.54 51.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -1.085 . . . . 1.0 110.096 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.82 110.34 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 1.0 110.297 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -55.68 -28.99 58.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.401 -0.812 . . . . 1.0 110.36 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -66.91 -70.31 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 1.0 110.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -81.93 -55.83 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 1.0 110.312 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.66 30.36 2.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -97.02 128.81 44.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 1.0 110.358 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' CE2' ' A' ' 40' ' ' TYR . 98.0 m -112.99 121.6 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 1.0 110.211 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.85 -147.92 5.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.588 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.3 mmt -84.2 138.72 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 1.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 51' ' ' MET . 7.3 mp -123.25 148.55 55.26 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.8 Cg_endo -72.19 110.3 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.684 1.36 . . . . 1.0 110.134 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.95 -23.09 65.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.567 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.01 7.95 25.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.9 m-85 -117.13 -58.67 2.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 1.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.12 161.6 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 1.0 110.177 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -169.19 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 1.0 109.964 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 147.11 27.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 1.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 7' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.207 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.228 0.537 . . . . 1.0 110.305 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.49 -172.91 4.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 1.0 110.438 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.55 22.01 32.74 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -78.17 -168.99 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 1.0 110.371 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.85 137.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 1.0 109.744 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -119.37 -176.47 3.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 1.0 109.894 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.68 136.56 5.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 1.0 110.543 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 23' ' ' LYS . . . -65.52 140.73 58.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 1.0 110.155 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.2 mtp -129.0 12.8 6.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 51.2 m-85 -131.76 -7.15 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.063 -1.023 . . . . 1.0 111.463 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.68 90.59 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.963 -1.086 . . . . 1.0 109.697 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 21.7 t80 -111.66 132.34 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 1.0 110.53 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' MET . . . . . 0.484 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 5.2 ptt? -110.81 22.87 14.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.0 110.019 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 12' ' ' TYR . . . 57.23 158.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.538 0.685 . . . . 1.0 110.721 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.78 -22.83 11.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 1.0 110.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.02 -155.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.98 20.1 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 1.0 110.205 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -87.55 -36.3 17.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.0 110.606 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -119.76 -173.81 2.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 1.0 110.51 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.625 ' CG2' HD11 ' A' ' 52' ' ' LEU . 24.4 m -108.52 -178.01 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 1.0 109.92 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 13' ' ' MET . 2.2 p -131.02 133.44 45.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 1.0 110.648 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' A' ' 26' ' ' ASP . 6.4 p90 -137.72 168.84 18.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 1.0 109.845 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 13.9 mttp -94.34 -174.75 3.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -77.42 1.09 20.13 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.268 -0.895 . . . . 1.0 110.921 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.89 20.23 5.73 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.801 -1.32 . . . . 1.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' HG13 ' A' ' 43' ' ' VAL . 37.6 t0 -78.17 155.26 30.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 1.0 110.081 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.68 128.91 55.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 1.0 110.537 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 29' ' ' ILE . 27.7 mt -147.34 171.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -0.81 . . . . 1.0 109.474 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.506 ' N ' HG22 ' A' ' 28' ' ' ILE . 7.0 pt -142.27 -178.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.099 -1.0 . . . . 1.0 110.778 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -88.04 70.2 9.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 1.0 110.365 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.7 t -54.23 -62.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.83 151.68 47.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 109.909 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.24 132.21 27.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 1.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -95.55 -56.52 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 1.0 109.914 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.73 -161.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 134.54 52.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.126 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.21 85.24 1.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.461 -1.456 . . . . 1.0 109.461 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 38' ' ' TRP . 26.6 m95 55.07 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.51 -0.994 . . . . 1.0 110.552 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.0 ptt? -149.61 -147.96 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.15 -0.969 . . . . 1.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.21 128.52 30.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.79 170.39 28.49 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.1 m -123.76 104.17 8.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 1.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 26' ' ' ASP . 61.0 t -53.07 131.18 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 1.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -85.62 -16.3 39.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 1.0 110.554 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -68.12 -35.71 78.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.0 110.448 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.8 p -124.25 -42.84 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 1.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.88 34.95 2.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -106.2 111.4 24.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -1.151 . . . . 1.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.0 m -92.82 124.93 37.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 1.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 -153.68 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.818 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.1 mtt -78.39 143.44 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -1.151 . . . . 1.0 110.283 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 51' ' ' MET . 3.1 mp -132.53 141.65 41.98 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 1.0 110.209 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.08 93.75 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.599 1.315 . . . . 1.0 110.374 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.99 -27.88 61.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 1.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -76.73 -2.39 32.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 1.0 110.917 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.7 m-85 -105.3 -51.61 2.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 1.0 110.237 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 57' ' ' VAL . 33.9 m -76.54 152.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 110.168 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.31 173.33 12.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.9 . . . . 1.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.56 139.36 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 1.0 110.163 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.159 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 1.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.61 -178.21 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 1.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.15 -39.06 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -56.51 -63.21 1.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 1.0 110.491 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 6' ' ' PHE . 21.3 mm 54.94 171.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 1.0 110.275 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' H ' HG22 ' A' ' 5' ' ' ILE . 38.8 m-85 -145.24 178.25 8.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.953 . . . . 1.0 110.148 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -153.87 117.05 4.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 1.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -62.27 132.39 52.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 1.0 110.175 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 mtp -114.0 9.76 17.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 1.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 9' ' ' MET . 48.6 m-85 -142.86 152.16 41.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.999 -1.063 . . . . 1.0 110.366 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -85.9 86.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 1.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 25.5 t80 -94.02 131.67 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 1.0 110.484 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.43 22.09 15.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 1.0 110.098 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . 55.15 166.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.633 0.73 . . . . 1.0 110.986 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 -19.79 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 1.0 109.908 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.86 -157.86 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 1.0 109.971 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.35 19.29 9.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.196 -0.94 . . . . 1.0 110.401 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.0 -34.92 22.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 1.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -122.4 -176.97 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.94 . . . . 1.0 110.303 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' A' ' 52' ' ' LEU . 12.0 m -105.24 -162.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0 110.179 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -139.55 105.93 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 1.0 110.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' HE2' HD12 ' A' ' 52' ' ' LEU . 4.4 p90 -118.77 154.47 32.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 1.0 109.897 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -97.68 178.27 5.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 1.0 110.378 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -69.83 81.73 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.0 110.054 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 163.43 -28.19 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 4.5 m-20 -53.39 151.53 5.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -1.114 . . . . 1.0 110.162 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.47 143.47 50.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 1.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 41' ' ' GLY . 56.8 mt -138.98 146.75 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 1.0 109.926 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.901 HG13 HG23 ' A' ' 31' ' ' VAL . 2.9 pt -81.69 -161.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 1.0 110.771 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 32' ' ' GLN . 35.6 m-20 -72.29 -47.42 50.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.369 -0.832 . . . . 1.0 110.937 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.901 HG23 HG13 ' A' ' 29' ' ' ILE . 72.8 t 56.28 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 1.0 110.461 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -171.09 139.93 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 110.522 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.52 145.72 37.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 1.0 110.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -126.86 -33.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 1.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.13 170.09 16.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 1.0 110.408 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.6 tm-20 -79.3 -22.8 44.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 1.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.6 -75.73 0.29 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.74 152.88 38.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -1.184 . . . . 1.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.06 -160.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 1.0 110.446 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -137.15 135.29 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.813 . . . . 1.0 109.807 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -164.74 159.02 31.98 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.599 -1.286 . . . . 1.0 109.906 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 49' ' ' THR . 55.5 m -108.98 121.68 45.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -1.088 . . . . 1.0 109.96 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 45' ' ' ARG . 34.1 t -63.92 122.81 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 1.0 110.319 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -76.03 -10.39 59.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 1.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -70.44 -68.0 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 110.33 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.72 -40.13 8.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 1.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.44 24.73 3.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -84.48 126.47 33.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -1.164 . . . . 1.0 110.012 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 15.6 p -97.75 133.47 42.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 110.327 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . 178.86 -174.34 46.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.845 ' O ' HD13 ' A' ' 52' ' ' LEU . 29.6 mtp -87.6 153.68 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -1.181 . . . . 1.0 110.589 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -126.02 145.02 50.66 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 1.0 109.65 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 47.6 Cg_endo -72.11 112.57 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.66 1.347 . . . . 1.0 110.09 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 36' ' ' GLU . . . -64.03 -39.77 94.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.99 . . . . 1.0 110.206 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -23.15 14.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.171 -0.956 . . . . 1.0 109.956 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 1.7 m-85 -88.29 -73.66 0.48 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.0 110.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 8' ' ' ALA . 33.2 m -52.9 151.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 1.0 110.075 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -124.24 159.39 30.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 1.0 110.234 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 149.93 29.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 1.0 110.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.278 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.255 0.55 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.37 178.46 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 1.0 110.199 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.99 25.93 8.72 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -100.24 -174.35 2.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -1.121 . . . . 1.0 110.411 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mt -122.05 151.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.323 -0.861 . . . . 1.0 109.731 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -119.95 179.23 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -161.88 144.55 11.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 1.0 110.21 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.27 124.71 41.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 1.0 110.099 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.411 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 3.0 mmm -95.5 -3.0 47.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 1.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -127.87 177.43 6.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.931 -1.105 . . . . 1.0 110.336 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.67 83.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.716 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.61 140.94 41.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 1.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.9 mtt -112.16 108.33 17.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.468 -0.77 . . . . 1.0 109.507 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -48.1 120.92 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.881 . . . . 1.0 110.803 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.18 64.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 1.0 109.847 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.57 -175.25 2.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 1.0 109.939 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -17.36 56.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 1.0 110.313 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.09 -31.65 62.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 1.0 110.298 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 1.9 mp0 -84.92 171.92 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 1.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG13 ' HA3' ' A' ' 50' ' ' GLY . 35.7 m -116.67 167.62 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 1.0 109.877 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 t -129.56 108.57 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 1.0 110.554 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 1.0 110.098 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.04 178.62 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 1.0 110.601 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 34.3 t0 -75.03 99.63 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 1.0 110.111 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.08 -28.23 2.38 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.083 -1.607 . . . . 1.0 109.083 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' OD1' HG13 ' A' ' 43' ' ' VAL . 9.7 t70 -63.1 165.92 6.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.063 . . . . 1.0 109.994 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.57 169.19 15.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 1.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.525 ' C ' HG23 ' A' ' 29' ' ' ILE . 27.0 mm -130.78 163.55 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.681 -0.637 . . . . 1.0 109.439 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.525 HG23 ' C ' ' A' ' 28' ' ' ILE . 7.6 pt -151.86 161.25 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.079 . . . . 1.0 110.956 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.9 m120 51.53 54.2 11.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 1.0 110.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 28' ' ' ILE . 27.3 m -104.3 170.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.185 -0.947 . . . . 1.0 110.377 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -158.67 -161.86 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0 109.928 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.66 20.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 1.0 110.264 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 34' ' ' ILE . 3.0 mp -78.81 -70.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.353 -0.842 . . . . 1.0 110.081 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.85 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 1.0 110.032 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 1.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.05 -55.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -54.4 155.89 3.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -1.114 . . . . 1.0 109.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.426 ' CE ' HG21 ' A' ' 57' ' ' VAL . 1.9 ptt? -131.94 -164.1 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 1.0 110.483 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -124.86 158.76 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 1.0 109.872 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -175.06 159.9 28.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.772 ' OG1' HG22 ' A' ' 49' ' ' THR . 54.6 m -126.86 117.23 22.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 1.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' OD1' ' A' ' 26' ' ' ASP . 22.0 t -57.14 109.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 1.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -23.68 63.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.866 . . . . 1.0 110.701 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -75.83 -74.07 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 1.0 110.649 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 p -68.66 -56.79 7.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 1.0 110.312 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.15 32.23 1.72 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -97.48 148.56 23.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 1.0 110.13 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.772 HG22 ' OG1' ' A' ' 42' ' ' THR . 29.7 p -125.21 135.83 52.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 1.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -178.56 -163.59 30.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.793 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.87 141.86 34.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 1.0 110.129 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 51' ' ' MET . 8.9 mp -123.1 125.8 26.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.549 -0.719 . . . . 1.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 107.47 2.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.408 1.215 . . . . 1.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.59 55.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 1.0 110.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -62.19 -17.34 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 1.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -98.52 -60.95 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 1.0 109.794 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 ' CE ' ' A' ' 39' ' ' MET . 28.7 m -78.51 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 1.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.83 -174.74 2.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.915 . . . . 1.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -105.23 167.18 9.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 1.0 110.525 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.177 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.289 0.566 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 72.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 1.0 110.135 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.94 62.86 0.55 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.479 -1.449 . . . . 1.0 109.479 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -74.26 -34.01 63.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -1.105 . . . . 1.0 110.15 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm 58.1 159.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.39 -0.819 . . . . 1.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.32 -174.71 3.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 1.0 110.23 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -153.12 164.17 38.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 1.0 110.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.72 133.22 53.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 1.0 110.141 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 8.9 mtp -111.35 -6.3 14.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 1.0 110.743 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -131.79 167.12 20.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 1.0 110.148 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -98.69 105.45 17.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.289 -0.882 . . . . 1.0 109.86 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -109.62 160.94 15.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 1.0 110.908 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 114.45 9.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -0.76 . . . . 1.0 109.759 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.15 117.47 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.642 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.36 49.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 1.0 110.014 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.72 -154.85 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 1.0 109.973 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.46 15.55 27.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 1.0 110.518 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 1.1 t70 -85.38 -35.22 21.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.031 -1.043 . . . . 1.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 18' ' ' ASP . 6.5 pm0 -124.71 -175.87 3.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 1.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.6 m -113.7 -165.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 1.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.54 123.78 24.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 1.0 110.331 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.3 153.74 51.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 1.0 110.115 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -97.85 178.58 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 1.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.45 119.36 17.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 1.0 110.191 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.23 -35.36 3.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.38 160.3 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.145 . . . . 1.0 110.347 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 141.22 52.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.211 -0.931 . . . . 1.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 52' ' ' LEU . 39.1 mt -143.75 127.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.94 . . . . 1.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.7 -160.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 1.0 110.455 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -160.79 79.1 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.838 . . . . 1.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 31' ' ' VAL . 40.4 t -52.83 -62.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 1.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -119.6 147.13 44.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.868 . . . . 1.0 109.904 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.64 115.06 9.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 1.0 110.34 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 39.7 mm -93.45 -5.67 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 1.0 110.504 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.41 -72.19 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -0.977 . . . . 1.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.11 47.05 1.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 1.0 110.371 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.74 49.55 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.2 m95 52.99 178.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -1.177 . . . . 1.0 110.123 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.694 ' CE ' HD12 ' A' ' 52' ' ' LEU . 5.3 ptm -138.66 173.05 11.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 1.0 110.324 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -120.68 158.77 26.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.02 -175.31 47.36 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.847 ' OG1' HG22 ' A' ' 49' ' ' THR . 52.3 m -125.64 122.55 36.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -1.109 . . . . 1.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.67 118.52 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 1.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -21.21 64.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.92 . . . . 1.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -69.56 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 1.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -86.94 -28.34 22.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 1.0 110.354 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.89 8.55 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -106.34 142.9 35.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -1.091 . . . . 1.0 110.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' THR . . . . . 0.847 HG22 ' OG1' ' A' ' 42' ' ' THR . 37.2 p -104.95 143.24 33.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.1 178.09 48.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.933 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.9 mmm -79.48 153.53 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 1.0 110.216 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.933 HD23 ' O ' ' A' ' 51' ' ' MET . 12.3 mt -129.64 162.92 50.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 1.0 109.931 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.5 Cg_endo -74.88 114.99 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 1.0 110.378 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.84 -18.34 62.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 1.0 110.459 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.21 -1.04 57.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.972 . . . . 1.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -110.91 -65.41 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.96 -1.088 . . . . 1.0 110.396 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 53' ' ' PRO . 19.8 m -56.3 170.33 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 1.0 110.34 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.54 157.87 37.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 1.0 110.298 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.51 140.53 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.208 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.279 0.562 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.57 162.05 39.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 1.0 110.325 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.19 31.23 3.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.433 -1.467 . . . . 1.0 109.433 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -56.05 -168.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -1.074 . . . . 1.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mt -106.07 148.83 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 1.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -119.57 179.78 4.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 1.0 110.141 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.37 142.53 12.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.1 155.49 20.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 1.0 110.122 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 mtp -134.19 4.93 3.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 1.0 110.921 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -134.32 129.21 35.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.988 -1.07 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.3 103.47 2.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 1.0 109.825 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -104.22 147.64 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.983 . . . . 1.0 110.722 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.16 105.41 11.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 1.0 109.79 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.84 120.42 3.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.244 -0.91 . . . . 1.0 110.661 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.46 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 1.0 110.114 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -171.22 2.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 1.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 11.36 15.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 1.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -26.35 43.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 1.0 110.054 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -131.85 -176.97 4.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.308 -0.87 . . . . 1.0 110.243 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 29.9 m -115.79 -169.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 1.0 109.964 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.6 p -133.21 123.97 26.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 1.0 110.725 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.04 159.57 37.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 1.0 109.891 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -105.4 176.95 4.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 1.0 110.393 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.96 93.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.221 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.33 -24.45 0.59 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 3.8 t0 -65.01 177.09 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -1.137 . . . . 1.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.99 164.38 33.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 1.0 110.259 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 29' ' ' ILE . 20.8 mm -118.51 172.02 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.334 -0.854 . . . . 1.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.424 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -171.61 -35.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.044 -1.035 . . . . 1.0 110.477 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.66 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.209 -0.932 . . . . 1.0 111.117 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 32' ' ' GLN . 42.5 t -95.13 -109.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.085 -1.01 . . . . 1.0 110.192 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.9 tt0 -176.26 -152.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.469 -1.394 . . . . 1.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 39' ' ' MET . . . -122.6 129.07 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 1.0 110.455 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.99 -8.4 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.75 146.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.11 -0.994 . . . . 1.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.49 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 1.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.61 27.48 5.47 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.1 m95 54.8 171.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.46 -1.024 . . . . 1.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.538 ' SD ' HD12 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -122.56 -167.84 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 1.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -147.61 144.64 28.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.166 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.28 178.39 44.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -106.88 132.53 52.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -1.067 . . . . 1.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 49.3 t -69.75 129.11 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 1.0 109.801 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -70.75 -35.18 72.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 1.0 110.652 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -57.85 8.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 1.0 110.572 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 p -91.93 -52.28 4.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 1.0 110.613 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.96 25.38 6.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.353 -1.499 . . . . 1.0 109.353 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -95.45 138.58 32.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 1.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.34 135.93 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 1.0 110.171 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.78 177.27 47.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.876 ' O ' HD23 ' A' ' 52' ' ' LEU . 11.1 mmt -82.6 151.9 26.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -1.148 . . . . 1.0 109.99 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.876 HD23 ' O ' ' A' ' 51' ' ' MET . 9.7 mt -128.27 161.92 53.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 1.0 109.917 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.593 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.4 Cg_endo -74.55 115.08 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.677 1.357 . . . . 1.0 110.267 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.37 -17.19 60.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 1.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.2 -8.29 51.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 1.0 110.85 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.94 -60.69 1.48 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.008 -1.058 . . . . 1.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 53' ' ' PRO . 26.9 m -70.48 163.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 1.0 109.863 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 -177.46 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.031 -1.043 . . . . 1.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 169.23 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 1.0 110.245 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.216 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' THR . . . . . 0.513 HG23 ' N ' ' A' ' 2' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.875 0.369 . . . . 1.0 110.938 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' N ' HG23 ' A' ' 1' ' ' THR . . . -152.88 30.38 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.141 . . . . 1.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.06 -18.93 5.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.927 -1.269 . . . . 1.0 109.927 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -73.18 -172.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -1.205 . . . . 1.0 110.347 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.98 152.88 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 1.0 109.558 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.4 179.84 4.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 1.0 110.409 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.4 ttp85 -160.46 155.4 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 1.0 110.377 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.88 149.3 27.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 1.0 110.029 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.473 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 22.7 mtm -139.81 28.75 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 1.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.4 m-85 -150.22 109.86 4.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 110.609 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.21 133.88 49.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.0 109.45 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 19.3 t80 -147.24 137.39 23.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.946 -1.096 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.2 ttp -102.74 103.9 14.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -45.59 115.39 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.473 -0.767 . . . . 1.0 111.356 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.77 -48.6 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 1.0 109.586 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.48 150.1 28.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 1.0 109.664 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.16 -28.37 10.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.0 110.509 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.3 -35.6 79.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 110.366 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 4.7 mp0 -84.75 172.14 11.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.261 -0.899 . . . . 1.0 110.724 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 52' ' ' LEU . 13.5 m -120.94 169.12 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 1.0 110.032 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -103.49 126.02 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.948 . . . . 1.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 53' ' ' PRO . 5.4 m-85 -84.36 167.1 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 1.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.8 tptt -152.93 122.09 6.62 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 20.4 t0 -46.73 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 1.0 111.035 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 120.65 31.08 1.28 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -105.75 172.82 6.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -1.211 . . . . 1.0 110.065 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . . . -148.1 155.85 41.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 1.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.12 135.86 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 1.0 110.031 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.619 HG13 HG23 ' A' ' 31' ' ' VAL . 2.0 pt -69.07 -152.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 1.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -105.0 82.14 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 1.0 110.469 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' A' ' 41' ' ' GLY . 75.3 t -100.98 -83.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 1.0 110.39 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -167.32 149.31 5.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 1.0 109.945 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 35' ' ' ASP . . . -165.92 -166.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 1.0 110.388 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' ALA . 26.5 mt 65.96 -60.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.856 -0.528 . . . . 1.0 110.658 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' ALA . 5.8 t70 -56.09 171.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 1.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.25 -168.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.196 -0.94 . . . . 1.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.46 -25.81 11.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -117.38 162.98 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -1.158 . . . . 1.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 22.7 ttt -90.53 169.65 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 1.0 109.648 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -145.91 136.17 23.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 1.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 31' ' ' VAL . . . -177.23 -177.04 45.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 47' ' ' GLY . 94.8 m -113.8 137.18 52.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 1.0 110.346 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 45' ' ' ARG . 18.8 t -70.29 129.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 1.0 109.511 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -14.21 58.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 1.0 110.986 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' H ' HG12 ' A' ' 43' ' ' VAL . 3.5 ttt85 -86.92 -38.49 16.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.068 . . . . 1.0 110.567 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 p -110.71 -43.79 3.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 1.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 42' ' ' THR . . . 112.81 -16.97 23.13 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -59.66 139.88 56.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.265 . . . . 1.0 110.348 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -117.39 129.87 56.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.0 110.031 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -159.7 -158.72 9.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.974 -1.251 . . . . 1.0 109.974 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.709 ' C ' HD12 ' A' ' 52' ' ' LEU . 5.0 mmt -87.2 147.32 25.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -1.057 . . . . 1.0 110.415 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 51' ' ' MET . 8.3 mp -126.9 132.42 24.31 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.0 109.98 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' CZ ' ' A' ' 22' ' ' PHE . 43.4 Cg_endo -71.85 116.52 4.73 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.383 1.202 . . . . 1.0 110.265 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.74 -26.75 62.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.413 -0.804 . . . . 1.0 111.065 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.06 -5.42 31.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.099 -1.001 . . . . 1.0 110.854 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.3 m-30 -106.2 -66.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.007 -1.058 . . . . 1.0 110.23 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.52 168.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 1.0 110.68 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -170.3 161.26 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 1.0 109.956 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.73 148.09 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 1.0 110.349 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.103 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' HG22 ' A' ' 5' ' ' ILE . 5.7 mtmt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.022 0.439 . . . . 1.0 110.054 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 54.91 169.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.61 . . . . 1.0 110.268 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 7.2 m-85 -142.28 -166.01 2.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 1.0 110.036 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -169.1 142.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.467 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.69 163.15 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 1.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 37.1 mtm -136.72 7.08 2.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 1.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' MET . 45.0 m-85 -144.95 167.06 23.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.993 -1.067 . . . . 1.0 110.345 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -95.54 73.89 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 1.0 109.633 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -61.85 148.04 44.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 1.0 110.797 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 ttp -115.79 107.2 14.75 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.446 -0.784 . . . . 1.0 109.029 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.66 130.72 17.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 110.652 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.97 -32.3 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 1.0 109.754 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.69 -155.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 1.0 109.721 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.41 18.84 5.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.971 . . . . 1.0 110.202 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -105.9 -22.44 12.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 1.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE2' ' CZ3' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -103.35 -168.62 1.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.039 -1.038 . . . . 1.0 109.867 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.561 HG13 ' HA3' ' A' ' 50' ' ' GLY . 27.8 m -131.36 169.36 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.684 . . . . 1.0 109.727 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -121.48 75.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 1.0 110.644 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE2' HD23 ' A' ' 52' ' ' LEU . 9.2 p90 -93.68 148.94 21.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 1.0 109.783 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 169.66 8.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.069 -1.019 . . . . 1.0 110.721 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -65.25 122.89 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 1.0 110.13 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.7 -24.35 13.49 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.61 154.75 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -1.11 . . . . 1.0 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' GLN . . . -109.96 160.49 16.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 1.0 110.328 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 29' ' ' ILE . 41.4 mt -147.7 170.18 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.825 . . . . 1.0 109.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.677 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -106.62 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.159 -0.963 . . . . 1.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.677 ' N ' HG23 ' A' ' 29' ' ' ILE . 11.8 t-20 -169.03 79.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.401 -1.437 . . . . 1.0 110.529 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.7 -25.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.184 -0.948 . . . . 1.0 110.067 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.55 179.22 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 1.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.22 103.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 1.0 110.37 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -80.42 -19.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 1.0 110.225 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER 59.99 155.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 1.0 110.538 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' ASP . 19.5 pt-20 38.28 38.85 0.24 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.225 0.536 . . . . 1.0 111.581 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.41 ' C ' ' CD1' ' A' ' 38' ' ' TRP . . . -174.37 -82.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.883 -1.287 . . . . 1.0 109.883 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.504 ' CZ3' ' OE2' ' A' ' 19' ' ' GLU . 26.2 m95 -141.63 177.39 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.293 . . . . 1.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 3.2 mmt -130.9 -166.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 1.0 110.2 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.82 125.64 2.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 1.0 110.098 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.3 37.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.4 m -101.81 117.09 34.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 1.0 110.155 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.84 107.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 1.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -63.65 -14.76 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.0 110.474 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -73.59 -24.7 60.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.079 -1.013 . . . . 1.0 110.373 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -140.05 -47.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 1.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.74 7.45 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.73 141.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.317 . . . . 1.0 110.221 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.548 HG22 ' OG1' ' A' ' 42' ' ' THR . 12.7 p -109.87 129.27 55.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 1.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.41 -164.85 15.31 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.892 -1.283 . . . . 1.0 109.892 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.61 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.2 tpp -95.07 157.74 15.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -1.005 . . . . 1.0 110.847 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 52' ' ' LEU . 4.0 mp -137.46 141.87 35.2 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.485 -0.759 . . . . 1.0 109.965 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 44.2 Cg_endo -73.63 120.74 6.61 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.552 1.29 . . . . 1.0 110.327 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.14 -19.78 55.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.241 -0.912 . . . . 1.0 110.848 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.71 4.4 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 1.0 110.73 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 11.6 m-85 -117.56 -62.01 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.05 -1.031 . . . . 1.0 110.07 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 57' ' ' VAL . 34.8 m -78.96 160.73 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 110.405 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.403 ' OE2' ' CE ' ' A' ' 9' ' ' MET . 16.5 mt-10 -149.36 179.53 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 1.0 109.983 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.409 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -93.69 171.88 8.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.932 . . . . 1.0 110.325 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 59' ' ' ALA . 4.5 pt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mttt . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.238 0.542 . . . . 1.0 110.062 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 mt -107.84 131.87 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 1.0 109.637 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.34 -178.74 3.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 1.0 110.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HB3' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.59 144.76 19.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 1.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.76 163.72 22.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.318 -0.864 . . . . 1.0 110.114 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.442 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 16.4 mtp -134.55 9.12 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 1.0 110.774 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 9' ' ' MET . 70.5 m-85 -148.31 140.64 24.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.015 -1.053 . . . . 1.0 110.305 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 101.79 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 1.0 109.841 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -104.71 133.2 49.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 1.0 110.849 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 112.6 25.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 1.0 109.429 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.23 117.69 2.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.21 -0.932 . . . . 1.0 110.762 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.92 67.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 1.0 110.046 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 178.77 6.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 1.0 110.147 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 1.0 110.567 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.83 -29.59 44.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 1.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -82.09 173.88 11.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.184 -0.948 . . . . 1.0 110.346 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.899 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 23.8 m -109.62 -173.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 1.0 109.976 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.31 89.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.974 . . . . 1.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 10.1 p90 -113.23 149.29 33.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 1.0 110.013 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 164.32 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 1.0 110.514 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 17.9 t70 -52.77 115.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 1.0 110.197 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.0 -22.78 8.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.16 160.2 21.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -1.177 . . . . 1.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.14 133.18 51.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 1.0 110.202 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 52' ' ' LEU . 25.3 mm -118.67 156.27 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 1.0 109.789 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.724 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -126.98 -143.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.0 109.569 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.724 ' N ' HG23 ' A' ' 29' ' ' ILE . 42.0 p-10 -157.15 76.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.795 -1.191 . . . . 1.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 32' ' ' GLN . 14.1 p -60.0 -34.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 1.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.45 -72.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 59.86 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.853 . . . . 1.0 110.534 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.54 -49.87 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 1.0 110.076 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 1.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.75 124.17 14.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.0 110.053 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . 121.38 80.22 0.56 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.298 -1.521 . . . . 1.0 109.298 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 40.0 m95 59.67 140.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.864 -0.786 . . . . 1.0 110.59 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ptp -149.6 -176.57 5.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.848 -1.158 . . . . 1.0 110.806 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -105.8 141.56 37.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 1.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.663 ' N ' HD21 ' A' ' 52' ' ' LEU . . . -159.79 158.4 29.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.782 -1.327 . . . . 1.0 109.782 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.6 m -114.7 126.95 55.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 1.0 109.952 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 45' ' ' ARG . 21.8 t -64.97 108.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 1.0 109.944 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -55.89 -24.23 35.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 1.0 110.502 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -67.23 -65.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 1.0 110.279 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.5 p -86.33 -65.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 1.0 110.231 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.69 -11.67 3.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -60.91 158.48 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.305 . . . . 1.0 110.158 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.4 m -133.11 123.57 25.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 1.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -148.02 -159.18 8.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.652 ' C ' HD23 ' A' ' 52' ' ' LEU . 3.1 mtm -95.19 149.53 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 1.0 110.223 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.663 HD21 ' N ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -136.35 146.15 54.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 1.0 110.052 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.0 Cg_endo -72.58 110.85 3.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.736 1.387 . . . . 1.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.49 68.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -66.66 -17.3 64.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 1.0 110.561 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m-30 -95.27 -62.6 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 1.0 110.227 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.46 156.33 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.0 110.409 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.06 178.89 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 1.0 110.046 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.87 163.91 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 1.0 110.235 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 7' ' ' ARG . 1.1 pt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 121.37 0.605 . . . . 1.0 111.165 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -138.59 142.5 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.217 -0.927 . . . . 1.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.1 -178.51 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 1.0 109.847 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -154.7 152.79 30.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.0 110.632 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -108.94 123.76 49.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.838 . . . . 1.0 109.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.46 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -100.98 8.96 42.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 1.0 110.926 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 9' ' ' MET . 53.9 m-85 -143.52 161.23 39.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.113 . . . . 1.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.09 96.31 6.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 1.0 109.789 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.69 152.15 20.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 1.0 110.893 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 ttp -118.34 103.72 10.07 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.33 -0.856 . . . . 1.0 109.382 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.35 130.14 16.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.198 -0.939 . . . . 1.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.02 -28.27 18.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 1.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -141.26 170.88 14.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 1.0 110.018 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.12 44.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 1.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -51.52 -40.26 59.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.038 . . . . 1.0 110.429 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' ' N ' ' A' ' 51' ' ' MET . 4.7 pm0 -124.33 -173.2 2.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 1.0 110.657 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.953 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.4 m -120.11 -151.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.477 -0.764 . . . . 1.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.79 150.99 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.952 -1.093 . . . . 1.0 110.757 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 8.2 p90 -161.62 149.4 14.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 1.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -97.95 179.48 4.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.171 -0.956 . . . . 1.0 110.547 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 36.6 t70 -70.97 107.22 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 1.0 110.21 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.65 -19.98 4.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.951 -1.259 . . . . 1.0 109.951 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.09 163.45 27.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 1.0 110.5 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.9 149.06 52.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.345 -0.847 . . . . 1.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 42' ' ' THR . 32.3 mt -143.7 133.77 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 1.0 110.454 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 1.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -151.9 105.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 1.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.3 p -102.28 -23.21 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 1.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -159.03 145.11 16.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 1.0 110.138 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -164.56 120.94 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 1.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.8 -72.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 1.0 110.236 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -176.37 -63.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 1.0 109.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -134.74 23.76 3.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 1.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . -126.05 71.78 0.46 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.35 -1.5 . . . . 1.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 12.1 m95 55.25 170.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -1.026 . . . . 1.0 110.435 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 51' ' ' MET . 4.6 ptp -148.89 165.69 30.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 1.0 110.26 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' CE1' ' HA2' ' A' ' 50' ' ' GLY . 9.6 t80 -105.75 123.84 48.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -177.31 21.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 28' ' ' ILE . 84.9 m -121.2 125.96 48.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.113 . . . . 1.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.71 107.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 1.0 110.125 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.18 -35.63 49.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 1.0 110.457 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -59.78 -62.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 1.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -92.11 -68.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 42' ' ' THR . . . 137.57 -12.69 3.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -52.34 147.71 7.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.292 . . . . 1.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 2.2 p -116.66 119.35 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 1.0 109.963 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.77 170.08 35.89 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.74 155.7 37.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -1.099 . . . . 1.0 110.217 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 51' ' ' MET . 8.4 mt -132.76 155.64 80.96 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.363 -0.836 . . . . 1.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.31 118.62 5.25 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.587 1.309 . . . . 1.0 110.263 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.83 58.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 1.0 110.348 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -78.39 -2.58 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.923 . . . . 1.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.36 -50.25 3.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.907 -1.12 . . . . 1.0 110.335 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 8' ' ' ALA . 34.1 m -81.13 -176.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 1.0 110.636 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.1 146.52 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 1.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -71.78 164.79 25.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 1.0 110.321 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.424 HG23 ' C ' ' A' ' 59' ' ' ALA . 7.1 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.382 0.611 . . . . 1.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 tt -129.39 167.38 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 1.0 109.906 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -134.44 -177.03 4.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.12 -0.987 . . . . 1.0 110.483 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.35 153.83 16.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 1.0 110.306 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.38 135.99 38.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 1.0 109.893 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.42 -22.36 13.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 1.0 110.617 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -121.43 178.69 4.7 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.057 -1.027 . . . . 1.0 110.102 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 41.8 p-10 -110.2 96.79 6.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 1.0 109.759 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -81.55 146.2 30.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mtm -114.42 94.9 5.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.56 -0.712 . . . . 1.0 109.222 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -46.82 138.04 6.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.815 . . . . 1.0 111.049 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.43 -22.16 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 1.0 109.911 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -142.97 169.98 16.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 1.0 110.168 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.12 -12.72 53.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 1.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -51.09 -41.81 60.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.001 -1.062 . . . . 1.0 110.538 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' N ' ' A' ' 51' ' ' MET . 2.0 pm0 -124.89 -173.98 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.99 . . . . 1.0 110.624 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 26.8 m -113.34 -174.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 1.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -129.18 115.59 17.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 1.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 p90 -125.88 160.5 29.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 1.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -108.77 179.52 4.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 1.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -73.79 111.99 9.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 1.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.49 -29.66 3.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.34 151.31 41.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -1.201 . . . . 1.0 110.347 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 156.67 20.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 110.449 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 52' ' ' LEU . 28.3 mt -149.1 129.48 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 1.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -73.71 -159.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.906 . . . . 1.0 110.655 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -114.6 87.19 2.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -0.755 . . . . 1.0 109.624 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 29' ' ' ILE . 84.4 t -73.43 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 1.0 110.847 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -166.97 156.76 11.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.968 -1.082 . . . . 1.0 110.595 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.09 146.1 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.16 -80.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 1.0 110.284 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -169.53 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.119 -0.988 . . . . 1.0 111.8 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.31 -170.75 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.788 -1.195 . . . . 1.0 110.475 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.36 -69.52 1.12 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -53.16 135.39 37.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 1.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -133.74 -163.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 1.0 110.141 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 137.2 52.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 1.0 110.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.679 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -144.05 141.94 10.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.61 ' OG1' HG23 ' A' ' 49' ' ' THR . 55.4 m -103.06 104.68 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -1.194 . . . . 1.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 48' ' ' ARG . 2.8 m -48.33 128.92 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.373 -0.83 . . . . 1.0 110.473 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.401 ' NE2' ' CG2' ' A' ' 29' ' ' ILE . 3.4 mm100 -85.66 9.96 14.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 1.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -58.2 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 1.0 109.876 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -100.7 -26.03 13.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.82 25.48 10.6 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 43' ' ' VAL . 84.2 mtm180 -93.79 149.86 20.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -1.128 . . . . 1.0 110.334 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.61 HG23 ' OG1' ' A' ' 42' ' ' THR . 1.5 m -121.03 146.69 46.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 110.421 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.68 172.58 44.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.544 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.1 ttm -60.7 156.46 16.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -1.191 . . . . 1.0 110.197 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.679 HD22 ' HA3' ' A' ' 41' ' ' GLY . 1.1 mp -132.63 139.17 33.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 1.0 110.659 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 43.8 Cg_endo -70.93 121.04 7.51 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.654 1.344 . . . . 1.0 110.644 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.84 60.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 1.0 110.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.49 24.54 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 1.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 4.9 m-85 -131.78 -40.15 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 1.0 109.996 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.07 173.51 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 1.0 110.123 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.89 . . . . 1.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.58 170.65 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 1.0 110.238 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.232 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.7 mtmm . . . . . 0 N--CA 1.488 1.444 0 CA-C-O 121.221 0.534 . . . . 1.0 110.61 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt 61.25 141.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.512 -0.742 . . . . 1.0 109.97 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 10.4 m-85 -118.69 175.02 5.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.018 -1.051 . . . . 1.0 109.579 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.39 139.48 35.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 1.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' ASP . . . -86.47 124.66 33.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.185 -0.947 . . . . 1.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.0 mtt -92.6 -17.44 24.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 1.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.36 155.86 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 1.0 109.891 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.47 126.32 46.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 1.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -118.71 152.64 35.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.068 -1.02 . . . . 1.0 110.531 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 ttm -116.4 98.57 6.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.405 -0.809 . . . . 1.0 109.429 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.895 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.86 124.62 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.475 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.35 -26.46 35.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 1.0 110.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -176.59 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 1.0 110.243 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.95 -12.96 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 1.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.09 -47.16 53.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.045 . . . . 1.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 -165.46 1.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 1.0 110.171 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.895 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.9 m -121.07 -172.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 1.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 t -133.26 117.28 17.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -137.54 166.8 23.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 1.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -120.96 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 1.0 110.52 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 12.4 t70 -69.12 130.36 42.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 1.0 110.365 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.76 -11.44 49.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -68.52 155.79 39.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.938 -1.33 . . . . 1.0 110.341 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.65 129.25 56.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 1.0 110.288 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 29' ' ' ILE . 42.3 mt -147.48 171.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 1.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.733 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.14 -177.89 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.095 . . . . 1.0 110.252 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -122.42 88.93 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.484 -0.76 . . . . 1.0 110.264 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.54 -65.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.241 -0.912 . . . . 1.0 109.781 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -101.43 -48.25 4.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 1.0 109.828 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 53.31 80.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 1.0 110.68 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 36' ' ' GLU . 61.7 mt -84.11 -5.17 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 1.0 110.568 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 65.42 -69.92 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.213 -0.93 . . . . 1.0 110.676 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' ILE . 4.5 mt-10 -75.85 124.43 27.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 1.0 110.396 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.99 61.46 1.93 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.674 -1.37 . . . . 1.0 109.674 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m95 52.56 179.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -1.151 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG3' ' HB2' ' A' ' 52' ' ' LEU . 2.5 ptp -136.88 -174.42 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 1.0 109.879 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -129.28 139.73 51.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -0.969 . . . . 1.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.58 152.83 22.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ARG . 88.3 m -98.95 128.95 45.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -1.183 . . . . 1.0 110.241 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 46' ' ' THR . 45.2 t -61.98 97.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 1.0 110.061 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -19.5 25.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 1.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -53.12 16.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 1.0 110.294 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.423 ' H ' HG12 ' A' ' 43' ' ' VAL . 20.3 p -97.48 -49.66 4.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 1.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.43 -14.36 5.86 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -70.54 -168.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.947 -1.325 . . . . 1.0 110.176 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 42' ' ' THR . 4.9 t -172.16 151.66 2.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 1.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.8 -158.74 20.25 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.814 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.89 137.41 38.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 1.0 110.073 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 51' ' ' MET . 10.7 mp -124.46 151.42 66.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 1.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.76 108.8 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.721 1.379 . . . . 1.0 110.122 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.13 65.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.7 6.48 34.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.026 . . . . 1.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -114.27 -64.37 1.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.044 -1.035 . . . . 1.0 110.156 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.66 157.17 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 1.0 110.258 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.51 -177.99 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.878 . . . . 1.0 110.294 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.56 148.92 24.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 1.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 pt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.139 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.4 mttm . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.366 0.603 . . . . 1.0 110.259 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 13.3 tt -127.61 170.51 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 1.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 39.1 m-85 -148.27 177.13 9.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 1.0 110.476 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.571 ' HB2' HG21 ' A' ' 60' ' ' ILE . 11.6 ttp180 -140.5 133.07 28.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 1.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.37 136.21 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.967 . . . . 1.0 110.44 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.49 ' HG3' ' CE1' ' A' ' 10' ' ' TYR . 9.2 tpp -128.01 1.2 5.92 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.306 -0.871 . . . . 1.0 109.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 9' ' ' MET . 33.5 m-85 -124.36 -7.68 7.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.905 -1.122 . . . . 1.0 111.316 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t0 60.36 71.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.003 -1.06 . . . . 1.0 108.774 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -77.65 148.68 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 1.0 111.296 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttp -121.59 99.64 6.58 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -47.55 115.9 1.28 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 1.0 110.893 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.48 -33.72 17.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 1.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 -151.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.47 -25.11 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 1.0 110.214 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' CA ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -79.56 -23.44 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.378 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 3.1 mp0 -80.05 172.05 14.28 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 1.0 110.53 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.761 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.7 m -117.05 169.0 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.441 -0.787 . . . . 1.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -128.89 101.29 6.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.987 -1.071 . . . . 1.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 7.9 p90 -123.32 148.64 45.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 1.0 109.862 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.56 -174.15 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 1.0 110.574 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.49 111.73 12.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 1.0 110.251 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.62 -18.32 7.21 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.28 165.92 5.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.248 . . . . 1.0 110.378 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.89 145.31 51.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 1.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.6 mm -111.27 147.26 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.914 . . . . 1.0 110.033 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 HE21 ' A' ' 44' ' ' GLN . 1.2 pt -58.88 -169.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 1.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 19.5 p-10 -83.32 55.07 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA2' ' A' ' 41' ' ' GLY . 1.8 p -80.84 -158.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.858 . . . . 1.0 109.997 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.624 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.5 pt20 -160.49 -156.89 0.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.914 -1.116 . . . . 1.0 110.054 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 39' ' ' MET . . . -137.23 -152.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 1.0 109.976 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -128.45 -85.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 1.0 109.773 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.555 ' H ' HG23 ' A' ' 34' ' ' ILE . 26.2 t0 -108.81 -64.2 1.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.114 . . . . 1.0 110.264 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -177.72 156.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 1.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.57 -55.92 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.674 -1.371 . . . . 1.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -143.55 163.05 34.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -1.223 . . . . 1.0 110.642 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.444 ' CB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.3 -152.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.716 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.539 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -144.09 166.77 24.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 1.0 109.973 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . 175.54 167.14 34.17 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.825 -1.31 . . . . 1.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 49' ' ' THR . 85.5 m -118.69 128.43 54.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.341 -1.093 . . . . 1.0 110.066 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.31 117.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 1.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.485 HE21 HG22 ' A' ' 29' ' ' ILE . 4.2 mm-40 -57.75 -23.06 50.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 1.0 110.473 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -71.56 0.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 1.0 110.304 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.9 p -72.69 -51.93 17.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 1.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 42' ' ' THR . . . 111.59 -15.14 27.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.72 166.3 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -1.23 . . . . 1.0 110.248 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 42' ' ' THR . 41.3 p -131.57 134.9 46.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 1.0 110.458 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.466 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -160.09 -164.63 15.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.701 -1.36 . . . . 1.0 109.701 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -80.45 142.55 34.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -1.13 . . . . 1.0 110.183 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 51' ' ' MET . 7.0 mp -124.51 142.33 40.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 1.0 110.539 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 49.1 Cg_endo -76.72 114.84 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.587 1.309 . . . . 1.0 109.99 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.03 67.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.136 -0.977 . . . . 1.0 110.849 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -71.97 -21.45 61.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.076 -1.015 . . . . 1.0 110.64 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.484 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 3.5 m-30 -81.89 -65.54 1.0 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 1.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -52.38 151.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 1.0 110.089 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.4 162.13 25.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.0 110.377 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 145.32 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 1.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 7' ' ' ARG . 4.9 pt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.161 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.276 0.56 . . . . 1.0 110.094 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.801 HG23 HD11 ' A' ' 60' ' ' ILE . 11.0 tt -154.7 169.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 1.0 110.123 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 55.9 m-85 -137.25 176.6 8.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.296 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.656 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -159.94 145.14 15.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 1.0 109.891 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.75 120.6 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 1.0 110.406 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -101.79 12.23 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 1.0 110.561 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.0 m-85 -141.77 140.71 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.0 110.375 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -80.62 115.62 20.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 1.0 109.297 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -121.3 163.1 19.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.911 -1.118 . . . . 1.0 111.129 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.85 115.84 13.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.61 -0.681 . . . . 1.0 109.3 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.31 133.69 15.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.162 -0.961 . . . . 1.0 110.761 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.07 -34.69 60.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -175.64 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 1.0 110.631 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 16' ' ' ASP . . . -176.64 -32.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.094 -1.004 . . . . 1.0 110.876 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.24 -26.33 0.77 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 1.0 111.027 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -136.23 -168.91 2.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 1.0 110.4 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.39 -174.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 1.0 110.241 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -136.03 115.14 12.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0 110.687 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -126.46 153.53 44.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 1.0 109.865 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -92.39 173.32 7.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 1.0 110.652 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -70.0 83.51 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.815 . . . . 1.0 109.977 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 156.45 -23.67 0.51 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.58 -1.408 . . . . 1.0 109.58 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.81 158.66 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -1.203 . . . . 1.0 110.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.86 145.81 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.356 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 29' ' ' ILE . 40.5 mm -122.58 170.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 1.0 109.747 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -131.01 -145.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 1.0 110.01 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.723 ' N ' HG23 ' A' ' 29' ' ' ILE . 5.1 t-20 -126.84 87.14 2.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 1.0 110.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -91.11 -59.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 1.0 110.323 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -172.4 178.26 2.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 1.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.2 123.44 5.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 1.0 110.079 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.489 HG22 ' OD2' ' A' ' 35' ' ' ASP . 72.5 mt -85.11 -43.92 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 1.0 110.304 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.489 ' OD2' HG22 ' A' ' 34' ' ' ILE . 3.0 m-20 -148.99 -169.53 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 1.0 110.18 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -25.82 30.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 1.0 109.942 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.4 -75.55 0.29 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -121.83 158.18 29.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -1.159 . . . . 1.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -123.44 -163.12 1.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 1.0 110.038 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -139.34 130.48 26.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 1.0 110.277 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -167.49 -171.18 33.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.407 ' O ' ' NE2' ' A' ' 44' ' ' GLN . 52.9 m -125.2 142.76 51.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 1.0 110.257 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.0 110.81 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.213 -0.93 . . . . 1.0 109.804 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 42' ' ' THR . 2.4 mp0 -60.13 -17.54 41.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 1.0 110.894 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -69.09 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.003 -1.06 . . . . 1.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.2 p -80.03 -41.01 26.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.942 . . . . 1.0 110.296 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 14.66 25.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -70.91 152.22 43.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.278 . . . . 1.0 110.05 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 p -128.34 129.82 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 1.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.83 40.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.768 ' C ' HD12 ' A' ' 52' ' ' LEU . 12.6 ttm -71.05 148.87 47.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 1.0 110.291 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 51' ' ' MET . 9.8 mp -126.53 140.4 37.26 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 1.0 110.302 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.89 95.84 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.586 1.308 . . . . 1.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.67 -24.06 60.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 1.0 110.456 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -76.79 -10.26 59.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 1.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.71 -45.25 6.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.029 . . . . 1.0 110.103 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.36 163.76 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 1.0 110.029 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.97 178.3 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 1.0 110.332 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 60' ' ' ILE . . . -90.15 14.92 11.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 1.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HG23 ' A' ' 5' ' ' ILE . 37.8 pt . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 117.988 -1.006 . . . . 1.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 5' ' ' ILE . 1.7 mtpt . . . . . 0 N--CA 1.49 1.537 0 CA-C-O 120.796 0.331 . . . . 1.0 110.217 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 4' ' ' LYS . 11.9 tt 47.75 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.571 0.7 . . . . 1.0 111.351 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 5' ' ' ILE . 14.4 m-85 -155.35 -175.18 5.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.0 110.4 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.72 ' HB2' HG21 ' A' ' 60' ' ' ILE . 18.2 tpp180 -162.9 132.86 4.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.0 110.05 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 22' ' ' PHE . . . -83.64 147.82 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 1.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 mtp -120.43 -14.98 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 1.0 110.656 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -124.03 125.33 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 1.0 110.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.13 92.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 1.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -82.02 167.37 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 1.0 110.775 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.82 117.2 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.767 . . . . 1.0 109.635 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.73 125.99 11.1 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 1.0 110.774 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.96 -34.52 15.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 1.0 110.291 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.21 -82.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 1.0 110.234 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.36 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.129 -0.982 . . . . 1.0 110.398 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.07 -24.34 6.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 1.0 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.07 171.03 7.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 52' ' ' LEU . 25.7 m -113.46 -156.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 1.0 109.975 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.96 128.12 7.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 1.0 110.579 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' CD1' ' HB1' ' A' ' 8' ' ' ALA . 17.1 p90 -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.368 -0.832 . . . . 1.0 109.878 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 4.4 pttt -96.71 -165.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 1.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.83 114.55 18.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.283 -0.886 . . . . 1.0 110.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.38 -2.39 50.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.83 157.15 7.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.912 -1.346 . . . . 1.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.0 130.35 50.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 1.0 110.279 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.4 HG21 ' CD2' ' A' ' 52' ' ' LEU . 34.3 mt -145.29 153.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 1.0 109.853 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -112.93 -142.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 1.0 110.182 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -153.68 105.28 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 1.0 110.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.2 p -83.34 -23.04 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 1.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.95 177.72 2.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 1.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.76 136.17 37.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 1.0 110.341 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.85 -13.63 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 1.0 110.569 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 63.88 10.97 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.139 -0.976 . . . . 1.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -113.22 -65.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.977 -1.077 . . . . 1.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.37 -52.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 51' ' ' MET . 7.9 m95 -84.2 178.19 7.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 1.0 110.105 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -147.07 174.37 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0 110.3 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.424 ' CE1' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -116.1 136.37 53.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 1.0 110.51 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 168.19 34.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -116.45 122.9 46.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.86 126.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 1.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -73.23 -30.39 63.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 1.0 110.597 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -24.04 66.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 1.0 110.318 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -131.77 -59.57 0.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.0 110.176 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.92 28.14 1.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -99.97 135.97 40.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 1.0 109.89 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 40' ' ' TYR . 25.5 m -101.3 123.88 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 1.0 110.512 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.46 ' CA ' ' CG1' ' A' ' 20' ' ' VAL . . . -153.82 -167.0 15.41 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.805 ' C ' HD12 ' A' ' 52' ' ' LEU . 8.0 mtp -78.99 143.68 35.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -1.159 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 51' ' ' MET . 9.4 mp -126.44 138.03 31.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 1.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.745 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.1 Cg_endo -74.05 113.5 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.529 1.279 . . . . 1.0 110.589 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.31 81.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.035 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -60.75 -17.59 49.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 1.0 110.186 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.8 m-85 -95.44 -59.64 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 1.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 53' ' ' PRO . 28.0 m -71.66 170.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 1.0 110.129 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.22 158.51 24.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 1.0 110.312 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 159.66 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 1.0 110.278 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.72 HG21 ' HB2' ' A' ' 7' ' ' ARG . 33.7 pt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.209 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.229 0.537 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mt 57.59 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.0 110.612 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.9 -178.36 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 1.0 110.031 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 60' ' ' ILE . 15.0 ttt85 -170.03 138.12 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 1.0 110.411 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.13 33.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 1.0 109.879 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.2 mmm -95.77 -14.37 23.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 1.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 35.2 m-85 -137.75 151.41 48.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.03 -1.044 . . . . 1.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -81.63 84.38 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 1.0 109.28 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -70.1 166.4 19.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 1.0 110.996 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.34 114.3 8.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.632 -0.668 . . . . 1.0 109.344 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.02 121.53 4.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.204 -0.935 . . . . 1.0 110.635 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 1.0 110.548 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.33 -69.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.074 -1.016 . . . . 1.0 110.748 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.63 -34.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.956 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.38 -29.53 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.197 -0.94 . . . . 1.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.07 -177.06 3.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.147 -0.97 . . . . 1.0 109.952 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 19.0 m -110.36 -152.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 1.0 110.585 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 t -157.07 141.93 16.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 1.0 110.41 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -150.95 149.69 29.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.353 -0.842 . . . . 1.0 109.78 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -174.87 4.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.516 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.13 114.56 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.98 -21.1 9.02 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.679 -1.369 . . . . 1.0 109.679 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.46 169.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -1.181 . . . . 1.0 110.311 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.507 ' O ' HD13 ' A' ' 28' ' ' ILE . . . -118.3 139.51 51.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.818 . . . . 1.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 27' ' ' ALA . 40.1 mm -123.08 173.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.0 109.992 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.717 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -117.96 -140.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 1.0 109.278 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.717 ' N ' HG23 ' A' ' 29' ' ' ILE . 12.3 t-20 -172.19 69.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.646 -1.284 . . . . 1.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 32' ' ' GLN . 20.7 m -70.56 -35.74 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.286 -0.884 . . . . 1.0 110.454 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.519 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 51.8 tt0 -144.53 -65.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 1.0 110.322 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 61.58 133.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.835 . . . . 1.0 110.577 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' GLU . 50.1 mm -119.8 -7.33 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.061 -1.024 . . . . 1.0 110.663 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 18.5 t0 66.71 -66.54 0.18 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.174 -0.954 . . . . 1.0 110.55 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -94.05 91.21 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.99 . . . . 1.0 110.587 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.85 64.82 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.5 m95 52.9 176.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.356 -1.084 . . . . 1.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 ptp -150.1 178.49 8.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 1.0 109.864 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CE2' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -124.11 122.2 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 110.311 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.75 176.68 24.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.658 ' H ' HG22 ' A' ' 29' ' ' ILE . 85.3 m -126.14 141.54 51.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -1.085 . . . . 1.0 110.096 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.82 110.34 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 1.0 110.297 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -55.68 -28.99 58.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.401 -0.812 . . . . 1.0 110.36 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -66.91 -70.31 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 1.0 110.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -81.93 -55.83 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 1.0 110.312 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.66 30.36 2.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -97.02 128.81 44.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 1.0 110.358 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' CE2' ' A' ' 40' ' ' TYR . 98.0 m -112.99 121.6 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 1.0 110.211 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.85 -147.92 5.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.588 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.3 mmt -84.2 138.72 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 1.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 51' ' ' MET . 7.3 mp -123.25 148.55 55.26 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.8 Cg_endo -72.19 110.3 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.684 1.36 . . . . 1.0 110.134 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.95 -23.09 65.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.567 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.01 7.95 25.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.9 m-85 -117.13 -58.67 2.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 1.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.12 161.6 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 1.0 110.177 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -169.19 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 1.0 109.964 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 147.11 27.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 1.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 7' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.207 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.334 0.588 . . . . 1.0 110.371 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.85 137.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 1.0 109.744 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -119.37 -176.47 3.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 1.0 109.894 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.68 136.56 5.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 1.0 110.543 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 23' ' ' LYS . . . -65.52 140.73 58.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 1.0 110.155 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.2 mtp -129.0 12.8 6.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 51.2 m-85 -131.76 -7.15 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.063 -1.023 . . . . 1.0 111.463 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.68 90.59 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.963 -1.086 . . . . 1.0 109.697 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 21.7 t80 -111.66 132.34 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 1.0 110.53 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . 0.484 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 5.2 ptt? -110.81 22.87 14.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.0 110.019 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 12' ' ' TYR . . . 57.23 158.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.538 0.685 . . . . 1.0 110.721 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.78 -22.83 11.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 1.0 110.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.02 -155.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.98 20.1 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 1.0 110.205 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -87.55 -36.3 17.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.0 110.606 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -119.76 -173.81 2.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 1.0 110.51 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.625 ' CG2' HD11 ' A' ' 52' ' ' LEU . 24.4 m -108.52 -178.01 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 1.0 109.92 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 13' ' ' MET . 2.2 p -131.02 133.44 45.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 1.0 110.648 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' A' ' 26' ' ' ASP . 6.4 p90 -137.72 168.84 18.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 1.0 109.845 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 13.9 mttp -94.34 -174.75 3.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -77.42 1.09 20.13 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.268 -0.895 . . . . 1.0 110.921 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.89 20.23 5.73 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.801 -1.32 . . . . 1.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' HG13 ' A' ' 43' ' ' VAL . 37.6 t0 -78.17 155.26 30.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 1.0 110.081 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.68 128.91 55.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 1.0 110.537 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 29' ' ' ILE . 27.7 mt -147.34 171.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -0.81 . . . . 1.0 109.474 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.506 ' N ' HG22 ' A' ' 28' ' ' ILE . 7.0 pt -142.27 -178.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.099 -1.0 . . . . 1.0 110.778 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -88.04 70.2 9.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 1.0 110.365 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.7 t -54.23 -62.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.83 151.68 47.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 109.909 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.24 132.21 27.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 1.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -95.55 -56.52 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 1.0 109.914 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.73 -161.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 134.54 52.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.126 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.21 85.24 1.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.461 -1.456 . . . . 1.0 109.461 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 38' ' ' TRP . 26.6 m95 55.07 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.51 -0.994 . . . . 1.0 110.552 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.0 ptt? -149.61 -147.96 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.15 -0.969 . . . . 1.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.21 128.52 30.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.79 170.39 28.49 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.1 m -123.76 104.17 8.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 1.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 26' ' ' ASP . 61.0 t -53.07 131.18 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 1.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -85.62 -16.3 39.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 1.0 110.554 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -68.12 -35.71 78.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.0 110.448 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.8 p -124.25 -42.84 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 1.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.88 34.95 2.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -106.2 111.4 24.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -1.151 . . . . 1.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.0 m -92.82 124.93 37.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 1.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 -153.68 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.818 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.1 mtt -78.39 143.44 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -1.151 . . . . 1.0 110.283 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 51' ' ' MET . 3.1 mp -132.53 141.65 41.98 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 1.0 110.209 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.08 93.75 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.599 1.315 . . . . 1.0 110.374 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.99 -27.88 61.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 1.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -76.73 -2.39 32.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 1.0 110.917 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.7 m-85 -105.3 -51.61 2.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 1.0 110.237 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 57' ' ' VAL . 33.9 m -76.54 152.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 110.168 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.31 173.33 12.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.9 . . . . 1.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.56 139.36 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 1.0 110.163 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.159 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.223 0.535 . . . . 1.0 110.491 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 6' ' ' PHE . 21.3 mm 54.94 171.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 1.0 110.275 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.461 ' H ' HG22 ' A' ' 5' ' ' ILE . 38.8 m-85 -145.24 178.25 8.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.953 . . . . 1.0 110.148 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -153.87 117.05 4.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 1.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -62.27 132.39 52.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 1.0 110.175 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 mtp -114.0 9.76 17.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 1.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 9' ' ' MET . 48.6 m-85 -142.86 152.16 41.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.999 -1.063 . . . . 1.0 110.366 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -85.9 86.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 1.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 25.5 t80 -94.02 131.67 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 1.0 110.484 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.43 22.09 15.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 1.0 110.098 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . 55.15 166.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.633 0.73 . . . . 1.0 110.986 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 -19.79 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 1.0 109.908 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.86 -157.86 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 1.0 109.971 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.35 19.29 9.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.196 -0.94 . . . . 1.0 110.401 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.0 -34.92 22.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 1.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -122.4 -176.97 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.94 . . . . 1.0 110.303 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' A' ' 52' ' ' LEU . 12.0 m -105.24 -162.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0 110.179 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -139.55 105.93 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 1.0 110.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' HE2' HD12 ' A' ' 52' ' ' LEU . 4.4 p90 -118.77 154.47 32.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 1.0 109.897 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -97.68 178.27 5.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 1.0 110.378 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -69.83 81.73 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.0 110.054 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 163.43 -28.19 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 4.5 m-20 -53.39 151.53 5.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -1.114 . . . . 1.0 110.162 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.47 143.47 50.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 1.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 41' ' ' GLY . 56.8 mt -138.98 146.75 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 1.0 109.926 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.901 HG13 HG23 ' A' ' 31' ' ' VAL . 2.9 pt -81.69 -161.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 1.0 110.771 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 32' ' ' GLN . 35.6 m-20 -72.29 -47.42 50.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.369 -0.832 . . . . 1.0 110.937 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.901 HG23 HG13 ' A' ' 29' ' ' ILE . 72.8 t 56.28 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 1.0 110.461 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -171.09 139.93 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 110.522 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.52 145.72 37.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 1.0 110.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -126.86 -33.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 1.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.13 170.09 16.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 1.0 110.408 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.6 tm-20 -79.3 -22.8 44.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 1.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.6 -75.73 0.29 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.74 152.88 38.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -1.184 . . . . 1.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.06 -160.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 1.0 110.446 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -137.15 135.29 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.813 . . . . 1.0 109.807 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -164.74 159.02 31.98 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.599 -1.286 . . . . 1.0 109.906 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 49' ' ' THR . 55.5 m -108.98 121.68 45.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -1.088 . . . . 1.0 109.96 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 45' ' ' ARG . 34.1 t -63.92 122.81 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 1.0 110.319 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -76.03 -10.39 59.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 1.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.496 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -70.44 -68.0 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 110.33 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.72 -40.13 8.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 1.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.44 24.73 3.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -84.48 126.47 33.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -1.164 . . . . 1.0 110.012 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 15.6 p -97.75 133.47 42.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 110.327 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . 178.86 -174.34 46.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.845 ' O ' HD13 ' A' ' 52' ' ' LEU . 29.6 mtp -87.6 153.68 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -1.181 . . . . 1.0 110.589 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -126.02 145.02 50.66 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 1.0 109.65 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 47.6 Cg_endo -72.11 112.57 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.66 1.347 . . . . 1.0 110.09 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 36' ' ' GLU . . . -64.03 -39.77 94.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.99 . . . . 1.0 110.206 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -23.15 14.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.171 -0.956 . . . . 1.0 109.956 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 1.7 m-85 -88.29 -73.66 0.48 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.0 110.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 8' ' ' ALA . 33.2 m -52.9 151.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 1.0 110.075 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -124.24 159.39 30.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 1.0 110.234 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 149.93 29.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 1.0 110.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.278 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.295 0.569 . . . . 1.0 110.411 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mt -122.05 151.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.323 -0.861 . . . . 1.0 109.731 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -119.95 179.23 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -161.88 144.55 11.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 1.0 110.21 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.27 124.71 41.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 1.0 110.099 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.411 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 3.0 mmm -95.5 -3.0 47.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 1.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -127.87 177.43 6.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.931 -1.105 . . . . 1.0 110.336 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.67 83.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.716 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.61 140.94 41.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 1.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.9 mtt -112.16 108.33 17.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.468 -0.77 . . . . 1.0 109.507 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -48.1 120.92 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.881 . . . . 1.0 110.803 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.18 64.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 1.0 109.847 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.57 -175.25 2.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 1.0 109.939 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -17.36 56.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 1.0 110.313 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.09 -31.65 62.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 1.0 110.298 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 1.9 mp0 -84.92 171.92 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 1.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.522 HG13 ' HA3' ' A' ' 50' ' ' GLY . 35.7 m -116.67 167.62 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 1.0 109.877 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 t -129.56 108.57 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 1.0 110.554 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 1.0 110.098 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.04 178.62 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 1.0 110.601 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 34.3 t0 -75.03 99.63 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 1.0 110.111 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.08 -28.23 2.38 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.083 -1.607 . . . . 1.0 109.083 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.618 ' OD1' HG13 ' A' ' 43' ' ' VAL . 9.7 t70 -63.1 165.92 6.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.063 . . . . 1.0 109.994 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.57 169.19 15.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 1.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.525 ' C ' HG23 ' A' ' 29' ' ' ILE . 27.0 mm -130.78 163.55 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.681 -0.637 . . . . 1.0 109.439 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.525 HG23 ' C ' ' A' ' 28' ' ' ILE . 7.6 pt -151.86 161.25 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.079 . . . . 1.0 110.956 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 51.53 54.2 11.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 1.0 110.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 28' ' ' ILE . 27.3 m -104.3 170.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.185 -0.947 . . . . 1.0 110.377 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -158.67 -161.86 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0 109.928 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.66 20.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 1.0 110.264 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 34' ' ' ILE . 3.0 mp -78.81 -70.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.353 -0.842 . . . . 1.0 110.081 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.85 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 1.0 110.032 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 1.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.05 -55.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -54.4 155.89 3.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -1.114 . . . . 1.0 109.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.426 ' CE ' HG21 ' A' ' 57' ' ' VAL . 1.9 ptt? -131.94 -164.1 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 1.0 110.483 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -124.86 158.76 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 1.0 109.872 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -175.06 159.9 28.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.772 ' OG1' HG22 ' A' ' 49' ' ' THR . 54.6 m -126.86 117.23 22.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 1.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' OD1' ' A' ' 26' ' ' ASP . 22.0 t -57.14 109.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 1.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -23.68 63.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.866 . . . . 1.0 110.701 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -75.83 -74.07 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 1.0 110.649 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 p -68.66 -56.79 7.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 1.0 110.312 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.15 32.23 1.72 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -97.48 148.56 23.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 1.0 110.13 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.772 HG22 ' OG1' ' A' ' 42' ' ' THR . 29.7 p -125.21 135.83 52.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 1.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.522 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -178.56 -163.59 30.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.793 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.87 141.86 34.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 1.0 110.129 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 51' ' ' MET . 8.9 mp -123.1 125.8 26.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.549 -0.719 . . . . 1.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 107.47 2.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.408 1.215 . . . . 1.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.59 55.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 1.0 110.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -62.19 -17.34 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 1.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -98.52 -60.95 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 1.0 109.794 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 ' CE ' ' A' ' 39' ' ' MET . 28.7 m -78.51 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 1.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.83 -174.74 2.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.915 . . . . 1.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.516 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -105.23 167.18 9.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 1.0 110.525 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.177 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.3 mttt . . . . . 0 N--CA 1.493 1.679 0 CA-C-O 121.173 0.511 . . . . 1.0 110.15 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm 58.1 159.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.39 -0.819 . . . . 1.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.32 -174.71 3.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 1.0 110.23 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -153.12 164.17 38.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 1.0 110.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.72 133.22 53.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 1.0 110.141 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 8.9 mtp -111.35 -6.3 14.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 1.0 110.743 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -131.79 167.12 20.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 1.0 110.148 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -98.69 105.45 17.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.289 -0.882 . . . . 1.0 109.86 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -109.62 160.94 15.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 1.0 110.908 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 114.45 9.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -0.76 . . . . 1.0 109.759 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.15 117.47 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.642 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.36 49.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 1.0 110.014 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.72 -154.85 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 1.0 109.973 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.46 15.55 27.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 1.0 110.518 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 1.1 t70 -85.38 -35.22 21.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.031 -1.043 . . . . 1.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 18' ' ' ASP . 6.5 pm0 -124.71 -175.87 3.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 1.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.6 m -113.7 -165.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 1.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.54 123.78 24.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 1.0 110.331 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.3 153.74 51.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 1.0 110.115 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -97.85 178.58 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 1.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.45 119.36 17.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 1.0 110.191 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.23 -35.36 3.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.38 160.3 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.145 . . . . 1.0 110.347 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 141.22 52.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.211 -0.931 . . . . 1.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 52' ' ' LEU . 39.1 mt -143.75 127.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.94 . . . . 1.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.7 -160.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 1.0 110.455 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -160.79 79.1 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.838 . . . . 1.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 31' ' ' VAL . 40.4 t -52.83 -62.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 1.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -119.6 147.13 44.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.868 . . . . 1.0 109.904 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.64 115.06 9.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 1.0 110.34 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 39.7 mm -93.45 -5.67 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 1.0 110.504 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.41 -72.19 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -0.977 . . . . 1.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.11 47.05 1.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 1.0 110.371 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.74 49.55 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.2 m95 52.99 178.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -1.177 . . . . 1.0 110.123 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.694 ' CE ' HD12 ' A' ' 52' ' ' LEU . 5.3 ptm -138.66 173.05 11.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 1.0 110.324 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -120.68 158.77 26.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.02 -175.31 47.36 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.847 ' OG1' HG22 ' A' ' 49' ' ' THR . 52.3 m -125.64 122.55 36.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -1.109 . . . . 1.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.67 118.52 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 1.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -21.21 64.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.92 . . . . 1.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -69.56 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 1.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -86.94 -28.34 22.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 1.0 110.354 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.89 8.55 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -106.34 142.9 35.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -1.091 . . . . 1.0 110.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . 0.847 HG22 ' OG1' ' A' ' 42' ' ' THR . 37.2 p -104.95 143.24 33.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.1 178.09 48.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.933 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.9 mmm -79.48 153.53 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 1.0 110.216 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.933 HD23 ' O ' ' A' ' 51' ' ' MET . 12.3 mt -129.64 162.92 50.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 1.0 109.931 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.5 Cg_endo -74.88 114.99 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 1.0 110.378 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.84 -18.34 62.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 1.0 110.459 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.21 -1.04 57.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.972 . . . . 1.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -110.91 -65.41 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.96 -1.088 . . . . 1.0 110.396 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 53' ' ' PRO . 19.8 m -56.3 170.33 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 1.0 110.34 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.54 157.87 37.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 1.0 110.298 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.51 140.53 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.208 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm . . . . . 0 N--CA 1.491 1.605 0 CA-C-O 121.439 0.637 . . . . 1.0 110.407 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mt -106.07 148.83 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 1.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -119.57 179.78 4.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 1.0 110.141 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.37 142.53 12.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.1 155.49 20.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 1.0 110.122 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 mtp -134.19 4.93 3.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 1.0 110.921 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -134.32 129.21 35.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.988 -1.07 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.3 103.47 2.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 1.0 109.825 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -104.22 147.64 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.983 . . . . 1.0 110.722 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.16 105.41 11.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 1.0 109.79 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.84 120.42 3.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.244 -0.91 . . . . 1.0 110.661 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.46 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 1.0 110.114 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -171.22 2.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 1.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 11.36 15.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 1.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -26.35 43.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 1.0 110.054 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -131.85 -176.97 4.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.308 -0.87 . . . . 1.0 110.243 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 29.9 m -115.79 -169.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 1.0 109.964 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.6 p -133.21 123.97 26.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 1.0 110.725 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.04 159.57 37.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 1.0 109.891 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -105.4 176.95 4.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 1.0 110.393 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.96 93.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.221 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.33 -24.45 0.59 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 3.8 t0 -65.01 177.09 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -1.137 . . . . 1.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.99 164.38 33.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 1.0 110.259 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 29' ' ' ILE . 20.8 mm -118.51 172.02 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.334 -0.854 . . . . 1.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.424 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -171.61 -35.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.044 -1.035 . . . . 1.0 110.477 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.66 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.209 -0.932 . . . . 1.0 111.117 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 32' ' ' GLN . 42.5 t -95.13 -109.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.085 -1.01 . . . . 1.0 110.192 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.9 tt0 -176.26 -152.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.469 -1.394 . . . . 1.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 39' ' ' MET . . . -122.6 129.07 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 1.0 110.455 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.99 -8.4 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.75 146.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.11 -0.994 . . . . 1.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.49 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 1.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.61 27.48 5.47 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.1 m95 54.8 171.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.46 -1.024 . . . . 1.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.538 ' SD ' HD12 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -122.56 -167.84 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 1.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -147.61 144.64 28.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.166 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.28 178.39 44.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -106.88 132.53 52.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -1.067 . . . . 1.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 49.3 t -69.75 129.11 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 1.0 109.801 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -70.75 -35.18 72.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 1.0 110.652 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -57.85 8.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 1.0 110.572 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 p -91.93 -52.28 4.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 1.0 110.613 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.96 25.38 6.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.353 -1.499 . . . . 1.0 109.353 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -95.45 138.58 32.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 1.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.34 135.93 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 1.0 110.171 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.78 177.27 47.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.876 ' O ' HD23 ' A' ' 52' ' ' LEU . 11.1 mmt -82.6 151.9 26.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -1.148 . . . . 1.0 109.99 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.876 HD23 ' O ' ' A' ' 51' ' ' MET . 9.7 mt -128.27 161.92 53.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 1.0 109.917 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.593 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.4 Cg_endo -74.55 115.08 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.677 1.357 . . . . 1.0 110.267 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.37 -17.19 60.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 1.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.2 -8.29 51.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 1.0 110.85 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.94 -60.69 1.48 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.008 -1.058 . . . . 1.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 53' ' ' PRO . 26.9 m -70.48 163.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 1.0 109.863 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 -177.46 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.031 -1.043 . . . . 1.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 169.23 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 1.0 110.245 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.216 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mttm . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.342 0.592 . . . . 1.0 110.347 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.98 152.88 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 1.0 109.558 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.4 179.84 4.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 1.0 110.409 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.4 ttp85 -160.46 155.4 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 1.0 110.377 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.88 149.3 27.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 1.0 110.029 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . 0.473 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 22.7 mtm -139.81 28.75 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 1.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.4 m-85 -150.22 109.86 4.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 110.609 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.21 133.88 49.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.0 109.45 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 19.3 t80 -147.24 137.39 23.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.946 -1.096 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.2 ttp -102.74 103.9 14.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -45.59 115.39 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.473 -0.767 . . . . 1.0 111.356 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.77 -48.6 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 1.0 109.586 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.48 150.1 28.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 1.0 109.664 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.16 -28.37 10.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.0 110.509 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.3 -35.6 79.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 110.366 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 4.7 mp0 -84.75 172.14 11.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.261 -0.899 . . . . 1.0 110.724 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 52' ' ' LEU . 13.5 m -120.94 169.12 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 1.0 110.032 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -103.49 126.02 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.948 . . . . 1.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 53' ' ' PRO . 5.4 m-85 -84.36 167.1 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 1.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.8 tptt -152.93 122.09 6.62 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 20.4 t0 -46.73 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 1.0 111.035 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 120.65 31.08 1.28 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -105.75 172.82 6.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -1.211 . . . . 1.0 110.065 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . . . -148.1 155.85 41.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 1.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.12 135.86 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 1.0 110.031 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.619 HG13 HG23 ' A' ' 31' ' ' VAL . 2.0 pt -69.07 -152.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 1.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -105.0 82.14 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 1.0 110.469 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' A' ' 41' ' ' GLY . 75.3 t -100.98 -83.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 1.0 110.39 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -167.32 149.31 5.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 1.0 109.945 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 35' ' ' ASP . . . -165.92 -166.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 1.0 110.388 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' ALA . 26.5 mt 65.96 -60.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.856 -0.528 . . . . 1.0 110.658 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' ALA . 5.8 t70 -56.09 171.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 1.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.25 -168.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.196 -0.94 . . . . 1.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.46 -25.81 11.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -117.38 162.98 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -1.158 . . . . 1.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 22.7 ttt -90.53 169.65 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 1.0 109.648 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -145.91 136.17 23.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 1.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 31' ' ' VAL . . . -177.23 -177.04 45.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 47' ' ' GLY . 94.8 m -113.8 137.18 52.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 1.0 110.346 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 45' ' ' ARG . 18.8 t -70.29 129.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 1.0 109.511 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -14.21 58.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 1.0 110.986 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ARG . . . . . 0.431 ' H ' HG12 ' A' ' 43' ' ' VAL . 3.5 ttt85 -86.92 -38.49 16.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.068 . . . . 1.0 110.567 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 p -110.71 -43.79 3.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 1.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 42' ' ' THR . . . 112.81 -16.97 23.13 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -59.66 139.88 56.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.265 . . . . 1.0 110.348 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -117.39 129.87 56.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.0 110.031 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -159.7 -158.72 9.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.974 -1.251 . . . . 1.0 109.974 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.709 ' C ' HD12 ' A' ' 52' ' ' LEU . 5.0 mmt -87.2 147.32 25.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -1.057 . . . . 1.0 110.415 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 51' ' ' MET . 8.3 mp -126.9 132.42 24.31 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.0 109.98 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' CZ ' ' A' ' 22' ' ' PHE . 43.4 Cg_endo -71.85 116.52 4.73 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.383 1.202 . . . . 1.0 110.265 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.74 -26.75 62.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.413 -0.804 . . . . 1.0 111.065 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.06 -5.42 31.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.099 -1.001 . . . . 1.0 110.854 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.3 m-30 -106.2 -66.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.007 -1.058 . . . . 1.0 110.23 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.52 168.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 1.0 110.68 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -170.3 161.26 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 1.0 109.956 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.73 148.09 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 1.0 110.349 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.103 -179.994 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 CA-C-O 121.246 0.546 . . . . 1.0 109.892 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 54.82 68.29 0.88 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.194 -0.941 . . . . 1.0 110.081 -179.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -132.64 24.62 3.86 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.52 ' O ' HG22 ' A' ' 5' ' ' ILE . 5.7 mtmt -60.5 -53.4 57.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -1.135 . . . . 1.0 110.054 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.52 HG22 ' O ' ' A' ' 4' ' ' LYS . 0.1 OUTLIER 54.91 169.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.725 -0.61 . . . . 1.0 110.268 179.919 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.412 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 7.2 m-85 -142.28 -166.01 2.15 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.171 -0.956 . . . . 1.0 110.036 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 21.8 ttm-85 -169.1 142.21 2.76 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 1.0 110.467 -179.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -91.69 163.15 14.2 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.317 -0.864 . . . . 1.0 110.038 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.47 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 37.1 mtm -136.72 7.08 2.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.263 -0.898 . . . . 1.0 110.748 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.47 ' CD1' ' O ' ' A' ' 9' ' ' MET . 45.0 m-85 -144.95 167.06 23.55 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.993 -1.067 . . . . 1.0 110.345 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.3 t0 -95.54 73.89 3.23 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.349 -0.845 . . . . 1.0 109.633 179.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 47.6 t80 -61.85 148.04 44.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 1.0 110.797 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 14.8 ttp -115.79 107.2 14.75 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.446 -0.784 . . . . 1.0 109.029 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.66 130.72 17.64 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.283 -0.886 . . . . 1.0 110.652 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.97 -32.3 34.47 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.886 . . . . 1.0 109.754 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -147.69 -155.86 0.67 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.42 -0.8 . . . . 1.0 109.721 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -90.41 18.84 5.71 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.147 -0.971 . . . . 1.0 110.202 179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -105.9 -22.44 12.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.182 -0.949 . . . . 1.0 110.627 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.504 ' OE2' ' CZ3' ' A' ' 38' ' ' TRP . 0.2 OUTLIER -103.35 -168.62 1.53 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.039 -1.038 . . . . 1.0 109.867 -179.654 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.561 HG13 ' HA3' ' A' ' 50' ' ' GLY . 27.8 m -131.36 169.36 21.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.605 -0.684 . . . . 1.0 109.727 179.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -121.48 75.56 1.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.107 -0.996 . . . . 1.0 110.644 -179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' CE2' HD23 ' A' ' 52' ' ' LEU . 9.2 p90 -93.68 148.94 21.64 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.214 -0.929 . . . . 1.0 109.783 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.24 169.66 8.64 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.069 -1.019 . . . . 1.0 110.721 -179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -65.25 122.89 18.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.36 -0.838 . . . . 1.0 110.13 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 112.7 -24.35 13.49 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.445 -1.462 . . . . 1.0 109.445 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -74.61 154.75 38.41 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.313 -1.11 . . . . 1.0 110.155 179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.401 ' O ' ' HB2' ' A' ' 44' ' ' GLN . . . -109.96 160.49 16.36 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.315 -0.866 . . . . 1.0 110.328 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.524 HG22 ' N ' ' A' ' 29' ' ' ILE . 41.4 mt -147.7 170.18 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.379 -0.825 . . . . 1.0 109.75 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.677 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.8 OUTLIER -106.62 -135.24 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.159 -0.963 . . . . 1.0 109.103 179.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.677 ' N ' HG23 ' A' ' 29' ' ' ILE . 11.8 t-20 -169.03 79.29 0.12 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.401 -1.437 . . . . 1.0 110.529 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.8 p -75.7 -25.98 17.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.184 -0.948 . . . . 1.0 110.067 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -147.55 179.22 7.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.276 -0.89 . . . . 1.0 110.187 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -172.22 103.7 0.17 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -0.921 . . . . 1.0 110.37 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 65.7 mt -80.42 -19.85 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.312 -0.868 . . . . 1.0 110.225 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.447 ' O ' ' CG ' ' A' ' 36' ' ' GLU . 0.6 OUTLIER 59.99 155.53 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.228 -0.92 . . . . 1.0 110.538 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' CG ' ' O ' ' A' ' 35' ' ' ASP . 19.5 pt-20 38.28 38.85 0.24 Allowed 'General case' 0 N--CA 1.502 2.153 0 CA-C-O 121.225 0.536 . . . . 1.0 111.581 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.41 ' C ' ' CD1' ' A' ' 38' ' ' TRP . . . -174.37 -82.79 0.05 OUTLIER Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.883 -1.287 . . . . 1.0 109.883 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.504 ' CZ3' ' OE2' ' A' ' 19' ' ' GLU . 26.2 m95 -141.63 177.39 8.18 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.002 -1.293 . . . . 1.0 110.404 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.409 ' HB2' ' HB2' ' A' ' 52' ' ' LEU . 3.2 mmt -130.9 -166.97 1.77 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.267 -0.896 . . . . 1.0 110.2 -179.855 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -164.82 125.64 2.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.307 -0.871 . . . . 1.0 110.098 179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.57 175.3 37.31 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.607 -1.397 . . . . 1.0 109.607 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.591 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.4 m -101.81 117.09 34.14 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.262 -1.14 . . . . 1.0 110.155 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 96.4 t -55.84 107.68 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.285 -0.884 . . . . 1.0 109.963 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.401 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 0.0 OUTLIER -63.65 -14.76 54.92 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.209 -0.932 . . . . 1.0 110.474 -179.808 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 2.5 tmt_? -73.59 -24.7 60.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.079 -1.013 . . . . 1.0 110.373 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.4 p -140.05 -47.3 0.44 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.152 -0.968 . . . . 1.0 110.267 -179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 123.74 7.45 6.74 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.2 -1.16 . . . . 1.0 110.2 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 -79.73 141.07 36.69 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.961 -1.317 . . . . 1.0 110.221 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.548 HG22 ' OG1' ' A' ' 42' ' ' THR . 12.7 p -109.87 129.27 55.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.208 -0.933 . . . . 1.0 110.078 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.561 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.41 -164.85 15.31 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.892 -1.283 . . . . 1.0 109.892 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.61 ' C ' HD12 ' A' ' 52' ' ' LEU . 7.2 tpp -95.07 157.74 15.76 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.491 -1.005 . . . . 1.0 110.847 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.723 ' N ' HD12 ' A' ' 52' ' ' LEU . 4.0 mp -137.46 141.87 35.2 Favored Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 121.485 -0.759 . . . . 1.0 109.965 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.427 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 44.2 Cg_endo -73.63 120.74 6.61 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.552 1.29 . . . . 1.0 110.327 179.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.14 -19.78 55.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.241 -0.912 . . . . 1.0 110.848 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -80.71 4.4 19.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.094 -1.004 . . . . 1.0 110.73 -179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.427 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 11.6 m-85 -117.56 -62.01 1.62 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.05 -1.031 . . . . 1.0 110.07 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.417 HG22 ' H ' ' A' ' 57' ' ' VAL . 34.8 m -78.96 160.73 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.324 -0.86 . . . . 1.0 110.405 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.403 ' OE2' ' CE ' ' A' ' 9' ' ' MET . 16.5 mt-10 -149.36 179.53 7.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.338 -0.851 . . . . 1.0 109.983 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.409 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -93.69 171.88 8.61 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.208 -0.932 . . . . 1.0 110.325 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.409 HG23 ' C ' ' A' ' 59' ' ' ALA . 4.5 pt . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 117.969 -1.015 . . . . 1.0 110.123 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.3 p . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.162 0.506 . . . . 1.0 110.242 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 53.27 -150.2 0.37 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 1.0 110.151 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 87.83 10.87 68.93 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.104 -1.198 . . . . 1.0 110.104 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.1 mttt -72.73 177.54 4.73 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.93 -1.335 . . . . 1.0 110.062 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.9 mt -107.84 131.87 56.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 O-C-N 121.282 -0.886 . . . . 1.0 109.637 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -120.34 -178.74 3.76 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.948 . . . . 1.0 110.351 -179.862 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.711 ' HB3' HG21 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -156.59 144.76 19.61 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.316 -0.865 . . . . 1.0 110.309 179.95 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -81.76 163.72 22.2 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.318 -0.864 . . . . 1.0 110.114 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.442 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 16.4 mtp -134.55 9.12 3.66 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.171 -0.956 . . . . 1.0 110.774 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 9' ' ' MET . 70.5 m-85 -148.31 140.64 24.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.015 -1.053 . . . . 1.0 110.305 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.54 101.79 4.3 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.223 -0.923 . . . . 1.0 109.841 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 39.7 t80 -104.71 133.2 49.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.062 -1.024 . . . . 1.0 110.849 -179.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.66 112.6 25.66 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.433 -0.792 . . . . 1.0 109.429 179.14 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.899 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.23 117.69 2.07 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.21 -0.932 . . . . 1.0 110.762 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.83 -28.92 67.97 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.345 -0.847 . . . . 1.0 110.046 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.66 178.77 6.68 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 1.0 110.147 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.216 -0.927 . . . . 1.0 110.567 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -78.83 -29.59 44.82 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.116 -0.99 . . . . 1.0 110.384 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.413 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 2.1 mp0 -82.09 173.88 11.74 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.184 -0.948 . . . . 1.0 110.346 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.899 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 23.8 m -109.62 -173.42 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.403 -0.81 . . . . 1.0 109.976 179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -149.31 89.75 1.67 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.141 -0.974 . . . . 1.0 110.566 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.463 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 10.1 p90 -113.23 149.29 33.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.287 -0.883 . . . . 1.0 110.013 179.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -107.02 164.32 12.24 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 1.0 110.514 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.442 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 17.9 t70 -52.77 115.26 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.312 -0.867 . . . . 1.0 110.197 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.0 -22.78 8.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -65.16 160.2 21.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -1.177 . . . . 1.0 110.09 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -106.14 133.18 51.25 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 1.0 110.202 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.421 HG21 HD13 ' A' ' 52' ' ' LEU . 25.3 mm -118.67 156.27 20.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.153 -0.967 . . . . 1.0 109.789 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.724 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.6 OUTLIER -126.98 -143.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.227 -0.921 . . . . 1.0 109.569 179.896 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.724 ' N ' HG23 ' A' ' 29' ' ' ILE . 42.0 p-10 -157.15 76.82 0.86 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.795 -1.191 . . . . 1.0 110.441 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG13 ' N ' ' A' ' 32' ' ' GLN . 14.1 p -60.0 -34.99 58.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.209 -0.932 . . . . 1.0 110.357 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.494 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -133.45 -72.25 0.5 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.143 -0.973 . . . . 1.0 110.174 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.494 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 59.86 116.18 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.336 -0.853 . . . . 1.0 110.534 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 49.2 mm -93.54 -49.87 12.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.232 -0.917 . . . . 1.0 110.076 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -177.81 -177.43 0.64 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 1.0 110.136 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -53.75 124.17 14.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.262 -0.899 . . . . 1.0 110.053 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . 121.38 80.22 0.56 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.298 -1.521 . . . . 1.0 109.298 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.44 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 40.0 m95 59.67 140.07 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.864 -0.786 . . . . 1.0 110.59 -179.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 11.8 ptp -149.6 -176.57 5.45 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.848 -1.158 . . . . 1.0 110.806 -179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -105.8 141.56 37.01 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.421 -0.8 . . . . 1.0 109.823 179.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.663 ' N ' HD21 ' A' ' 52' ' ' LEU . . . -159.79 158.4 29.64 Favored Glycine 0 N--CA 1.49 2.236 0 N-CA-C 109.782 -1.327 . . . . 1.0 109.782 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.455 ' H ' HG22 ' A' ' 29' ' ' ILE . 54.6 m -114.7 126.95 55.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.284 -1.127 . . . . 1.0 109.952 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.491 HG12 ' HB2' ' A' ' 45' ' ' ARG . 21.8 t -64.97 108.79 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.188 -0.945 . . . . 1.0 109.944 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -55.89 -24.23 35.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.198 -0.939 . . . . 1.0 110.502 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.491 ' HB2' HG12 ' A' ' 43' ' ' VAL . 0.6 OUTLIER -67.23 -65.41 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.173 -0.955 . . . . 1.0 110.279 -179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 27.5 p -86.33 -65.16 1.04 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 1.0 110.231 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 137.69 -11.67 3.71 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.078 -1.209 . . . . 1.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 33.7 mtt180 -60.91 158.48 13.11 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.981 -1.305 . . . . 1.0 110.158 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 97.4 m -133.11 123.57 25.95 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.268 -0.895 . . . . 1.0 110.213 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.458 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -148.02 -159.18 8.29 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.652 ' C ' HD23 ' A' ' 52' ' ' LEU . 3.1 mtm -95.19 149.53 21.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.32 -1.106 . . . . 1.0 110.223 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.663 HD21 ' N ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -136.35 146.15 54.79 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 1.0 110.052 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.419 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.0 Cg_endo -72.58 110.85 3.09 Favored 'Trans proline' 0 C--N 1.313 -1.339 0 O-C-N 123.736 1.387 . . . . 1.0 110.234 179.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.67 -27.49 68.72 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 1.0 110.583 -179.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -66.66 -17.3 64.77 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.121 -0.987 . . . . 1.0 110.561 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 3.1 m-30 -95.27 -62.6 1.28 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.204 -0.935 . . . . 1.0 110.227 -179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.8 m -66.46 156.33 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.338 -0.851 . . . . 1.0 110.409 -179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -170.06 178.89 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.364 -0.835 . . . . 1.0 110.046 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -77.87 163.91 25.62 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.176 -0.952 . . . . 1.0 110.235 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 7' ' ' ARG . 1.1 pt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 118.015 -0.993 . . . . 1.0 110.183 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 15.3 p . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.207 0.527 . . . . 1.0 110.171 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -105.55 -82.42 0.53 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.259 -0.9 . . . . 1.0 110.238 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 81.67 -56.32 4.91 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 5.1 mtmt 45.14 -170.45 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.489 -1.007 . . . . 1.0 111.165 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.0 mm -138.59 142.5 34.62 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 O-C-N 121.217 -0.927 . . . . 1.0 109.823 -179.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -128.1 -178.51 4.56 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.313 -0.867 . . . . 1.0 109.847 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -154.7 152.79 30.34 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.133 -0.979 . . . . 1.0 110.632 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -108.94 123.76 49.61 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.36 -0.838 . . . . 1.0 109.949 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.46 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.1 OUTLIER -100.98 8.96 42.78 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.156 -0.965 . . . . 1.0 110.926 -179.634 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.46 ' CD1' ' O ' ' A' ' 9' ' ' MET . 53.9 m-85 -143.52 161.23 39.0 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.92 -1.113 . . . . 1.0 110.462 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -104.09 96.31 6.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.278 -0.889 . . . . 1.0 109.789 179.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.6 t80 -91.69 152.15 20.34 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.172 -0.955 . . . . 1.0 110.893 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 22.3 ttp -118.34 103.72 10.07 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 121.33 -0.856 . . . . 1.0 109.382 179.501 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.953 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.35 130.14 16.21 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.198 -0.939 . . . . 1.0 110.889 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -91.02 -28.27 18.09 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.311 -0.868 . . . . 1.0 109.718 179.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 50.4 p-10 -141.26 170.88 14.89 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.334 -0.853 . . . . 1.0 110.018 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -62.19 -15.12 44.26 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 1.0 110.64 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -51.52 -40.26 59.27 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.04 -1.038 . . . . 1.0 110.429 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.414 ' HA ' ' N ' ' A' ' 51' ' ' MET . 4.7 pm0 -124.33 -173.2 2.72 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 1.0 110.657 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.953 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.4 m -120.11 -151.81 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.477 -0.764 . . . . 1.0 110.12 -179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.79 150.99 34.02 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.952 -1.093 . . . . 1.0 110.757 -179.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.47 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 8.2 p90 -161.62 149.4 14.94 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.334 -0.854 . . . . 1.0 109.926 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 pttm -97.95 179.48 4.77 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.171 -0.956 . . . . 1.0 110.547 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.456 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 36.6 t70 -70.97 107.22 3.97 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.402 -0.811 . . . . 1.0 110.21 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 132.65 -19.98 4.41 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.951 -1.259 . . . . 1.0 109.951 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -71.09 163.45 27.58 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.119 -1.224 . . . . 1.0 110.5 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.9 149.06 52.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.345 -0.847 . . . . 1.0 109.969 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.673 HG23 ' O ' ' A' ' 42' ' ' THR . 32.3 mt -143.7 133.77 21.08 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.14 -0.975 . . . . 1.0 110.454 -179.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -64.74 -156.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.233 -0.917 . . . . 1.0 110.153 179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 13.9 t-20 -151.9 105.61 3.12 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.304 -0.873 . . . . 1.0 110.241 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.3 p -102.28 -23.21 4.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.305 -0.872 . . . . 1.0 110.279 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.6 tm0? -159.03 145.11 16.63 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.124 -0.985 . . . . 1.0 110.138 179.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -164.56 120.94 1.53 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.255 -0.903 . . . . 1.0 110.239 -179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 55.6 mt -59.8 -72.05 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.285 -0.884 . . . . 1.0 110.236 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -176.37 -63.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.344 -0.848 . . . . 1.0 109.609 -179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -134.74 23.76 3.65 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.431 -0.793 . . . . 1.0 109.729 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 38' ' ' TRP . . . -126.05 71.78 0.46 Allowed Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.35 -1.5 . . . . 1.0 109.35 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.413 ' HB2' ' O ' ' A' ' 37' ' ' GLY . 12.1 m95 55.25 170.99 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.456 -1.026 . . . . 1.0 110.435 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.422 ' O ' ' HA ' ' A' ' 51' ' ' MET . 4.6 ptp -148.89 165.69 30.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.222 -0.924 . . . . 1.0 110.26 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' CE1' ' HA2' ' A' ' 50' ' ' GLY . 9.6 t80 -105.75 123.84 48.59 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.062 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.0 -177.31 21.46 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.656 -1.378 . . . . 1.0 109.656 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.673 ' O ' HG23 ' A' ' 28' ' ' ILE . 84.9 m -121.2 125.96 48.45 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.309 -1.113 . . . . 1.0 110.225 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.71 107.1 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.188 -0.945 . . . . 1.0 110.125 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -52.18 -35.63 49.5 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -0.911 . . . . 1.0 110.457 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.1 tpt180 -59.78 -62.35 1.94 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.252 -0.905 . . . . 1.0 110.358 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.5 p -92.11 -68.16 0.81 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.43 -179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.442 ' O ' HG23 ' A' ' 42' ' ' THR . . . 137.57 -12.69 3.73 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.906 -1.278 . . . . 1.0 109.906 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 3.6 mtp-105 -52.34 147.71 7.59 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.004 -1.292 . . . . 1.0 110.383 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 2.2 p -116.66 119.35 35.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.314 -0.866 . . . . 1.0 109.963 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.631 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -159.77 170.08 35.89 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 -179.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.758 ' O ' HD23 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -66.74 155.7 37.39 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.331 -1.099 . . . . 1.0 110.217 179.931 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.758 HD23 ' O ' ' A' ' 51' ' ' MET . 8.4 mt -132.76 155.64 80.96 Favored Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 121.363 -0.836 . . . . 1.0 109.523 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -75.31 118.62 5.25 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.587 1.309 . . . . 1.0 110.263 179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.56 -26.83 58.3 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.171 -0.956 . . . . 1.0 110.348 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -78.39 -2.58 38.98 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.222 -0.923 . . . . 1.0 110.796 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -104.36 -50.25 3.38 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.907 -1.12 . . . . 1.0 110.335 -179.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 8' ' ' ALA . 34.1 m -81.13 -176.64 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.33 -0.856 . . . . 1.0 110.636 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 15.9 pt-20 -167.1 146.52 5.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.361 -0.837 . . . . 1.0 109.932 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.424 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -71.78 164.79 25.35 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.196 -0.94 . . . . 1.0 110.321 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.424 HG23 ' C ' ' A' ' 59' ' ' ALA . 7.1 pt . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 118.003 -0.998 . . . . 1.0 110.219 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 121.214 0.531 . . . . 1.0 110.192 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.76 46.76 2.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.29 -0.882 . . . . 1.0 110.165 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -131.16 54.01 0.79 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.48 -1.448 . . . . 1.0 109.48 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.7 mtpp -77.83 -169.43 1.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.259 -1.142 . . . . 1.0 110.241 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.5 tt -129.39 167.38 24.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.298 -0.876 . . . . 1.0 109.906 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 28.6 m-85 -134.44 -177.03 4.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.12 -0.987 . . . . 1.0 110.483 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.35 153.83 16.05 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.281 -0.887 . . . . 1.0 110.306 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.38 135.99 38.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 1.0 109.893 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 30.6 mmm -103.42 -22.36 13.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.198 -0.938 . . . . 1.0 110.617 -179.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -121.43 178.69 4.7 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.057 -1.027 . . . . 1.0 110.102 -179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.428 ' OD1' ' N ' ' A' ' 11' ' ' ASP . 41.8 p-10 -110.2 96.79 6.44 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.37 -0.831 . . . . 1.0 109.759 179.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 22.1 t80 -81.55 146.2 30.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.104 -0.998 . . . . 1.0 111.023 -179.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 3.6 mtm -114.42 94.9 5.0 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.56 -0.712 . . . . 1.0 109.222 179.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -46.82 138.04 6.62 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.397 -0.815 . . . . 1.0 111.049 -179.229 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -100.43 -22.16 15.13 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.487 -0.758 . . . . 1.0 109.911 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 28.1 p30 -142.97 169.98 16.55 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.262 -0.899 . . . . 1.0 110.168 179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -65.12 -12.72 53.95 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 1.0 110.691 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 0.3 OUTLIER -51.09 -41.81 60.22 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.001 -1.062 . . . . 1.0 110.538 -179.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.439 ' HA ' ' N ' ' A' ' 51' ' ' MET . 2.0 pm0 -124.89 -173.98 2.93 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.115 -0.99 . . . . 1.0 110.624 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.562 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 26.8 m -113.34 -174.18 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 1.0 110.419 -179.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 11.1 t -129.18 115.59 17.91 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.277 -0.889 . . . . 1.0 110.189 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.418 ' C ' ' CD1' ' A' ' 22' ' ' PHE . 12.0 p90 -125.88 160.5 29.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.372 -0.83 . . . . 1.0 110.111 179.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 21.3 mttt -108.77 179.52 4.16 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 1.0 110.281 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -73.79 111.99 9.47 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.291 -0.881 . . . . 1.0 110.208 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 133.49 -29.66 3.11 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.711 -1.356 . . . . 1.0 109.711 179.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -63.34 151.31 41.15 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.158 -1.201 . . . . 1.0 110.347 -179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.41 156.67 20.48 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.38 -0.825 . . . . 1.0 110.449 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.447 HD13 HD21 ' A' ' 52' ' ' LEU . 28.3 mt -149.1 129.48 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.343 -0.848 . . . . 1.0 110.103 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.407 HD11 HG22 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -73.71 -159.19 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.25 -0.906 . . . . 1.0 110.655 -179.737 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 12.1 t-20 -114.6 87.19 2.59 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.491 -0.755 . . . . 1.0 109.624 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.407 HG22 HD11 ' A' ' 29' ' ' ILE . 84.4 t -73.43 -80.96 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 1.0 110.847 -179.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -166.97 156.76 11.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.968 -1.082 . . . . 1.0 110.595 -179.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -122.09 146.1 47.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.297 -0.877 . . . . 1.0 109.9 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 3.2 mt -73.16 -80.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.185 -0.947 . . . . 1.0 110.284 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -169.53 18.07 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.119 -0.988 . . . . 1.0 111.8 -179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -145.31 -170.75 3.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.788 -1.195 . . . . 1.0 110.475 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -51.36 -69.52 1.12 Allowed Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.746 -1.342 . . . . 1.0 109.746 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 28.2 m95 -53.16 135.39 37.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.297 -1.119 . . . . 1.0 110.035 179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.447 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.4 OUTLIER -133.74 -163.36 1.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.263 -0.898 . . . . 1.0 110.141 179.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.97 137.2 52.33 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.095 -1.003 . . . . 1.0 110.561 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.679 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -144.05 141.94 10.68 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.211 -1.556 . . . . 1.0 109.211 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.61 ' OG1' HG23 ' A' ' 49' ' ' THR . 55.4 m -103.06 104.68 14.88 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.171 -1.194 . . . . 1.0 110.415 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.702 HG22 ' O ' ' A' ' 48' ' ' ARG . 2.8 m -48.33 128.92 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 121.373 -0.83 . . . . 1.0 110.473 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.401 ' NE2' ' CG2' ' A' ' 29' ' ' ILE . 3.4 mm100 -85.66 9.96 14.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.305 -0.872 . . . . 1.0 110.76 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -92.07 -58.2 2.47 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.958 -1.089 . . . . 1.0 109.876 179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 1.2 p -100.7 -26.03 13.94 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.255 -0.903 . . . . 1.0 110.043 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 97.82 25.48 10.6 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.565 -1.414 . . . . 1.0 109.565 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.702 ' O ' HG22 ' A' ' 43' ' ' VAL . 84.2 mtm180 -93.79 149.86 20.87 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.283 -1.128 . . . . 1.0 110.334 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.61 HG23 ' OG1' ' A' ' 42' ' ' THR . 1.5 m -121.03 146.69 46.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.207 -0.933 . . . . 1.0 110.421 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.467 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.68 172.58 44.34 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.384 -1.486 . . . . 1.0 109.384 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.544 ' O ' HD12 ' A' ' 52' ' ' LEU . 3.1 ttm -60.7 156.46 16.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.176 -1.191 . . . . 1.0 110.197 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.679 HD22 ' HA3' ' A' ' 41' ' ' GLY . 1.1 mp -132.63 139.17 33.84 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 1.0 110.659 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.47 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 43.8 Cg_endo -70.93 121.04 7.51 Favored 'Trans proline' 0 C--N 1.313 -1.317 0 O-C-N 123.654 1.344 . . . . 1.0 110.644 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.76 -21.84 60.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.281 -0.887 . . . . 1.0 110.537 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -92.49 24.54 3.43 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 1.0 110.201 179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.47 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 4.9 m-85 -131.78 -40.15 1.08 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 1.0 109.996 -179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 31.1 m -105.07 173.51 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.306 -0.871 . . . . 1.0 110.123 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -168.59 -171.07 1.34 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.275 -0.89 . . . . 1.0 110.248 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -94.58 170.65 9.31 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.215 -0.928 . . . . 1.0 110.238 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 pt . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 118.028 -0.987 . . . . 1.0 110.232 179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 32.1 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.212 0.529 . . . . 1.0 110.26 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -136.27 169.74 17.16 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 1.0 110.146 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 169.06 -45.82 0.22 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.361 -1.496 . . . . 1.0 109.361 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' O ' ' O ' ' A' ' 5' ' ' ILE . 12.7 mtmm -54.6 -68.05 0.22 Allowed 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.279 -1.13 . . . . 1.0 110.61 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' O ' ' O ' ' A' ' 4' ' ' LYS . 19.5 mt 61.25 141.59 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.512 -0.742 . . . . 1.0 109.97 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 28' ' ' ILE . 10.4 m-85 -118.69 175.02 5.93 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.018 -1.051 . . . . 1.0 109.579 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.39 139.48 35.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.316 -0.865 . . . . 1.0 109.879 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.448 ' O ' ' HA ' ' A' ' 24' ' ' ASP . . . -86.47 124.66 33.04 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.185 -0.947 . . . . 1.0 109.892 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 6.0 mtt -92.6 -17.44 24.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.203 -0.936 . . . . 1.0 110.122 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -126.36 155.86 41.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.191 -0.943 . . . . 1.0 109.891 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -100.47 126.32 46.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.193 -0.942 . . . . 1.0 109.843 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -118.71 152.64 35.77 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.068 -1.02 . . . . 1.0 110.531 -179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 35.1 ttm -116.4 98.57 6.64 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.405 -0.809 . . . . 1.0 109.429 179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.895 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.86 124.62 11.55 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -0.923 . . . . 1.0 110.475 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -81.35 -26.46 35.55 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.269 -0.895 . . . . 1.0 110.093 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -144.25 -176.59 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 1.0 110.243 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.95 -12.96 61.83 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 1.0 110.627 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -50.09 -47.16 53.9 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.027 -1.045 . . . . 1.0 110.339 179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -118.14 -165.46 1.11 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.232 -0.917 . . . . 1.0 110.171 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.895 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 21.9 m -121.07 -172.71 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 1.0 110.256 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.6 t -133.26 117.28 17.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.26 -0.9 . . . . 1.0 110.426 -179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -137.54 166.8 23.01 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.324 -0.86 . . . . 1.0 109.997 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -120.96 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.139 -0.975 . . . . 1.0 110.52 -179.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.448 ' HA ' ' O ' ' A' ' 8' ' ' ALA . 12.4 t70 -69.12 130.36 42.48 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.328 -0.857 . . . . 1.0 110.365 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 104.76 -11.44 49.66 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 110.205 -1.158 . . . . 1.0 110.205 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -68.52 155.79 39.26 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.938 -1.33 . . . . 1.0 110.341 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -111.65 129.25 56.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.175 -0.953 . . . . 1.0 110.288 179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.545 HG22 ' N ' ' A' ' 29' ' ' ILE . 42.3 mt -147.48 171.89 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.3 -0.875 . . . . 1.0 109.607 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.733 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -128.14 -177.89 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.947 -1.095 . . . . 1.0 110.252 179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -122.42 88.93 3.02 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.484 -0.76 . . . . 1.0 110.264 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 53.2 t -58.54 -65.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 O-C-N 121.241 -0.912 . . . . 1.0 109.781 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.9 mm100 -101.43 -48.25 4.42 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.314 -0.866 . . . . 1.0 109.828 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 53.31 80.76 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.268 -0.895 . . . . 1.0 110.68 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.436 ' O ' ' N ' ' A' ' 36' ' ' GLU . 61.7 mt -84.11 -5.17 9.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.249 -0.907 . . . . 1.0 110.568 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 4.1 t0 65.42 -69.92 0.1 Allowed 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.213 -0.93 . . . . 1.0 110.676 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.436 ' N ' ' O ' ' A' ' 34' ' ' ILE . 4.5 mt-10 -75.85 124.43 27.3 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 1.0 110.396 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.99 61.46 1.93 Allowed Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.674 -1.37 . . . . 1.0 109.674 179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 23.1 m95 52.56 179.04 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.243 -1.151 . . . . 1.0 110.342 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.402 ' HG3' ' HB2' ' A' ' 52' ' ' LEU . 2.5 ptp -136.88 -174.42 3.72 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.308 -0.87 . . . . 1.0 109.879 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -129.28 139.73 51.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.15 -0.969 . . . . 1.0 110.456 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -166.58 152.83 22.14 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.394 -1.482 . . . . 1.0 109.394 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.649 HG23 ' O ' ' A' ' 48' ' ' ARG . 88.3 m -98.95 128.95 45.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.189 -1.183 . . . . 1.0 110.241 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.423 HG12 ' H ' ' A' ' 46' ' ' THR . 45.2 t -61.98 97.45 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.185 -0.947 . . . . 1.0 110.061 179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -57.5 -19.5 25.04 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 1.0 110.434 -179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -53.12 16.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 1.0 110.294 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.423 ' H ' HG12 ' A' ' 43' ' ' VAL . 20.3 p -97.48 -49.66 4.81 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.19 -0.944 . . . . 1.0 110.296 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 129.43 -14.36 5.86 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.967 -1.253 . . . . 1.0 109.967 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.649 ' O ' HG23 ' A' ' 42' ' ' THR . 0.1 OUTLIER -70.54 -168.93 0.28 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.947 -1.325 . . . . 1.0 110.176 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.414 ' HB ' HG23 ' A' ' 42' ' ' THR . 4.9 t -172.16 151.66 2.68 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.211 -0.931 . . . . 1.0 110.37 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -175.8 -158.74 20.25 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.443 -1.463 . . . . 1.0 109.443 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.814 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.0 OUTLIER -77.89 137.41 38.34 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.234 -1.156 . . . . 1.0 110.073 179.941 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.814 HD12 ' C ' ' A' ' 51' ' ' MET . 10.7 mp -124.46 151.42 66.87 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.285 -0.884 . . . . 1.0 110.145 179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.76 108.8 2.64 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.721 1.379 . . . . 1.0 110.122 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.43 -22.13 65.53 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.311 -0.868 . . . . 1.0 110.601 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -87.7 6.48 34.66 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.059 -1.026 . . . . 1.0 110.833 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -114.27 -64.37 1.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.044 -1.035 . . . . 1.0 110.156 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 30.0 m -67.66 157.17 6.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.228 -0.92 . . . . 1.0 110.258 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -151.51 -177.99 6.42 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.296 -0.878 . . . . 1.0 110.294 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -100.56 148.92 24.26 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.287 -0.883 . . . . 1.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 pt . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.961 -1.019 . . . . 1.0 110.139 179.807 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.9 t . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.288 0.566 . . . . 1.0 110.267 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -135.06 164.83 26.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 1.0 109.973 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 138.28 43.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.506 -1.438 . . . . 1.0 109.506 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 36.4 mttm -69.58 -171.59 0.39 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.264 -1.139 . . . . 1.0 110.259 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 ' O ' ' CD1' ' A' ' 6' ' ' PHE . 13.3 tt -127.61 170.51 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.276 -0.89 . . . . 1.0 110.039 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.439 ' CD1' ' O ' ' A' ' 5' ' ' ILE . 39.1 m-85 -148.27 177.13 9.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.174 -0.954 . . . . 1.0 110.476 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.571 ' HB2' HG21 ' A' ' 60' ' ' ILE . 11.6 ttp180 -140.5 133.07 28.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.325 -0.86 . . . . 1.0 110.063 179.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.37 136.21 57.37 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.154 -0.967 . . . . 1.0 110.44 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.49 ' HG3' ' CE1' ' A' ' 10' ' ' TYR . 9.2 tpp -128.01 1.2 5.92 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.306 -0.871 . . . . 1.0 109.54 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.49 ' CE1' ' HG3' ' A' ' 9' ' ' MET . 33.5 m-85 -124.36 -7.68 7.56 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 120.905 -1.122 . . . . 1.0 111.316 -179.106 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.6 t0 60.36 71.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.003 -1.06 . . . . 1.0 108.774 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.1 t80 -77.65 148.68 34.91 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.419 -0.801 . . . . 1.0 111.296 -178.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 4.1 ttp -121.59 99.64 6.58 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.926 -0.768 . . . . 1.0 108.926 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.761 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -47.55 115.9 1.28 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.251 -0.906 . . . . 1.0 110.893 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -88.48 -33.72 17.71 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.368 -0.832 . . . . 1.0 109.984 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -95.77 -151.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.289 -0.882 . . . . 1.0 110.037 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -111.47 -25.11 9.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.215 -0.928 . . . . 1.0 110.214 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.424 ' O ' ' CA ' ' A' ' 50' ' ' GLY . 0.5 OUTLIER -79.56 -23.44 42.79 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.378 -179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.403 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 3.1 mp0 -80.05 172.05 14.28 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.209 -0.932 . . . . 1.0 110.53 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.761 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.7 m -117.05 169.0 7.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.441 -0.787 . . . . 1.0 109.626 179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 t -128.89 101.29 6.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.987 -1.071 . . . . 1.0 110.874 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.479 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 7.9 p90 -123.32 148.64 45.78 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.886 . . . . 1.0 109.862 179.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -94.56 -174.15 3.24 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.218 -0.926 . . . . 1.0 110.574 -179.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -76.49 111.73 12.27 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 1.0 110.251 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.62 -18.32 7.21 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.804 -1.318 . . . . 1.0 109.804 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.28 165.92 5.45 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.078 -1.248 . . . . 1.0 110.378 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -131.89 145.31 51.45 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.882 . . . . 1.0 110.142 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 36.6 mm -111.27 147.26 15.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.237 -0.914 . . . . 1.0 110.033 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.485 HG22 HE21 ' A' ' 44' ' ' GLN . 1.2 pt -58.88 -169.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.127 -0.983 . . . . 1.0 110.26 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.414 ' OD1' ' N ' ' A' ' 30' ' ' ASN . 19.5 p-10 -83.32 55.07 3.02 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.396 -0.815 . . . . 1.0 110.092 179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.717 HG21 ' HA2' ' A' ' 41' ' ' GLY . 1.8 p -80.84 -158.42 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.328 -0.858 . . . . 1.0 109.997 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.624 ' H ' HG22 ' A' ' 31' ' ' VAL . 19.5 pt20 -160.49 -156.89 0.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.914 -1.116 . . . . 1.0 110.054 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.444 ' HB2' ' CB ' ' A' ' 39' ' ' MET . . . -137.23 -152.46 0.44 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.317 -0.864 . . . . 1.0 109.976 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.555 HG23 ' H ' ' A' ' 35' ' ' ASP . 0.3 OUTLIER -128.45 -85.79 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.19 -0.944 . . . . 1.0 109.773 179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.555 ' H ' HG23 ' A' ' 34' ' ' ILE . 26.2 t0 -108.81 -64.2 1.26 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.917 -1.114 . . . . 1.0 110.264 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -177.72 156.27 1.1 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 1.0 110.185 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 100.57 -55.92 0.81 Allowed Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.674 -1.371 . . . . 1.0 109.674 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 41.4 m95 -143.55 163.05 34.27 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.122 -1.223 . . . . 1.0 110.642 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.444 ' CB ' ' HB2' ' A' ' 33' ' ' ALA . 0.0 OUTLIER -146.3 -152.13 0.41 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.462 -0.774 . . . . 1.0 109.716 179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.539 ' O ' HG11 ' A' ' 31' ' ' VAL . 0.4 OUTLIER -144.09 166.77 24.08 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.078 -1.014 . . . . 1.0 109.973 179.828 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.717 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . 175.54 167.14 34.17 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.825 -1.31 . . . . 1.0 109.825 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.716 ' OG1' HG22 ' A' ' 49' ' ' THR . 85.5 m -118.69 128.43 54.5 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.341 -1.093 . . . . 1.0 110.066 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -69.31 117.09 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.209 -0.932 . . . . 1.0 109.885 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.485 HE21 HG22 ' A' ' 29' ' ' ILE . 4.2 mm-40 -57.75 -23.06 50.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.276 -0.89 . . . . 1.0 110.473 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.85 -71.56 0.37 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.177 -0.952 . . . . 1.0 110.304 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 30.9 p -72.69 -51.93 17.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.384 -0.822 . . . . 1.0 110.389 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.435 ' O ' HG23 ' A' ' 42' ' ' THR . . . 111.59 -15.14 27.08 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.797 -1.321 . . . . 1.0 109.797 -179.673 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -60.72 166.3 3.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.109 -1.23 . . . . 1.0 110.248 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.716 HG22 ' OG1' ' A' ' 42' ' ' THR . 41.3 p -131.57 134.9 46.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.185 -0.947 . . . . 1.0 110.458 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.466 ' CA ' HG13 ' A' ' 20' ' ' VAL . . . -160.09 -164.63 15.51 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.701 -1.36 . . . . 1.0 109.701 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.694 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.1 OUTLIER -80.45 142.55 34.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.279 -1.13 . . . . 1.0 110.183 -179.898 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.694 HD12 ' C ' ' A' ' 51' ' ' MET . 7.0 mp -124.51 142.33 40.15 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.365 -0.834 . . . . 1.0 110.539 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 49.1 Cg_endo -76.72 114.84 3.93 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.587 1.309 . . . . 1.0 109.99 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.1 -33.03 67.54 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.136 -0.977 . . . . 1.0 110.849 -179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -71.97 -21.45 61.58 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.076 -1.015 . . . . 1.0 110.64 -179.611 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.484 ' HA ' ' CE1' ' A' ' 10' ' ' TYR . 3.5 m-30 -81.89 -65.54 1.0 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.22 -0.925 . . . . 1.0 110.327 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 34.5 m -52.38 151.42 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.166 -0.959 . . . . 1.0 110.089 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.4 162.13 25.49 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.123 -0.986 . . . . 1.0 110.377 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -74.13 145.32 44.39 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.255 -0.903 . . . . 1.0 110.206 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.571 HG21 ' HB2' ' A' ' 7' ' ' ARG . 4.9 pt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.966 -1.016 . . . . 1.0 110.161 179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.208 0.528 . . . . 1.0 110.173 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.44 33.28 2.07 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.279 -0.888 . . . . 1.0 110.226 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -107.63 20.43 32.0 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.9 mtpp -87.23 -174.05 4.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -1.181 . . . . 1.0 110.094 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.801 HG23 HD11 ' A' ' 60' ' ' ILE . 11.0 tt -154.7 169.75 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.178 -0.951 . . . . 1.0 110.123 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.424 ' CD1' ' C ' ' A' ' 5' ' ' ILE . 55.9 m-85 -137.25 176.6 8.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.296 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.656 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.9 OUTLIER -159.94 145.14 15.21 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.405 -0.809 . . . . 1.0 109.891 179.845 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -87.75 120.6 29.23 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.172 -0.955 . . . . 1.0 110.406 -179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.448 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 0.0 OUTLIER -101.79 12.23 37.4 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.247 -0.908 . . . . 1.0 110.561 179.831 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.448 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.0 m-85 -141.77 140.71 33.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.047 -1.033 . . . . 1.0 110.375 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -80.62 115.62 20.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 1.0 109.297 179.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 36.2 t80 -121.3 163.1 19.15 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.911 -1.118 . . . . 1.0 111.129 -179.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -135.85 115.84 13.23 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.61 -0.681 . . . . 1.0 109.3 179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.31 133.69 15.52 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.162 -0.961 . . . . 1.0 110.761 -179.39 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.07 -34.69 60.78 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.334 -0.854 . . . . 1.0 110.235 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.408 ' O ' ' HB2' ' A' ' 17' ' ' ALA . 0.4 OUTLIER -175.64 -35.02 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.212 -0.93 . . . . 1.0 110.631 -179.839 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.408 ' HB2' ' O ' ' A' ' 16' ' ' ASP . . . -176.64 -32.36 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.094 -1.004 . . . . 1.0 110.876 -179.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.24 -26.33 0.77 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.215 -0.928 . . . . 1.0 111.027 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.5 pm0 -136.23 -168.91 2.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.124 -0.985 . . . . 1.0 110.4 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.7 m -113.39 -174.68 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.316 -0.865 . . . . 1.0 110.241 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 m -136.03 115.14 12.36 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.18 -0.95 . . . . 1.0 110.687 -179.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.6 p90 -126.46 153.53 44.95 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.345 -0.847 . . . . 1.0 109.865 179.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 17.7 mttp -92.39 173.32 7.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 1.0 110.652 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -70.0 83.51 0.5 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.397 -0.815 . . . . 1.0 109.977 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 156.45 -23.67 0.51 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.58 -1.408 . . . . 1.0 109.58 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -51.81 158.66 0.95 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.155 -1.203 . . . . 1.0 110.173 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.86 145.81 37.58 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.215 -0.928 . . . . 1.0 110.356 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 29' ' ' ILE . 40.5 mm -122.58 170.21 13.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.305 -0.872 . . . . 1.0 109.747 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.723 HG23 ' N ' ' A' ' 30' ' ' ASN . 1.0 OUTLIER -131.01 -145.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.123 -0.986 . . . . 1.0 110.01 -179.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.723 ' N ' HG23 ' A' ' 29' ' ' ILE . 5.1 t-20 -126.84 87.14 2.61 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.077 -1.015 . . . . 1.0 110.042 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG21 ' HA2' ' A' ' 41' ' ' GLY . 60.5 t -91.11 -59.58 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.273 -0.892 . . . . 1.0 110.323 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -172.4 178.26 2.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 1.0 110.321 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -156.2 123.44 5.38 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 1.0 110.079 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.489 HG22 ' OD2' ' A' ' 35' ' ' ASP . 72.5 mt -85.11 -43.92 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 1.0 110.304 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.489 ' OD2' HG22 ' A' ' 34' ' ' ILE . 3.0 m-20 -148.99 -169.53 3.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 1.0 110.18 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -83.71 -25.82 30.3 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.265 -0.897 . . . . 1.0 109.942 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.4 -75.55 0.29 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.49 -1.444 . . . . 1.0 109.49 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 13.7 m95 -121.83 158.18 29.45 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.23 -1.159 . . . . 1.0 110.074 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 51' ' ' MET . 0.0 OUTLIER -123.44 -163.12 1.09 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.254 -0.904 . . . . 1.0 110.038 179.921 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -139.34 130.48 26.59 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.241 -0.912 . . . . 1.0 110.277 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.469 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -167.49 -171.18 33.22 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 1.0 109.537 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.407 ' O ' ' NE2' ' A' ' 44' ' ' GLN . 52.9 m -125.2 142.76 51.3 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.287 -1.125 . . . . 1.0 110.257 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 16.6 t -79.0 110.81 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.213 -0.93 . . . . 1.0 109.804 179.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.407 ' NE2' ' O ' ' A' ' 42' ' ' THR . 2.4 mp0 -60.13 -17.54 41.09 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.293 -0.879 . . . . 1.0 110.894 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.99 -69.09 0.65 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.003 -1.06 . . . . 1.0 110.381 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 63.2 p -80.03 -41.01 26.61 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.194 -0.942 . . . . 1.0 110.296 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 103.47 14.66 25.13 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.018 -1.233 . . . . 1.0 110.018 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 64.0 mtt-85 -70.91 152.22 43.89 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.027 -1.278 . . . . 1.0 110.05 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 24.3 p -128.34 129.82 46.83 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.325 -0.86 . . . . 1.0 110.287 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 170.05 -166.83 40.01 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.768 ' C ' HD12 ' A' ' 52' ' ' LEU . 12.6 ttm -71.05 148.87 47.12 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -1.129 . . . . 1.0 110.291 -179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.768 HD12 ' C ' ' A' ' 51' ' ' MET . 9.8 mp -126.53 140.4 37.26 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.247 -0.908 . . . . 1.0 110.302 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.89 95.84 0.91 Allowed 'Trans proline' 0 C--N 1.312 -1.35 0 O-C-N 123.586 1.308 . . . . 1.0 110.198 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.67 -24.06 60.52 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.224 -0.923 . . . . 1.0 110.456 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -76.79 -10.26 59.25 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.146 -0.971 . . . . 1.0 110.637 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -97.71 -45.25 6.43 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.054 -1.029 . . . . 1.0 110.103 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.8 m -86.36 163.76 2.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.219 -0.926 . . . . 1.0 110.029 179.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -142.97 178.3 7.77 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.18 -0.95 . . . . 1.0 110.332 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.431 ' O ' ' CG1' ' A' ' 60' ' ' ILE . . . -90.15 14.92 11.27 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.25 -0.906 . . . . 1.0 110.576 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.801 HD11 HG23 ' A' ' 5' ' ' ILE . 37.8 pt . . . . . 0 N--CA 1.504 2.272 0 CA-C-O 117.988 -1.006 . . . . 1.0 111.799 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 17.1 p . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.26 0.553 . . . . 1.0 110.212 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -171.47 163.46 6.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 1.0 110.102 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 176.68 -37.0 0.09 OUTLIER Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.669 -1.372 . . . . 1.0 109.669 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.763 ' O ' HG22 ' A' ' 5' ' ' ILE . 1.7 mtpt -54.96 -43.24 73.28 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.211 -1.17 . . . . 1.0 110.217 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.763 HG22 ' O ' ' A' ' 4' ' ' LYS . 11.9 tt 47.75 175.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 CA-C-O 121.571 0.7 . . . . 1.0 111.351 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 5' ' ' ILE . 14.4 m-85 -155.35 -175.18 5.3 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.87 -1.144 . . . . 1.0 110.4 -179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.72 ' HB2' HG21 ' A' ' 60' ' ' ILE . 18.2 tpp180 -162.9 132.86 4.42 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.401 -0.812 . . . . 1.0 110.05 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HB1' ' CD1' ' A' ' 22' ' ' PHE . . . -83.64 147.82 27.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 1.0 110.303 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 11.4 mtp -120.43 -14.98 8.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.236 -0.915 . . . . 1.0 110.656 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -124.03 125.33 44.35 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.082 -1.011 . . . . 1.0 110.263 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -59.13 92.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.223 -0.923 . . . . 1.0 109.921 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -82.02 167.37 18.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.276 -0.89 . . . . 1.0 110.775 -179.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -148.82 117.2 6.49 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.474 -0.767 . . . . 1.0 109.635 179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -48.73 125.99 11.1 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.295 -0.878 . . . . 1.0 110.774 -179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -90.96 -34.52 15.14 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.396 -0.815 . . . . 1.0 110.291 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -109.21 -82.04 0.57 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.228 -0.92 . . . . 1.0 110.234 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -170.36 -54.25 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.129 -0.982 . . . . 1.0 110.398 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -52.07 -24.34 6.66 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.211 -0.931 . . . . 1.0 110.205 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -68.07 171.03 7.41 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.238 -0.914 . . . . 1.0 110.057 -179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.506 HG11 HD11 ' A' ' 52' ' ' LEU . 25.7 m -113.46 -156.75 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.359 -0.838 . . . . 1.0 109.975 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -155.96 128.12 7.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.157 -0.965 . . . . 1.0 110.579 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' CD1' ' HB1' ' A' ' 8' ' ' ALA . 17.1 p90 -152.69 147.29 25.94 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.368 -0.832 . . . . 1.0 109.878 179.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 4.4 pttt -96.71 -165.25 1.24 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.194 -0.941 . . . . 1.0 110.503 -179.665 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -79.83 114.55 18.84 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.283 -0.886 . . . . 1.0 110.321 -179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 102.38 -2.39 50.25 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.234 -1.146 . . . . 1.0 110.234 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -57.83 157.15 7.87 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.912 -1.346 . . . . 1.0 110.205 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -103.0 130.35 50.07 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.228 -0.92 . . . . 1.0 110.279 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.4 HG21 ' CD2' ' A' ' 52' ' ' LEU . 34.3 mt -145.29 153.24 14.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.362 -0.836 . . . . 1.0 109.853 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -112.93 -142.32 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.174 -0.954 . . . . 1.0 110.182 179.885 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -153.68 105.28 2.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.063 -1.023 . . . . 1.0 110.359 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 ' H ' HG12 ' A' ' 31' ' ' VAL . 7.2 p -83.34 -23.04 8.35 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 1.0 110.275 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -172.95 177.72 2.72 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.208 -0.933 . . . . 1.0 110.171 -179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.76 136.17 37.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.262 -0.899 . . . . 1.0 110.341 -179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 58.1 mt -77.85 -13.63 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.215 -0.928 . . . . 1.0 110.569 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 7.7 t70 63.88 10.97 5.62 Favored 'General case' 0 N--CA 1.501 2.096 0 O-C-N 121.139 -0.976 . . . . 1.0 111.073 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -113.22 -65.17 1.21 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.977 -1.077 . . . . 1.0 110.146 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -157.37 -52.04 0.01 OUTLIER Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.42 ' CE3' ' HB3' ' A' ' 51' ' ' MET . 7.9 m95 -84.2 178.19 7.9 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.312 -1.111 . . . . 1.0 110.105 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.429 ' HG2' ' HB2' ' A' ' 52' ' ' LEU . 0.0 OUTLIER -147.07 174.37 11.61 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.322 -0.861 . . . . 1.0 110.3 179.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.424 ' CE1' HG22 ' A' ' 49' ' ' THR . 0.2 OUTLIER -116.1 136.37 53.09 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.111 -0.993 . . . . 1.0 110.51 -179.835 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.02 168.19 34.48 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.308 -1.517 . . . . 1.0 109.308 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 57.3 m -116.45 122.9 46.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.211 -1.17 . . . . 1.0 110.385 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 58.4 t -61.86 126.48 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.273 -0.892 . . . . 1.0 110.176 179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mt-30 -73.23 -30.39 63.44 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.267 -0.896 . . . . 1.0 110.597 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.49 -24.04 66.31 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.152 -0.967 . . . . 1.0 110.318 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 2.4 p -131.77 -59.57 0.95 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.22 -0.925 . . . . 1.0 110.176 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 119.92 28.14 1.93 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.985 -1.246 . . . . 1.0 109.985 179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 14.4 mtt85 -99.97 135.97 40.59 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.09 -1.241 . . . . 1.0 109.89 179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.424 HG22 ' CE1' ' A' ' 40' ' ' TYR . 25.5 m -101.3 123.88 46.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 1.0 110.512 -179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.46 ' CA ' ' CG1' ' A' ' 20' ' ' VAL . . . -153.82 -167.0 15.41 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.479 -1.448 . . . . 1.0 109.479 179.837 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.805 ' C ' HD12 ' A' ' 52' ' ' LEU . 8.0 mtp -78.99 143.68 35.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.23 -1.159 . . . . 1.0 110.247 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 51' ' ' MET . 9.4 mp -126.44 138.03 31.54 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.385 -0.822 . . . . 1.0 109.877 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.745 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.1 Cg_endo -74.05 113.5 3.8 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.529 1.279 . . . . 1.0 110.589 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.41 -39.31 81.68 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.222 -0.924 . . . . 1.0 110.035 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -60.75 -17.59 49.65 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.377 -0.827 . . . . 1.0 110.186 179.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.4 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.8 m-85 -95.44 -59.64 1.84 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.175 -0.953 . . . . 1.0 110.011 179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.745 HG22 ' O ' ' A' ' 53' ' ' PRO . 28.0 m -71.66 170.26 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 1.0 110.129 179.787 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -162.22 158.51 24.53 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.225 -0.922 . . . . 1.0 110.312 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -68.65 159.66 31.66 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -0.863 . . . . 1.0 110.278 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.72 HG21 ' HB2' ' A' ' 7' ' ' ARG . 33.7 pt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 118.024 -0.989 . . . . 1.0 110.209 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 3.6 m . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.311 0.577 . . . . 1.0 110.158 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -80.02 72.22 6.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.243 -0.91 . . . . 1.0 110.294 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -84.69 -50.13 4.32 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.592 -1.403 . . . . 1.0 109.592 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.8 mtpp -74.13 -43.74 56.34 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.307 -1.114 . . . . 1.0 110.221 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 23.0 mt 57.59 160.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 121.373 -0.829 . . . . 1.0 110.612 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -141.9 -178.36 5.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.19 -0.944 . . . . 1.0 110.031 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.455 ' HD3' HG21 ' A' ' 60' ' ' ILE . 15.0 ttt85 -170.03 138.12 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.175 -0.953 . . . . 1.0 110.411 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -85.79 136.13 33.45 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.214 -0.929 . . . . 1.0 109.879 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 63.2 mmm -95.77 -14.37 23.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.267 -0.896 . . . . 1.0 110.572 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.467 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 35.2 m-85 -137.75 151.41 48.14 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.03 -1.044 . . . . 1.0 110.406 -179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -81.63 84.38 6.8 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.319 -0.863 . . . . 1.0 109.28 179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -70.1 166.4 19.92 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.254 -0.904 . . . . 1.0 110.996 -179.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.34 114.3 8.13 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.632 -0.668 . . . . 1.0 109.344 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.59 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.02 121.53 4.31 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.204 -0.935 . . . . 1.0 110.635 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.58 -30.88 70.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.421 -0.799 . . . . 1.0 110.548 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -154.33 -69.73 0.13 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.074 -1.016 . . . . 1.0 110.748 -179.756 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -163.63 -34.11 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.17 -0.956 . . . . 1.0 111.2 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 t0 -44.38 -29.53 0.69 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 121.197 -0.94 . . . . 1.0 110.949 -179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -122.07 -177.06 3.49 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.147 -0.97 . . . . 1.0 109.952 179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.59 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 19.0 m -110.36 -152.72 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.201 -0.937 . . . . 1.0 110.585 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.0 t -157.07 141.93 16.93 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.209 -0.932 . . . . 1.0 110.41 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -150.95 149.69 29.92 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.353 -0.842 . . . . 1.0 109.78 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.66 -174.87 4.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.516 -179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 35.7 t0 -78.13 114.56 17.13 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.276 -0.89 . . . . 1.0 110.272 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.98 -21.1 9.02 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.679 -1.369 . . . . 1.0 109.679 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -53.46 169.63 0.12 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.192 -1.181 . . . . 1.0 110.311 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.507 ' O ' HD13 ' A' ' 28' ' ' ILE . . . -118.3 139.51 51.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.39 -0.818 . . . . 1.0 110.13 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.507 HD13 ' O ' ' A' ' 27' ' ' ALA . 40.1 mm -123.08 173.06 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 1.0 109.992 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.717 HG23 ' N ' ' A' ' 30' ' ' ASN . 0.7 OUTLIER -117.96 -140.03 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 1.0 109.278 179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.717 ' N ' HG23 ' A' ' 29' ' ' ILE . 12.3 t-20 -172.19 69.83 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.646 -1.284 . . . . 1.0 110.29 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.433 HG23 ' N ' ' A' ' 32' ' ' GLN . 20.7 m -70.56 -35.74 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.286 -0.884 . . . . 1.0 110.454 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.519 ' O ' ' HB3' ' A' ' 33' ' ' ALA . 51.8 tt0 -144.53 -65.61 0.34 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.963 -1.086 . . . . 1.0 110.322 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.519 ' HB3' ' O ' ' A' ' 32' ' ' GLN . . . 61.58 133.91 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.363 -0.835 . . . . 1.0 110.577 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.434 ' O ' ' N ' ' A' ' 36' ' ' GLU . 50.1 mm -119.8 -7.33 10.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.061 -1.024 . . . . 1.0 110.663 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.405 ' CB ' ' O ' ' A' ' 34' ' ' ILE . 18.5 t0 66.71 -66.54 0.18 Allowed 'General case' 0 N--CA 1.5 2.065 0 O-C-N 121.174 -0.954 . . . . 1.0 110.55 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.434 ' N ' ' O ' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -94.05 91.21 6.73 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.117 -0.99 . . . . 1.0 110.587 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.85 64.82 0.27 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.745 -1.342 . . . . 1.0 109.745 179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 58.5 m95 52.9 176.69 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.356 -1.084 . . . . 1.0 110.554 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 1.2 ptp -150.1 178.49 8.91 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 1.0 109.864 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.446 ' CE2' HG22 ' A' ' 49' ' ' THR . 1.0 OUTLIER -124.11 122.2 37.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.977 -1.077 . . . . 1.0 110.311 -179.707 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -145.75 176.68 24.6 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.752 -1.339 . . . . 1.0 109.752 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.658 ' H ' HG22 ' A' ' 29' ' ' ILE . 85.3 m -126.14 141.54 51.9 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -1.085 . . . . 1.0 110.096 179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 45.5 t -85.82 110.34 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -0.938 . . . . 1.0 110.297 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -55.68 -28.99 58.53 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.401 -0.812 . . . . 1.0 110.36 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 5.7 ttt180 -66.91 -70.31 0.26 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.247 -0.908 . . . . 1.0 110.4 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 18.7 p -81.93 -55.83 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.179 -0.951 . . . . 1.0 110.312 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.66 30.36 2.03 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.655 -1.378 . . . . 1.0 109.655 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 10.6 mmt-85 -97.02 128.81 44.35 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.201 -1.176 . . . . 1.0 110.358 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.446 HG22 ' CE2' ' A' ' 40' ' ' TYR . 98.0 m -112.99 121.6 45.14 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.2 -0.938 . . . . 1.0 110.211 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -160.85 -147.92 5.1 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.47 -1.452 . . . . 1.0 109.47 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.588 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.3 mmt -84.2 138.72 32.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.313 -1.11 . . . . 1.0 110.198 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.588 HD12 ' O ' ' A' ' 51' ' ' MET . 7.3 mp -123.25 148.55 55.26 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.301 -0.874 . . . . 1.0 110.168 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.413 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 46.8 Cg_endo -72.19 110.3 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.374 0 O-C-N 123.684 1.36 . . . . 1.0 110.134 179.818 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.95 -23.09 65.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.28 -0.888 . . . . 1.0 110.567 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -87.01 7.95 25.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.148 -0.97 . . . . 1.0 110.795 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.467 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.9 m-85 -117.13 -58.67 2.03 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.057 -1.027 . . . . 1.0 110.168 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.4 m -78.12 161.6 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.329 -0.857 . . . . 1.0 110.177 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -169.19 167.46 10.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.284 -0.885 . . . . 1.0 109.964 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.51 147.11 27.99 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.922 . . . . 1.0 110.281 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.455 HG21 ' HD3' ' A' ' 7' ' ' ARG . 3.6 pt . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 118.003 -0.999 . . . . 1.0 110.207 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 14.5 p . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.228 0.537 . . . . 1.0 110.305 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.49 -172.91 4.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.139 -0.976 . . . . 1.0 110.438 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 91.55 22.01 32.74 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 22.8 mtpt -78.17 -168.99 1.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.162 -1.199 . . . . 1.0 110.371 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -97.85 137.89 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.257 -0.902 . . . . 1.0 109.744 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 12.4 m-85 -119.37 -176.47 3.15 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.295 -0.878 . . . . 1.0 109.894 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -163.68 136.56 5.31 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.091 -1.006 . . . . 1.0 110.543 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 23' ' ' LYS . . . -65.52 140.73 58.59 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.249 -0.907 . . . . 1.0 110.155 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 21.2 mtp -129.0 12.8 6.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.165 -0.959 . . . . 1.0 110.543 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.51 ' HB2' ' CD2' ' A' ' 56' ' ' TYR . 51.2 m-85 -131.76 -7.15 3.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.063 -1.023 . . . . 1.0 111.463 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 13.1 t70 58.68 90.59 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.963 -1.086 . . . . 1.0 109.697 -179.377 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.486 ' CZ ' ' HA ' ' A' ' 14' ' ' ALA . 21.7 t80 -111.66 132.34 54.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 1.0 110.53 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . 0.484 ' HA ' ' CB ' ' A' ' 21' ' ' SER . 5.2 ptt? -110.81 22.87 14.87 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.28 -0.888 . . . . 1.0 110.019 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.486 ' HA ' ' CZ ' ' A' ' 12' ' ' TYR . . . 57.23 158.57 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.538 0.685 . . . . 1.0 110.721 -179.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -110.78 -22.83 11.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.95 . . . . 1.0 110.007 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -141.02 -155.66 0.61 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -99.98 20.1 15.01 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.194 -0.941 . . . . 1.0 110.205 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -87.55 -36.3 17.64 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.243 -0.911 . . . . 1.0 110.606 -179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.2 pm0 -119.76 -173.81 2.62 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.071 -1.018 . . . . 1.0 110.51 -179.748 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.625 ' CG2' HD11 ' A' ' 52' ' ' LEU . 24.4 m -108.52 -178.01 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.422 -0.799 . . . . 1.0 109.92 179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.484 ' CB ' ' HA ' ' A' ' 13' ' ' MET . 2.2 p -131.02 133.44 45.75 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.149 -0.969 . . . . 1.0 110.648 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.432 ' HB2' ' CB ' ' A' ' 26' ' ' ASP . 6.4 p90 -137.72 168.84 18.86 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.365 -0.835 . . . . 1.0 109.845 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.44 ' O ' ' HB3' ' A' ' 8' ' ' ALA . 13.9 mttp -94.34 -174.75 3.45 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.224 -0.922 . . . . 1.0 110.376 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 48.4 p-10 -77.42 1.09 20.13 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 121.268 -0.895 . . . . 1.0 110.921 -179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -127.89 20.23 5.73 Favored Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.801 -1.32 . . . . 1.0 109.801 -179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.471 ' OD2' HG13 ' A' ' 43' ' ' VAL . 37.6 t0 -78.17 155.26 30.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.171 -1.194 . . . . 1.0 110.081 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -110.68 128.91 55.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.302 -0.874 . . . . 1.0 110.537 -179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 29' ' ' ILE . 27.7 mt -147.34 171.46 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.405 -0.81 . . . . 1.0 109.474 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.506 ' N ' HG22 ' A' ' 28' ' ' ILE . 7.0 pt -142.27 -178.43 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.099 -1.0 . . . . 1.0 110.778 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -88.04 70.2 9.36 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.384 -0.823 . . . . 1.0 110.365 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 84.7 t -54.23 -62.99 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.199 -0.938 . . . . 1.0 109.969 179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.83 151.68 47.23 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.322 -0.861 . . . . 1.0 109.909 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.24 132.21 27.75 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 1.0 110.517 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.2 mm -95.55 -56.52 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.248 -0.907 . . . . 1.0 109.914 179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -171.73 -161.99 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.337 -0.852 . . . . 1.0 110.01 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.11 134.54 52.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 1.0 110.126 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 111.21 85.24 1.54 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.461 -1.456 . . . . 1.0 109.461 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . 0.429 ' CD1' ' N ' ' A' ' 38' ' ' TRP . 26.6 m95 55.07 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.51 -0.994 . . . . 1.0 110.552 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 9.0 ptt? -149.61 -147.96 0.25 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.15 -0.969 . . . . 1.0 110.079 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -136.21 128.52 30.11 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.081 -1.012 . . . . 1.0 110.182 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -147.79 170.39 28.49 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 98.1 m -123.76 104.17 8.82 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -1.153 . . . . 1.0 110.198 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.471 HG13 ' OD2' ' A' ' 26' ' ' ASP . 61.0 t -53.07 131.18 15.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.196 -0.94 . . . . 1.0 110.093 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -85.62 -16.3 39.67 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 1.0 110.554 -179.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 4.5 tpt180 -68.12 -35.71 78.56 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.123 -0.986 . . . . 1.0 110.448 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 69.8 p -124.25 -42.84 2.1 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.159 -0.963 . . . . 1.0 110.346 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 108.88 34.95 2.47 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.438 -1.465 . . . . 1.0 109.438 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -106.2 111.4 24.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.244 -1.151 . . . . 1.0 110.189 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 36.0 m -92.82 124.93 37.17 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.311 -0.868 . . . . 1.0 110.213 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -162.98 -153.68 7.31 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.547 -1.421 . . . . 1.0 109.547 -179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.818 ' O ' HD12 ' A' ' 52' ' ' LEU . 7.1 mtt -78.39 143.44 36.82 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.242 -1.151 . . . . 1.0 110.283 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.818 HD12 ' O ' ' A' ' 51' ' ' MET . 3.1 mp -132.53 141.65 41.98 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.407 -0.808 . . . . 1.0 110.209 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.08 93.75 0.96 Allowed 'Trans proline' 0 C--N 1.312 -1.392 0 O-C-N 123.599 1.315 . . . . 1.0 110.374 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.99 -27.88 61.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.225 -0.922 . . . . 1.0 110.354 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -76.73 -2.39 32.74 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.194 -0.941 . . . . 1.0 110.917 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' CD2' ' HB2' ' A' ' 10' ' ' TYR . 1.7 m-85 -105.3 -51.61 2.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.972 -1.08 . . . . 1.0 110.237 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.405 ' H ' HG22 ' A' ' 57' ' ' VAL . 33.9 m -76.54 152.97 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 1.0 110.168 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -164.31 173.33 12.4 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.259 -0.9 . . . . 1.0 110.461 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -83.56 139.36 32.91 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.339 -0.851 . . . . 1.0 110.163 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.975 -1.012 . . . . 1.0 110.159 179.943 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 19.7 p . . . . . 0 N--CA 1.492 1.639 0 CA-C-O 121.247 0.546 . . . . 1.0 110.186 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.61 -178.21 4.59 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 1.0 110.097 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -171.15 -39.06 0.03 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.819 -1.312 . . . . 1.0 109.819 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -56.51 -63.21 1.27 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.165 -1.197 . . . . 1.0 110.491 -179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.461 HG22 ' H ' ' A' ' 6' ' ' PHE . 21.3 mm 54.94 171.74 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 O-C-N 121.31 -0.869 . . . . 1.0 110.275 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.461 ' H ' HG22 ' A' ' 5' ' ' ILE . 38.8 m-85 -145.24 178.25 8.22 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.174 -0.953 . . . . 1.0 110.148 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 11.4 ttt180 -153.87 117.05 4.54 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 1.0 110.213 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.463 ' HA ' HG12 ' A' ' 57' ' ' VAL . . . -62.27 132.39 52.52 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.209 -0.932 . . . . 1.0 110.175 179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.477 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 2.0 mtp -114.0 9.76 17.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.225 -0.922 . . . . 1.0 110.686 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.477 ' CD1' ' O ' ' A' ' 9' ' ' MET . 48.6 m-85 -142.86 152.16 41.84 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.999 -1.063 . . . . 1.0 110.366 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -85.9 86.35 7.36 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.276 -0.89 . . . . 1.0 109.751 179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.459 ' CE2' ' HA ' ' A' ' 14' ' ' ALA . 25.5 t80 -94.02 131.67 39.27 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.256 -0.902 . . . . 1.0 110.484 -179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 8.1 ptp -110.43 22.09 15.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.35 -0.844 . . . . 1.0 110.098 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.589 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . 55.15 166.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 CA-C-O 121.633 0.73 . . . . 1.0 110.986 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -115.45 -19.79 10.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.383 -0.823 . . . . 1.0 109.908 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -149.86 -157.86 0.86 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -0.879 . . . . 1.0 109.971 179.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -94.35 19.29 9.74 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.196 -0.94 . . . . 1.0 110.401 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -85.0 -34.92 22.26 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.205 -0.935 . . . . 1.0 110.204 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 51' ' ' MET . 0.8 OUTLIER -122.4 -176.97 3.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.197 -0.94 . . . . 1.0 110.303 179.866 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.621 HG22 ' CD1' ' A' ' 52' ' ' LEU . 12.0 m -105.24 -162.62 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.245 -0.91 . . . . 1.0 110.179 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.6 t -139.55 105.93 5.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.109 -0.994 . . . . 1.0 110.658 -179.633 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' HE2' HD12 ' A' ' 52' ' ' LEU . 4.4 p90 -118.77 154.47 32.77 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.299 -0.876 . . . . 1.0 109.897 179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 68.1 mttt -97.68 178.27 5.22 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.176 -0.953 . . . . 1.0 110.378 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -69.83 81.73 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.36 -0.838 . . . . 1.0 110.054 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 163.43 -28.19 0.23 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.418 -1.473 . . . . 1.0 109.418 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASP . 4.5 m-20 -53.39 151.53 5.45 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.306 -1.114 . . . . 1.0 110.162 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -125.47 143.47 50.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -0.938 . . . . 1.0 110.405 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.452 HG21 ' HA3' ' A' ' 41' ' ' GLY . 56.8 mt -138.98 146.75 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.342 -0.849 . . . . 1.0 109.926 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.901 HG13 HG23 ' A' ' 31' ' ' VAL . 2.9 pt -81.69 -161.75 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.152 -0.967 . . . . 1.0 110.771 -179.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . 0.439 ' O ' ' N ' ' A' ' 32' ' ' GLN . 35.6 m-20 -72.29 -47.42 50.15 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.369 -0.832 . . . . 1.0 110.937 -179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.901 HG23 HG13 ' A' ' 29' ' ' ILE . 72.8 t 56.28 -86.64 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.447 -0.783 . . . . 1.0 110.461 -179.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' N ' ' O ' ' A' ' 30' ' ' ASN . 0.0 OUTLIER -171.09 139.93 1.45 Allowed 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.901 -1.124 . . . . 1.0 110.522 -179.843 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.52 145.72 37.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.281 -0.887 . . . . 1.0 110.1 179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 2.0 pt -126.86 -33.37 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.209 -0.932 . . . . 1.0 110.994 -179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -141.13 170.09 16.37 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.99 -1.069 . . . . 1.0 110.408 -179.888 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 54' ' ' ALA . 1.6 tm-20 -79.3 -22.8 44.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.243 -0.911 . . . . 1.0 110.306 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.6 -75.73 0.29 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.502 -1.439 . . . . 1.0 109.502 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 62.5 m95 -121.74 152.88 38.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.187 -1.184 . . . . 1.0 110.179 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -132.06 -160.01 1.01 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.184 -0.948 . . . . 1.0 110.446 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.496 ' CE1' ' HG3' ' A' ' 51' ' ' MET . 0.1 OUTLIER -137.15 135.29 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.4 -0.813 . . . . 1.0 109.807 179.91 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.72 ' HA2' HG21 ' A' ' 31' ' ' VAL . . . -164.74 159.02 31.98 Favored Glycine 0 N--CA 1.489 2.176 0 C-N-CA 119.599 -1.286 . . . . 1.0 109.906 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.405 ' OG1' HG22 ' A' ' 49' ' ' THR . 55.5 m -108.98 121.68 45.65 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.351 -1.088 . . . . 1.0 109.96 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.496 HG12 ' H ' ' A' ' 45' ' ' ARG . 34.1 t -63.92 122.81 15.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.262 -0.899 . . . . 1.0 110.319 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -76.03 -10.39 59.38 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.272 -0.892 . . . . 1.0 110.58 179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.496 ' H ' HG12 ' A' ' 43' ' ' VAL . 0.1 OUTLIER -70.44 -68.0 0.46 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.047 . . . . 1.0 110.33 -179.878 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -97.72 -40.13 8.72 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.231 -0.918 . . . . 1.0 110.306 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 115.44 24.73 3.99 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.638 -1.385 . . . . 1.0 109.638 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.8 mmm-85 -84.48 126.47 33.3 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.221 -1.164 . . . . 1.0 110.012 -180.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.405 HG22 ' OG1' ' A' ' 42' ' ' THR . 15.6 p -97.75 133.47 42.22 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.351 -0.843 . . . . 1.0 110.327 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.528 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . 178.86 -174.34 46.48 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.535 -1.426 . . . . 1.0 109.535 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.845 ' O ' HD13 ' A' ' 52' ' ' LEU . 29.6 mtp -87.6 153.68 21.2 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.192 -1.181 . . . . 1.0 110.589 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.845 HD13 ' O ' ' A' ' 51' ' ' MET . 0.6 OUTLIER -126.02 145.02 50.66 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 1.0 109.65 179.662 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.408 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 47.6 Cg_endo -72.11 112.57 3.45 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.66 1.347 . . . . 1.0 110.09 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.584 ' HB3' ' O ' ' A' ' 36' ' ' GLU . . . -64.03 -39.77 94.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.115 -0.99 . . . . 1.0 110.206 -179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -54.31 -23.15 14.05 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.171 -0.956 . . . . 1.0 109.956 179.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.408 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 1.7 m-85 -88.29 -73.66 0.48 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.335 -0.853 . . . . 1.0 110.126 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.463 HG12 ' HA ' ' A' ' 8' ' ' ALA . 33.2 m -52.9 151.94 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.186 -0.946 . . . . 1.0 110.075 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 25.1 mm-40 -124.24 159.39 30.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.21 -0.931 . . . . 1.0 110.234 -179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -80.71 149.93 29.53 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -0.885 . . . . 1.0 110.134 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.0 pt . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 118.012 -0.994 . . . . 1.0 110.278 179.994 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 20.0 p . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.255 0.55 . . . . 1.0 110.235 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -89.37 178.46 6.32 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 1.0 110.199 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 99.99 25.93 8.72 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.423 -1.471 . . . . 1.0 109.423 -179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.8 mtpp -100.24 -174.35 2.65 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.295 -1.121 . . . . 1.0 110.411 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.8 mt -122.05 151.37 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 121.323 -0.861 . . . . 1.0 109.731 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.3 m-85 -119.95 179.23 4.32 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 1.0 109.978 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 52.7 ttt180 -161.88 144.55 11.75 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.146 -0.971 . . . . 1.0 110.21 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -97.27 124.71 41.46 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.299 -0.876 . . . . 1.0 110.099 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.411 ' HA ' ' OD1' ' A' ' 24' ' ' ASP . 3.0 mmm -95.5 -3.0 47.49 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.219 -0.926 . . . . 1.0 110.871 -179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -127.87 177.43 6.85 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.931 -1.105 . . . . 1.0 110.336 -179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -111.67 83.11 1.73 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.276 -0.89 . . . . 1.0 109.716 179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.4 t80 -76.61 140.94 41.2 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.252 -0.905 . . . . 1.0 110.903 -179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 7.9 mtt -112.16 108.33 17.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.468 -0.77 . . . . 1.0 109.507 179.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.431 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -48.1 120.92 3.83 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.291 -0.881 . . . . 1.0 110.803 -179.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.42 -40.18 64.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.315 -0.865 . . . . 1.0 109.847 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -120.57 -175.25 2.98 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.347 -0.845 . . . . 1.0 109.939 179.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -78.65 -17.36 56.1 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.169 -0.957 . . . . 1.0 110.313 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -74.09 -31.65 62.91 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.93 . . . . 1.0 110.298 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.408 ' CD ' ' N ' ' A' ' 19' ' ' GLU . 1.9 mp0 -84.92 171.92 11.78 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.203 -0.936 . . . . 1.0 110.583 -179.652 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.522 HG13 ' HA3' ' A' ' 50' ' ' GLY . 35.7 m -116.67 167.62 9.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.418 -0.801 . . . . 1.0 109.877 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.2 t -129.56 108.57 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.114 -0.991 . . . . 1.0 110.554 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.7 p90 -121.17 151.95 39.34 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.286 -0.884 . . . . 1.0 110.098 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.04 178.62 5.21 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 1.0 110.601 -179.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.411 ' OD1' ' HA ' ' A' ' 9' ' ' MET . 34.3 t0 -75.03 99.63 3.94 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 1.0 110.111 179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 141.08 -28.23 2.38 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.083 -1.607 . . . . 1.0 109.083 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.618 ' OD1' HG13 ' A' ' 43' ' ' VAL . 9.7 t70 -63.1 165.92 6.57 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.392 -1.063 . . . . 1.0 109.994 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -129.57 169.19 15.33 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.139 -0.976 . . . . 1.0 111.035 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.525 ' C ' HG23 ' A' ' 29' ' ' ILE . 27.0 mm -130.78 163.55 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.681 -0.637 . . . . 1.0 109.439 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.525 HG23 ' C ' ' A' ' 28' ' ' ILE . 7.6 pt -151.86 161.25 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.973 -1.079 . . . . 1.0 110.956 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 4.8 m-80 51.53 54.2 11.45 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.494 -0.754 . . . . 1.0 110.483 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.452 ' CG1' HG22 ' A' ' 28' ' ' ILE . 27.3 m -104.3 170.48 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.185 -0.947 . . . . 1.0 110.377 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -158.67 -161.86 1.03 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.388 -0.82 . . . . 1.0 109.928 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.72 127.66 20.63 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.25 -0.906 . . . . 1.0 110.264 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.4 ' H ' HD12 ' A' ' 34' ' ' ILE . 3.0 mp -78.81 -70.12 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.353 -0.842 . . . . 1.0 110.081 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.85 -47.59 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.205 -0.935 . . . . 1.0 110.032 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.29 -82.47 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.264 -0.898 . . . . 1.0 110.241 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -165.05 -55.92 0.02 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.427 -1.469 . . . . 1.0 109.427 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.8 m95 -54.4 155.89 3.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.306 -1.114 . . . . 1.0 109.874 179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.426 ' CE ' HG21 ' A' ' 57' ' ' VAL . 1.9 ptt? -131.94 -164.1 1.41 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.211 -0.931 . . . . 1.0 110.483 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -124.86 158.76 32.67 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.406 -0.809 . . . . 1.0 109.872 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.507 ' HA3' HD22 ' A' ' 52' ' ' LEU . . . -175.06 159.9 28.49 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.753 -1.339 . . . . 1.0 109.753 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.772 ' OG1' HG22 ' A' ' 49' ' ' THR . 54.6 m -126.86 117.23 22.19 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.352 -1.087 . . . . 1.0 109.866 179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.618 HG13 ' OD1' ' A' ' 26' ' ' ASP . 22.0 t -57.14 109.83 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.186 -0.946 . . . . 1.0 109.794 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.8 -23.68 63.51 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.315 -0.866 . . . . 1.0 110.701 -179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -75.83 -74.07 0.24 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.093 -1.004 . . . . 1.0 110.649 -179.586 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 p -68.66 -56.79 7.03 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.172 -0.955 . . . . 1.0 110.312 -179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 116.15 32.23 1.72 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.604 -1.398 . . . . 1.0 109.604 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 7.3 mtp180 -97.48 148.56 23.1 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.233 -1.157 . . . . 1.0 110.13 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.772 HG22 ' OG1' ' A' ' 42' ' ' THR . 29.7 p -125.21 135.83 52.97 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.316 -0.865 . . . . 1.0 110.06 -179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.522 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -178.56 -163.59 30.12 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.786 -1.326 . . . . 1.0 109.786 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.793 ' C ' HD12 ' A' ' 52' ' ' LEU . 0.5 OUTLIER -80.87 141.86 34.19 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.298 -1.119 . . . . 1.0 110.129 179.971 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.793 HD12 ' C ' ' A' ' 51' ' ' MET . 8.9 mp -123.1 125.8 26.15 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.549 -0.719 . . . . 1.0 109.99 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.18 107.47 2.38 Favored 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 123.408 1.215 . . . . 1.0 110.306 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.2 -27.59 55.19 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -0.957 . . . . 1.0 110.242 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -62.19 -17.34 57.84 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.27 -0.894 . . . . 1.0 110.48 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -98.52 -60.95 1.45 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 1.0 109.794 179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.426 HG21 ' CE ' ' A' ' 39' ' ' MET . 28.7 m -78.51 -176.54 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 1.0 110.078 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -167.83 -174.74 2.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.235 -0.915 . . . . 1.0 110.161 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.516 ' C ' HG23 ' A' ' 60' ' ' ILE . . . -105.23 167.18 9.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.272 -0.892 . . . . 1.0 110.525 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.516 HG23 ' C ' ' A' ' 59' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.979 -1.01 . . . . 1.0 110.177 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.289 0.566 . . . . 1.0 110.224 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -175.3 72.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.276 -0.89 . . . . 1.0 110.135 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -139.94 62.86 0.55 Allowed Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.479 -1.449 . . . . 1.0 109.479 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -74.26 -34.01 63.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.322 -1.105 . . . . 1.0 110.15 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm 58.1 159.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 O-C-N 121.39 -0.819 . . . . 1.0 110.337 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -139.32 -174.71 3.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.08 -1.013 . . . . 1.0 110.23 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 72.1 ttt180 -153.12 164.17 38.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -0.907 . . . . 1.0 110.138 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -108.72 133.22 53.1 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.285 -0.885 . . . . 1.0 110.141 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 8.9 mtp -111.35 -6.3 14.52 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.239 -0.913 . . . . 1.0 110.743 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -131.79 167.12 20.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.961 -1.087 . . . . 1.0 110.148 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -98.69 105.45 17.6 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.289 -0.882 . . . . 1.0 109.86 179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 38.3 t80 -109.62 160.94 15.85 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 1.0 110.908 -179.566 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -139.53 114.45 9.47 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.483 -0.76 . . . . 1.0 109.759 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.637 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -50.15 117.47 2.37 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.185 -0.947 . . . . 1.0 110.642 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.03 -29.36 49.39 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.371 -0.831 . . . . 1.0 110.014 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -130.72 -154.85 0.66 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.328 -0.857 . . . . 1.0 109.973 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.46 15.55 27.54 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.218 -0.926 . . . . 1.0 110.518 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.404 ' HB3' ' OE1' ' A' ' 19' ' ' GLU . 1.1 t70 -85.38 -35.22 21.5 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.031 -1.043 . . . . 1.0 110.255 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' OE1' ' HB3' ' A' ' 18' ' ' ASP . 6.5 pm0 -124.71 -175.87 3.39 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.229 -0.919 . . . . 1.0 110.49 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.637 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 31.6 m -113.7 -165.27 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.417 -0.802 . . . . 1.0 110.343 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -134.54 123.78 24.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.228 -0.92 . . . . 1.0 110.331 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 18.5 p90 -133.3 153.74 51.31 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.272 -0.892 . . . . 1.0 110.115 179.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 12.8 mttp -97.85 178.58 5.08 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.238 -0.914 . . . . 1.0 110.287 -179.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -73.45 119.36 17.58 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 1.0 110.191 -179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 120.23 -35.36 3.8 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.522 -1.431 . . . . 1.0 109.522 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.38 160.3 1.21 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.253 -1.145 . . . . 1.0 110.347 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -123.64 141.22 52.22 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.211 -0.931 . . . . 1.0 110.297 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.541 HG21 HD11 ' A' ' 52' ' ' LEU . 39.1 mt -143.75 127.77 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.195 -0.94 . . . . 1.0 110.199 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.1 pt -60.7 -160.23 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.169 -0.957 . . . . 1.0 110.455 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 -160.79 79.1 0.62 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.838 . . . . 1.0 110.265 179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.404 HG23 ' H ' ' A' ' 31' ' ' VAL . 40.4 t -52.83 -62.65 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 1.0 110.13 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 5.2 mt-30 -119.6 147.13 44.88 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.31 -0.868 . . . . 1.0 109.904 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -139.64 115.06 9.88 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 1.0 110.34 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.433 ' O ' ' N ' ' A' ' 36' ' ' GLU . 39.7 mm -93.45 -5.67 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.24 -0.912 . . . . 1.0 110.504 179.798 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 65.41 -72.19 0.07 Allowed 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.137 -0.977 . . . . 1.0 110.49 -179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -88.11 47.05 1.45 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.169 -0.957 . . . . 1.0 110.371 -179.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -177.74 49.55 0.1 OUTLIER Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.775 -1.33 . . . . 1.0 109.775 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.2 m95 52.99 178.52 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.199 -1.177 . . . . 1.0 110.123 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.694 ' CE ' HD12 ' A' ' 52' ' ' LEU . 5.3 ptm -138.66 173.05 11.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.112 -0.993 . . . . 1.0 110.324 -179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -120.68 158.77 26.73 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.292 -0.88 . . . . 1.0 109.99 179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 176.02 -175.31 47.36 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.672 -1.371 . . . . 1.0 109.672 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.847 ' OG1' HG22 ' A' ' 49' ' ' THR . 52.3 m -125.64 122.55 36.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.315 -1.109 . . . . 1.0 110.229 -179.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 53.5 t -65.67 118.52 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 1.0 110.041 179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.72 -21.21 64.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.227 -0.92 . . . . 1.0 110.434 -179.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.22 -69.56 0.3 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.183 -0.948 . . . . 1.0 110.279 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 41.1 p -86.94 -28.34 22.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.165 -0.959 . . . . 1.0 110.354 -179.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 91.06 32.89 8.55 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.32 -1.512 . . . . 1.0 109.32 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 6.9 mmt180 -106.34 142.9 35.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.345 -1.091 . . . . 1.0 110.101 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . 0.847 HG22 ' OG1' ' A' ' 42' ' ' THR . 37.2 p -104.95 143.24 33.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 1.0 110.223 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.431 ' HA3' HG13 ' A' ' 20' ' ' VAL . . . -179.1 178.09 48.66 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.436 -1.466 . . . . 1.0 109.436 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.933 ' O ' HD23 ' A' ' 52' ' ' LEU . 4.9 mmm -79.48 153.53 29.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.303 -1.116 . . . . 1.0 110.216 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.933 HD23 ' O ' ' A' ' 51' ' ' MET . 12.3 mt -129.64 162.92 50.24 Favored Pre-proline 0 N--CA 1.495 1.799 0 O-C-N 121.193 -0.942 . . . . 1.0 109.931 179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.598 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.5 Cg_endo -74.88 114.99 4.16 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.71 1.374 . . . . 1.0 110.378 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.84 -18.34 62.08 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 1.0 110.459 -179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -88.21 -1.04 57.79 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.144 -0.972 . . . . 1.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -110.91 -65.41 1.17 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.96 -1.088 . . . . 1.0 110.396 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 53' ' ' PRO . 19.8 m -56.3 170.33 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.25 -0.906 . . . . 1.0 110.34 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -155.54 157.87 37.56 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.287 -0.883 . . . . 1.0 110.298 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.51 140.53 33.27 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.285 -0.884 . . . . 1.0 110.296 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.3 pt . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.958 -1.02 . . . . 1.0 110.208 179.892 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.279 0.562 . . . . 1.0 110.221 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -156.57 162.05 39.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.11 -0.994 . . . . 1.0 110.325 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -127.19 31.23 3.9 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.433 -1.467 . . . . 1.0 109.433 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.3 mttm -56.05 -168.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.374 -1.074 . . . . 1.0 110.407 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 mt -106.07 148.83 10.05 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 O-C-N 121.416 -0.803 . . . . 1.0 109.387 179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 6.5 m-85 -119.57 179.78 4.11 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 1.0 110.141 -179.883 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -160.37 142.53 12.87 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.298 -0.876 . . . . 1.0 110.328 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -86.1 155.49 20.77 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.304 -0.872 . . . . 1.0 110.122 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.8 mtp -134.19 4.93 3.51 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.202 -0.936 . . . . 1.0 110.921 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . . . . . . . . . 34.4 m-85 -134.32 129.21 35.19 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.988 -1.07 . . . . 1.0 110.191 -179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -71.3 103.47 2.86 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.233 -0.917 . . . . 1.0 109.825 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -104.22 147.64 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.128 -0.983 . . . . 1.0 110.722 -179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.16 105.41 11.78 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.45 -0.781 . . . . 1.0 109.79 179.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 20' ' ' VAL . . . -48.84 120.42 3.84 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.244 -0.91 . . . . 1.0 110.661 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.5 -35.46 46.38 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.308 -0.87 . . . . 1.0 110.114 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -124.94 -171.22 2.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 1.0 110.18 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -87.65 11.36 15.34 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.235 -0.915 . . . . 1.0 110.648 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.07 -26.35 43.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.095 -1.003 . . . . 1.0 110.054 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -131.85 -176.97 4.23 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.308 -0.87 . . . . 1.0 110.243 179.844 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.617 ' O ' ' HB2' ' A' ' 14' ' ' ALA . 29.9 m -115.79 -169.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 1.0 109.964 179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 7.6 p -133.21 123.97 26.56 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.183 -0.948 . . . . 1.0 110.725 -179.47 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 3.6 p90 -131.04 159.57 37.15 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 1.0 109.891 179.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.7 mttp -105.4 176.95 4.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.254 -0.904 . . . . 1.0 110.393 -179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.96 93.06 0.18 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.233 -0.917 . . . . 1.0 110.221 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 155.33 -24.45 0.59 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.503 -1.439 . . . . 1.0 109.503 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.424 ' OD2' ' CG1' ' A' ' 43' ' ' VAL . 3.8 t0 -65.01 177.09 1.05 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.267 -1.137 . . . . 1.0 110.168 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -159.99 164.38 33.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.189 -0.944 . . . . 1.0 110.259 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . 0.424 HG22 ' H ' ' A' ' 29' ' ' ILE . 20.8 mm -118.51 172.02 6.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.334 -0.854 . . . . 1.0 109.501 179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.424 ' H ' HG22 ' A' ' 28' ' ' ILE . 0.3 OUTLIER -171.61 -35.58 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.044 -1.035 . . . . 1.0 110.477 -179.935 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -46.66 -78.64 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.209 -0.932 . . . . 1.0 111.117 -179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.467 HG12 ' N ' ' A' ' 32' ' ' GLN . 42.5 t -95.13 -109.21 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.406 0 O-C-N 121.085 -1.01 . . . . 1.0 110.192 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' N ' HG12 ' A' ' 31' ' ' VAL . 2.9 tt0 -176.26 -152.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.469 -1.394 . . . . 1.0 110.125 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.401 ' HB2' ' HE2' ' A' ' 39' ' ' MET . . . -122.6 129.07 51.49 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.201 -0.937 . . . . 1.0 110.455 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . . . . . . . . . 48.9 mm -95.99 -8.4 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.284 -0.885 . . . . 1.0 110.56 179.893 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 61.75 146.08 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.11 -0.994 . . . . 1.0 110.375 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 54.49 98.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.95 . . . . 1.0 110.178 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.61 27.48 5.47 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.451 -1.46 . . . . 1.0 109.451 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 16.1 m95 54.8 171.3 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.46 -1.024 . . . . 1.0 110.437 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.538 ' SD ' HD12 ' A' ' 52' ' ' LEU . 0.6 OUTLIER -122.56 -167.84 1.64 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.166 -0.959 . . . . 1.0 110.0 179.919 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -147.61 144.64 28.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.934 . . . . 1.0 110.166 -179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 174.28 178.39 44.15 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 1.0 109.695 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . . . . . . . . . 39.8 m -106.88 132.53 52.73 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.387 -1.067 . . . . 1.0 110.148 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.424 ' CG1' ' OD2' ' A' ' 26' ' ' ASP . 49.3 t -69.75 129.11 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.237 -0.914 . . . . 1.0 109.801 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -70.75 -35.18 72.52 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.19 -0.944 . . . . 1.0 110.652 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.02 -57.85 8.44 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.144 -0.972 . . . . 1.0 110.572 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 12.8 p -91.93 -52.28 4.8 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.237 -0.915 . . . . 1.0 110.613 -179.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 105.96 25.38 6.5 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.353 -1.499 . . . . 1.0 109.353 -179.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 19.2 mtt180 -95.45 138.58 32.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.275 -1.132 . . . . 1.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.34 135.93 33.62 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.268 -0.895 . . . . 1.0 110.171 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . 179.78 177.27 47.83 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.53 -1.428 . . . . 1.0 109.53 179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.876 ' O ' HD23 ' A' ' 52' ' ' LEU . 11.1 mmt -82.6 151.9 26.15 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.248 -1.148 . . . . 1.0 109.99 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.876 HD23 ' O ' ' A' ' 51' ' ' MET . 9.7 mt -128.27 161.92 53.56 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.153 -0.967 . . . . 1.0 109.917 -179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.593 ' O ' HG22 ' A' ' 57' ' ' VAL . 48.4 Cg_endo -74.55 115.08 4.19 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.677 1.357 . . . . 1.0 110.267 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.37 -17.19 60.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.192 -0.943 . . . . 1.0 110.505 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -90.2 -8.29 51.49 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.121 -0.987 . . . . 1.0 110.85 -179.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -98.94 -60.69 1.48 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.008 -1.058 . . . . 1.0 110.046 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.593 HG22 ' O ' ' A' ' 53' ' ' PRO . 26.9 m -70.48 163.43 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.239 -0.913 . . . . 1.0 109.863 179.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -162.02 -177.46 5.79 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.031 -1.043 . . . . 1.0 110.465 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -82.07 169.23 16.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.326 -0.859 . . . . 1.0 110.245 -179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 24.2 pt . . . . . 0 N--CA 1.49 1.546 0 CA-C-O 118.018 -0.991 . . . . 1.0 110.216 179.958 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' THR . . . . . 0.513 HG23 ' N ' ' A' ' 2' ' ' ALA . 12.9 t . . . . . 0 N--CA 1.495 1.804 0 CA-C-O 120.875 0.369 . . . . 1.0 110.938 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' N ' HG23 ' A' ' 1' ' ' THR . . . -152.88 30.38 0.5 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.875 -1.141 . . . . 1.0 110.211 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -117.06 -18.93 5.35 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.927 -1.269 . . . . 1.0 109.927 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 8.0 mttm -73.18 -172.46 1.1 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.152 -1.205 . . . . 1.0 110.347 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.8 mp -127.98 152.88 36.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.319 -0.863 . . . . 1.0 109.558 179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 -120.4 179.84 4.18 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.17 -0.956 . . . . 1.0 110.409 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ARG . . . . . 0.409 ' HA ' ' HA ' ' A' ' 27' ' ' ALA . 21.4 ttp85 -160.46 155.4 24.34 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.344 -0.847 . . . . 1.0 110.377 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -106.88 149.3 27.58 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.263 -0.898 . . . . 1.0 110.029 179.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.473 ' O ' ' CD1' ' A' ' 10' ' ' TYR . 22.7 mtm -139.81 28.75 2.14 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 1.0 110.389 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TYR . . . . . 0.473 ' CD1' ' O ' ' A' ' 9' ' ' MET . 42.4 m-85 -150.22 109.86 4.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 1.0 110.609 -179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.21 133.88 49.42 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.153 -0.967 . . . . 1.0 109.45 179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TYR . . . . . 0.431 ' HB3' ' HB2' ' A' ' 22' ' ' PHE . 19.3 t80 -147.24 137.39 23.24 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.946 -1.096 . . . . 1.0 111.229 -179.757 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' MET . . . . . . . . . . . . . 48.2 ttp -102.74 103.9 14.17 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.715 -0.846 . . . . 1.0 108.715 178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.554 ' HB2' ' C ' ' A' ' 20' ' ' VAL . . . -45.59 115.39 0.94 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.473 -0.767 . . . . 1.0 111.356 -179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.77 -48.6 45.59 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.346 -0.846 . . . . 1.0 109.586 179.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -109.48 150.1 28.63 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.373 -0.829 . . . . 1.0 109.664 179.454 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -51.16 -28.37 10.91 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.131 -0.981 . . . . 1.0 110.509 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' A' ' 51' ' ' MET . 0.2 OUTLIER -62.3 -35.6 79.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.294 -0.879 . . . . 1.0 110.366 179.926 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.4 ' N ' ' CD ' ' A' ' 19' ' ' GLU . 4.7 mp0 -84.75 172.14 11.74 Favored 'General case' 0 N--CA 1.499 1.99 0 O-C-N 121.261 -0.899 . . . . 1.0 110.724 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 52' ' ' LEU . 13.5 m -120.94 169.12 12.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.359 -0.838 . . . . 1.0 110.032 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.6 t -103.49 126.02 50.4 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.184 -0.948 . . . . 1.0 110.208 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.462 ' CZ ' ' HD2' ' A' ' 53' ' ' PRO . 5.4 m-85 -84.36 167.1 16.83 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.19 -0.944 . . . . 1.0 110.493 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.422 ' O ' ' N ' ' A' ' 25' ' ' GLY . 1.8 tptt -152.93 122.09 6.62 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.256 -1.387 . . . . 1.0 107.256 179.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASP . . . . . 0.415 ' N ' ' HD2' ' A' ' 23' ' ' LYS . 20.4 t0 -46.73 94.64 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.246 -0.909 . . . . 1.0 111.035 -179.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . 120.65 31.08 1.28 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.84 -1.304 . . . . 1.0 109.84 179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -105.75 172.82 6.59 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.142 -1.211 . . . . 1.0 110.065 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.409 ' HA ' ' HA ' ' A' ' 7' ' ' ARG . . . -148.1 155.85 41.93 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 1.0 110.194 179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ILE . . . . . . . . . . . . . 31.6 mm -120.12 135.86 59.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 1.0 110.031 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.619 HG13 HG23 ' A' ' 31' ' ' VAL . 2.0 pt -69.07 -152.77 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.28 -0.888 . . . . 1.0 110.328 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASN . . . . . . . . . . . . . 84.7 m-20 -105.0 82.14 1.82 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.28 -0.888 . . . . 1.0 110.469 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.632 HG11 ' HA2' ' A' ' 41' ' ' GLY . 75.3 t -100.98 -83.49 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.299 -0.875 . . . . 1.0 110.39 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -167.32 149.31 5.88 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.103 -0.998 . . . . 1.0 109.945 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.449 ' O ' ' N ' ' A' ' 35' ' ' ASP . . . -165.92 -166.59 0.95 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.203 -0.936 . . . . 1.0 110.388 -179.797 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.439 ' HB ' ' O ' ' A' ' 33' ' ' ALA . 26.5 mt 65.96 -60.63 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.945 0 O-C-N 121.856 -0.528 . . . . 1.0 110.658 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.449 ' N ' ' O ' ' A' ' 33' ' ' ALA . 5.8 t70 -56.09 171.49 0.25 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.098 -1.001 . . . . 1.0 109.975 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 54.25 -168.8 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.196 -0.94 . . . . 1.0 110.174 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -96.46 -25.81 11.73 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.561 -1.416 . . . . 1.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TRP . . . . . . . . . . . . . 4.5 m95 -117.38 162.98 17.05 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.231 -1.158 . . . . 1.0 110.401 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' MET . . . . . 0.44 ' HG3' ' HB2' ' A' ' 33' ' ' ALA . 22.7 ttt -90.53 169.65 10.85 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.356 -0.84 . . . . 1.0 109.648 179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.5 t80 -145.91 136.17 23.86 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.125 -0.985 . . . . 1.0 110.246 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.632 ' HA2' HG11 ' A' ' 31' ' ' VAL . . . -177.23 -177.04 45.82 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.514 -1.435 . . . . 1.0 109.514 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 47' ' ' GLY . 94.8 m -113.8 137.18 52.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.27 -1.135 . . . . 1.0 110.346 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.431 HG12 ' H ' ' A' ' 45' ' ' ARG . 18.8 t -70.29 129.92 34.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.947 . . . . 1.0 109.511 179.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -79.73 -14.21 58.9 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.276 -0.89 . . . . 1.0 110.986 -179.341 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.431 ' H ' HG12 ' A' ' 43' ' ' VAL . 3.5 ttt85 -86.92 -38.49 16.65 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.992 -1.068 . . . . 1.0 110.567 -179.647 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.1 p -110.71 -43.79 3.77 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.233 -0.917 . . . . 1.0 110.164 -179.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.468 ' O ' HG23 ' A' ' 42' ' ' THR . . . 112.81 -16.97 23.13 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.854 -1.299 . . . . 1.0 109.854 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 31.4 mtt180 -59.66 139.88 56.86 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.049 -1.265 . . . . 1.0 110.348 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' THR . . . . . . . . . . . . . 99.0 m -117.39 129.87 56.13 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.262 -0.899 . . . . 1.0 110.031 179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' N ' ' CG1' ' A' ' 20' ' ' VAL . . . -159.7 -158.72 9.31 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.974 -1.251 . . . . 1.0 109.974 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.709 ' C ' HD12 ' A' ' 52' ' ' LEU . 5.0 mmt -87.2 147.32 25.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.403 -1.057 . . . . 1.0 110.415 -179.804 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.709 HD12 ' C ' ' A' ' 51' ' ' MET . 8.3 mp -126.9 132.42 24.31 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.534 -0.729 . . . . 1.0 109.98 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HD2' ' CZ ' ' A' ' 22' ' ' PHE . 43.4 Cg_endo -71.85 116.52 4.73 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.383 1.202 . . . . 1.0 110.265 179.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -57.74 -26.75 62.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.413 -0.804 . . . . 1.0 111.065 -179.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -71.06 -5.42 31.28 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.099 -1.001 . . . . 1.0 110.854 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.448 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 2.3 m-30 -106.2 -66.99 0.96 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.007 -1.058 . . . . 1.0 110.23 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 17.7 m -73.52 168.49 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.589 -0.694 . . . . 1.0 110.68 -179.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -170.3 161.26 8.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.376 -0.828 . . . . 1.0 109.956 179.772 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -70.73 148.09 48.34 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.153 -0.967 . . . . 1.0 110.349 -179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 pt . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 117.951 -1.024 . . . . 1.0 110.103 -179.994 . . . . . . . . 0 0 . 1 stop_ save_